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Zusammenfassung
Zelluläre Variabilität entspricht der physiologischen Realität aber bleibt in Mod-
ellen üblicherweise unbeachtet. Im Rahmen der Doktorarbeit wurde eine neue
Vorgehensweise entwickelt, biochemische Signaltransduktionsnetzwerke in sich ver-
schiedenartig verhaltenden Zellen durch zelluläre Ensemble-Modelle zu beschreiben.
Zelluläre Ensemble-Modelle enthalten Netzwerke gekoppelter gewöhnlicher Differ-
entialgleichungen zur Beschreibung der Trajektorien von Proteinkonzentrationen in
verschiedenen Zellen, welche durch bestimmte Randbedingungen gekoppelt sind, um
den Bezug zu physiologischen Gegebenheiten zu gewährleisten. Durch die Beschrei-
bung experimenteller Einzelzell- und Populationsdaten im selben Modell konnte
die Modelldiskrimination erleichtert und die Genauigkeit der Parameterschätzung
verbessert werden.
Die Vorgehensweise wurde in zwei biochemischen Systemen, dem programmierten
Zelltod und dem intrazellulären Transport von Erythropoietinrezeptoren, angewandt.
Eine experimentelle Technik wurde entwickelt, um die Aktivität des Enzyms Caspase-
8, welches den Zelltod initiiert, in einzelnen Zellen zu quantifizieren. Die ana-
lytische Lösung eines Modells zur Oligomerisation von Zelltodrezeptoren wurde
mit einem zellulären Ensemble-Modell der Caspase-8 Aktivierung verknüpft. Ein
Aktivierungsmechanismus, welcher positives Feedback impliziert, konnte vorherge-
sagt und experimentell bestätigt werden. Vorhergesagte multivariate logarithmis-
che Normalverteilungen initialer Proteinkonzentrationen ermöglichten Simulationen,
um funktionelle Rollen involvierter Signaltransduktionsproteine zu analysieren. In
ähnlicher Weise konnte durch ein zelluläres Ensemble-Modell die Variabilität der in-
trazellulären Transportkinetik von Erythropoietinrezeptoren charakterisiert werden.
Die neue Vorgehensweise kann zur Optimierung therapeutischer Anwendungen
beitragen, die auf eine heterogene Population von Krebszellen gerichtet sind.
Summary
Cellular variability is fundamental to physiological reality but usually unattended
in signaling models. This thesis introduces the new approach of cell ensemble models,
which describe biochemical signal transduction networks in heterogeneously behav-
ing cells. Cell ensemble models comprise sets of coupled ordinary differential equa-
tions describing protein concentration trajectories in different cells, which are linked
by boundary conditions restricting models to physiological limitations. Simultane-
ous description of single-cell and population data facilitated model discrimination
and improved the accuracy of parameter estimations.
The approach was applied in two biochemical systems, programmed cell death
and the intracellular traffic of erythropoietin receptors. An experimental method
was developed to quantify the enzymatic activity of caspase-8, which initializes
programmed cell death, in single cells. The analytic solution of a death receptor
oligomerization model was combined with cell ensemble models of caspase-8 activa-
tion. An activation mechanism, which implies positive feedback, was predicted and
experimentally validated. Simulations based on estimated multivariate log-normal
distributions of initial cellular protein concentrations clarified the functional roles
of involved signaling proteins. In a similar manner, a cell ensemble model was ap-
plied to characterize cell-to-cell variability in intracellular erythropoietin receptor
transport.
The new approach might support optimization of therapeutic applications target-
ing heterogeneous populations of cancer cells.
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1. General Introduction
In this thesis, mathematical models of programmed cell death initiation and intra-
cellular erythropoietin receptor transport were studied. This chapter outlines basic
principles of these systems, and gives an overview of different modeling approaches
and successful applications of ODE models of apoptosis (sections 1.1 and 1.2) and
of Erythropoietin signaling (sections 1.3 and 1.4). This section contains parts of two
book chapters by Kallenberger et al. in ’Systems Biology of Apoptosis’ [1] and in
’Computational Systems Biology’ [2].
1.1. Biochemical basics of apoptosis
Apoptosis is an intensively regulated signal transduction process leading to self-
destruction of cells. While apoptosis is essential for embryogenesis and regulation of
the immune system, its dysregulation can be the cause for cancer, immune system dis-
eases and neurodegenerative disorders [3]. Two signaling cascades initiate apoptosis,
namely extrinsic and intrinsic apoptosis, which combine in a common final path. Ex-
trinsic apoptosis is initiated by cell death ligands binding to their specific receptors.
Important members of the death receptor (DR) family that belongs to the TNF-R
superfamily are the receptors TNFR1 (DR1), CD95 (DR2, Fas, APO-1) and DR 4/5
(TRAILR1/2), which specifically initiate extrinsic cell death [4]. Upon ligand bind-
ing to death receptors, death inducing signaling complexes (DISCs) are formed that
serve as a platform for the activation of caspase-8 and -10 [5–7]. Caspase enzymes
are aspartate-specific cysteine proteases and act as main executioners of apoptosis
by cleaving specific target proteins [8]. The initiator caspases caspase-8 and -10
cleave and activate effector caspases-3 and -7 as well as the pro-apoptotic Bcl-2
family member Bid to tBid, which leads to mitochondria outer membrane permeabi-
lization (MOMP) after stimulating pore formation by the proteins Bax or Bak [9,10].
MOMP irreversibly triggers activation of effector caspases: the pro-apoptotic pro-
teins Smac and cytochrome c are released from mitochondria. Together with the
cytosolic protein Apaf-1, cytochrome c forms apoptosomes, serving as platform for
the activation of procaspase-9 which then cleaves and activates effector caspases,
while Smac blocks the inhibition of caspase-9 and effector caspases by XIAP [11–17].
Active effector caspases cleave a variety of proteins including components of the
cytoskeleton, and cause activation of the nuclease CAD (caspase-activated DNase)
thus leading to chromosome fragmentation [8,18]. Dependent on the requirement of
effector caspases activation, two types of extrinsic apoptosis are distinguished: In
type I cells initiator caspases are sufficiently active to directly activate effector cas-
pases. In type II cells, amplification of the cell death signal through Bid cleavage and
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MOMP is required for undergoing apoptosis [19, 20]. Intrinsic apoptosis is directly
initiated at the level of mitochondria. Different influences such as cellular stress,
accumulation of reactive oxygen species (ROS) or DNA damage change the ratios
between pro- and anti-apoptotic Bcl-2 family member proteins which leads to pore
formation and MOMP, again leading to apoptosome formation and the activation
of caspase-3 and -7 [21,22].
Even though individual steps of the apoptotic signal transduction cascades are
well understood, we lack insights into the system properties and the dynamics of
the death decision. Questions to be addressed in apoptosis by systems biology
approaches include:
(i) How do cells ensure that apoptosis robustly occurs in all-or-none man-
ner? What is the "point-of-no-return" representing irreversibility in apop-
tosis? Which signaling motifs are responsible for such digital and context-
specific behavior?
(ii) How is specificity in the apoptosis vs. survival responses ensured? A
topic of particular interest for apoptosis modeling is that apoptotic stim-
uli trigger survival or death signaling depending on initial conditions and
the stimulus strength. At least in some cases, the inhibitory crosstalk be-
tween survival and cell death signaling pathways appears to be mutually
exclusive at the single-cell level [23], implying that death and survival
represent different attractor states for the cell.
(iii) What are the principles underlying cell-to-cell variability in the apopto-
sis response of a cell population? Why do cell types differ widely in their
sensitivity to death-inducing stimuli? Currently, several new therapeu-
tic agents are tested to stimulate apoptosis in cancer cells, to decelerate
tumor growth, or to prevent cells, preferentially neurons or cardiomy-
ocytes, from undergoing programmed cell death. Modeling approaches
could help to plan therapies and to predict the outcome on a population
of cells.
(iv) How can models be used to predict the responsiveness of cancer cell pop-
ulations towards cancer therapy? Starting from a certain model topology
and measured numbers of pro- or anti-apoptotic signaling species, predic-
tions of cell fates resulting from concentration trajectories at given input
stimulus, represented e.g. by a drug concentration, can be obtained.
1.2. Mathematical models of apoptosis
1.2.1. Overview of formalisms applied in apoptosis models
Analyzing the cell on a systems view can be done by top-down and bottom-up
approaches. Detailed mechanistic mathematical models constructed from the molec-
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ular characteristics of individual proteins (“bottom-up models”) have so far only
been developed for metabolic and signaling networks. In contrast, transcriptional
regulatory networks, and the link between signaling networks and ultimate cellular
decisions are best tackled by statistical methods which integrate huge amounts of
data but are mostly phenomenological (“top-down modeling”).
Top-down approaches examine the cell on a global level, treating individual regu-
latory modules as black boxes that are not analyzed mechanistically but only char-
acterized with respect to input-output behavior. Thus, top-down methods typically
do not require much prior knowledge about the system, so that many signaling
and/or metabolic pathways can be studied at once. Most top-down approaches are
solely data-driven and rely on high throughput screens of cellular behavior (gene
expression profiling, proteomics, siRNA screening, sequencing, and affinity assays).
Typically, the ultimate goal of top-down approaches is to identify biologically rele-
vant patterns and correlations to the data (e.g. disease marker gene identification)
or to predict new molecular interactions (e.g. reverse engineering algorithms).
Bottom-up approaches focus on well-characterized parts of the biochemical regula-
tory network, and are typically based on the assumption that the properties of these
subnetworks (or “modules”) can be studied in isolation. Based on prior knowledge
and on time-resolved experimental data, mechanistic mathematical models describ-
ing the interactions of individual proteins in the module are constructed (e.g. by
using sets of coupled differential equations). The goal of bottom-up modeling is
to identify physiologically relevant systems-level properties emerging from complex
interactions within the network (e.g. feedback).
Apoptosis-inducing signaling cascades, especially those induced by death ligands,
were mainly studied using bottom-up modeling approaches, since: (i) the molecular
events are well characterized; (ii) transcriptional events can be neglected; (iii) the
ultimate death decision often closely correlates with all-or-none activation of effec-
tor caspases, implying that statistical methods are not required to link signaling
to cellular phenotypes. However, bottom-up approaches to apoptosis are diverse
and the methodology of choice depends on the complexity of the signaling network
under study, the available experimental data, and the question to be addressed by
modeling. Boolean approaches are typically employed to qualitatively analyze the
(quasi-)static behavior of large apoptosis-survival crosstalk networks which comprise
many molecular species. Ordinary differential equation (ODE) models allow for the
quantitative description of network dynamics but typically require knowledge about
many kinetic parameters which either limits the network size and/or requires huge
amounts of experimental data. Standard ODE modeling may even not be sufficient
if spatiotemporally resolved single-cell data is available: (i) spatial gradients within
the cell can be modeled using subcellular compartment ODE models or partial dif-
ferential equations (PDEs). (ii) Cell-to-cell variability may arise due to stochastic
dynamics of the apoptotic signaling cascade (’intrinsic noise’) or due to cell-to-cell
variability in the expression of pathway components (’extrinsic noise’). While ODE
models with randomly sampled initial protein concentrations can be employed to
simulate extrinsic noise, stochastic simulation algorithms are required to understand
3
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intrinsic noise. In the following, an overview of top-down and bottom-up modeling
approaches is given that were applied to apoptosis signaling, before discussing ap-
plications of ODE models in more detail.
Linear regression models
To systematically analyze how the pro- and anti-apoptotic cytokines TNF, EGF
and insulin impinge on the cellular apoptosis decision, Janes et al. [24] generated a
compendium of co-stimulation measurements. Based on the assumption that sim-
ple linear combinations of signaling activity profiles account for apoptosis initiation,
they employed a top-down modeling approach known as partial least-squares regres-
sion (PLSR) which does not require prior knowledge. PLS modeling calculates super
axes as an orthogonal set of ”principal components”, which contain linear combina-
tions of the original signaling protein activities weighted by their contribution to the
apoptotic outputs. Thereby, the dimension of the data matrix is reduced to a small
set of informative super axes, which can be used to predict apoptosis initiation for
any experimental condition provided that measurements of signaling species used
for model training are available. PLSR has been successfully applied to large-scale
apoptosis datasets, and provided insights into complex phenomena such as autocrine
amplification loops [24] or cytokine-modulated inter-relationships between different
signaling pathways following DNA damage [25]. A major drawback of PLSR is the
lack of mechanistic insights into (i) how signaling activity patterns are generated
and (ii) how signaling activities are integrated, e.g., at the level of caspases, to con-
trol the death decision. Therefore, the next section will be devoted to bottom-up
approaches applied to apoptosis which take into account mechanisms of apoptosis
initiation.
Boolean models
Recent biomedical research revealed a plethora of protein-protein and enzymatic
interactions, and thus extensively characterized the topology of the intracellular
signaling network. However, quantitative information characterizing the affinity of
protein-protein interactions or enzyme kinetic parameters is still scarce. Moreover,
quantitative characterization is often performed using recombinant proteins in vitro,
with questionable relevance to the in vivo situation. Simulations of large-scale net-
works is therefore often performed using Boolean or logic modeling, a qualitative
approach that is based on network topology, but does not take into account quan-
titative features of individual reactions. Instead protein activities are represented
by nodes which can either be on or off (activity 0 or 1), depending on the activities
of upstream input nodes. Logic rules are applied at each iteration: For example,
in a so-called AND-gate, the node Z will be activated if and only if both input
nodes X and Y are active. In contrast, an OR-gate simply requires either X or
Y to be active. Thus, Boolean rules can be used to qualitatively represent real
biochemical mechanisms such as functional redundancy (OR-gate) or coincidence
detection (AND-gate), the latter, arising from sequential processing by two distinct
4
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enzymes. Since logical rules are applied iteratively, the approach can be used to
study temporal phenomena such as adaptation. Moreover, Boolean networks can
exhibit nonlinear dynamic phenomena such as oscillations, and stable vs. unstable
attractors.
A number of Boolean modeling studies have been presented in the context of
apoptosis [26–30]. All these studies analyzed the crosstalk of apoptosis signaling via
caspases and survival pathways such as NF-êB signaling. The main goal was the
identification of stable states in the systems, representing cell fates such as apop-
tosis, necrosis, and survival. Calzone et al. [26] and Mai and Liu [27] focused on
signaling upon death receptor engagement. They showed that the stable states of
the apoptosis network are robust and investigated the requirements for irreversibil-
ity in the apoptosis decision. Schlatter et al. [29] and Philippi et al. [28] took into
account co-stimulation with pro-death and pro-survival ligands, and experimentally
confirmed key model predictions. Zhang et al. [30] analyzed antigen-induced sur-
vival signaling network in T cell large granular lymphocyte (T-LGL) leukemia cells
including transcriptional induction of cytokines and autocrine stimulation events.
Model predictions could be confirmed in leukemic cells isolated from patients, thus
contributing to our understanding of signaling deregulation in the disease. Taken
together, Boolean modeling approaches provided valuable insights into apoptosis at
multiple timescales and for various experimental settings.
Quantitative modeling approaches
Although helpful to understand principles of network topologies, Boolean models
are inherently limited in their capability of quantitatively describing the temporal
dynamics of biochemical networks. In the context of perturbation analysis, Boolean
approaches are restricted to the simulation of complete elimination of network nodes
and/or reactions; thus, gradual phenomena such as dosage compensation cannot be
studied. Moreover, the qualitative effects of perturbations as revealed by Boolean
modeling are often intuitively clear. Thus, in many cases, nontrivial and experimen-
tally testable predictions require quantitative modeling approaches such as ODE
and PDE modeling, as well as stochastic simulations.
An ODE model comprises a network of coupled rate equations for every involved
signaling species. The kinetics of each involved reaction is described with reaction
rates dependent on the concentrations of educts and products. Specifically, one typ-
ically assumes that the number of product molecules synthesized in a certain time
interval is linearly dependent on the concentrations of educt molecules (law of mass
action). The net influx or eﬄux arising from all participating reactions determines
the rate of change in each molecular species. Thus, ODE modeling is based on the
assumption that the temporal derivatives of molecule concentrations equal the sum
of all relevant reaction rates. Larger biochemical signal transduction networks are
therefore reflected using coupled ODEs (for further details see section 2.3). ODE ap-
proaches assume that large numbers of signaling molecules are present within the cell,
so that random fluctuations in reaction events can be neglected by averaging over the
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whole molecule population. Moreover, in ODE modeling it is assumed that the cell
represents a well-stirred reactor, implying that diffusion effects do not matter and
that special gradients, which are described in PDEs, can be neglected. In apoptosis
networks, these assumptions are likely to be fulfilled, as caspases and their regula-
tors are typically expressed at the number of several hundred thousand molecules
per cell [31]. Furthermore, the time scale of apoptosis induction (hours) is slow
relative to the time scale of protein diffusion within a cell (milliseconds to seconds);
therefore, spatial gradients of apoptosis signaling molecules are unlikely to play a
decisive role in apoptosis initiation. Nonetheless, reaction-diffusion models allowed
investigating molecular mechanisms of apoptosis induction: Using live-cell imaging
with high temporal resolution, Rehm and colleagues observed that cytochrome c
release from mitochondria during apoptosis occurs in spatial waves that propagate
from a subcellular mitochondrial pool to the remainder of the mitochondrial popula-
tion [32]. Partial differential equation (PDE) modeling was employed to investigate
the dynamics of non-steady state diffusion. This approach revealed that localized
release and diffusion of inducers of mitochondrial outer membrane permeabilization
(MOMP) alone was insufficient to explain the data. However, then the authors took
into account that MOMP inducers bind to mitochondria, and modeling indicated
that this absorption shapes the dynamics of cytochrome c release, thus providing
insights into molecular mechanisms controlling apoptosis induction.
Owing to low molecule numbers of Bcl-2 family members, stochastic simulations
using cellular automaton approaches were performed by Chen et al. [33], Siehs et
al. [34], and Düssmann et al. [35] to describe the dynamics of mitochondrial outer
membrane permeabilization (MOMP). Chen et al. [33] focused on bistability and
concluded that the stochastic system attained two distinct stable states much like
the deterministic case; thus robustness of switching towards molecular noise could be
confirmed. Düssmann et al. [35] compared their model to measurements in cells ex-
pressing Bax-FRET probes monitoring Bax oligomerization. Their model could pro-
vide an explanation for pore formation upon Bax accumulation and oligomerization
in the outer mitochondria membrane. A further study making use of cellular automa-
ton approaches explained the stoichiometry of DISC components that was observed
in mass spectrometry experiments [36]. These experiments showed that in immuno-
precipitates of DISCs, the number of procaspase-8 and c-FLIP molecules exceeds the
number of FADD molecules several-fold, suggesting that chains of procaspase-8 and
c-FLIP are formed on DISC-bound FADD molecules. A cellular automaton model
was used to reproduce the observed protein ratios, and to test further hypotheses on
chain lengths and chain formation kinetics. This approach facilitated handling the
large combinatorial complexity arising from possible compositions of larger protein
chains of FADD, c-FLIP and procaspase-8, in comparison to an ODE model that
would require a large number of equations for each possible oligomer state.
Live cell imaging tools are increasingly important and allow the analysis of apop-
tosis at the single cell level or even with subcellular resolution. Thus, stochastic
and reaction-diffusion modeling are likely to become central to apoptosis model-
ing. For example, death receptors are frequently expressed at low levels and form
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localized (nano-) clusters on the cell membrane [37], implying that deterministic
ODE approaches will fail, especially upon weak stimulation. Stochastic and reaction-
diffusion modeling will reveal underlying mechanisms and, more importantly, predict
strategies for intervention for testing the functional relevance of such phenomena.
1.2.2. Mechanistic ODE models describing apoptosis networks
The first mechanistic apoptosis model of coupled differential equations, presented
by Fussenegger et al. [38], described sequential activation of caspase-8, caspase-9
and caspase-3 by intrinsic or extrinsic stimuli. The model accounted for a positive
feedback from caspase-3 promoting the release of cytochrome c from mitochondria
and thus promoting the additional activation of caspase-9 in apoptosomes. As this
model was not trained against quantitative data, it provided only predictions on
activated fractions of initiator and executioner caspases dependent on initial concen-
trations of apoptosis promoting or inhibiting proteins. A lot of progress has been
made since this first apoptosis model, and different aspects have been studied in
detail.
In the following, current literature on ODE-based apoptosis modeling will be
reviewed. Figure 1.1 shows an overview about subareas of the apoptotic signaling
network that were investigated by current models. First, models, which understand
apoptosis as a bistable process, will be described. Second, studies investigating
the temporal dynamics of apoptosis will be summarized. Third, crosstalk models
describing apoptosis and survival networks will be discussed. The final focus of this
review part will be cell-to-cell variability.
Origins of a robust all-or-none behavior - models characterized by bistability and
feedback mechanisms Bistability may play an important role for all-or-none and
irreversible decision making, thus allowing the suppression of noise and prevention
from accidental apoptotic stimuli. In the following, models will be reviewed that
exhibit bistability due to positive feedback in the intrinsic or extrinsic apoptosis
pathways.
Extrinsic apoptosis pathway Understanding bistability in the process of apoptosis
initiation was the focus of the study of Eissing et al. [45]. Their model described
the bistability in extrinsic apoptosis within the context of caspase-mediated pos-
itive feedback. Caspase-8 activated by receptor-induced apoptosis in type I cells
activates caspase-3, while caspase-3 promotes positive feedback by caspase-8 activa-
tion. A stability analysis showed, which kinetic parameter values allowed bistability,
and therefore a stable steady state for survival. It could be shown that bistability
was only possible at parameter values far off the experimentally measured kinetic
parameters. By extending the model topology, the authors concluded that bistable
caspase activation within the physiologically reasonable parameter range required
the consideration of inhibitors of activated caspase-8. Specifically, it was suggested
that caspase-8 inhibitory proteins such as the bifunctional apoptosis regulator pro-
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Figure 1.1. Overview of the extrinsic and intrinsic parts of the apoptotic signaling
network. Subareas are indicated that were investigated by current modeling studies.
(a) Modeling studies that captured extrinsic and intrinsic pathways [38–44]. (b) Mod-
eling studies with main focus on the level of death receptors, DISC assembly and
caspase activation processes [45–50]. (c) Modeling studies that described interactions
between members of the Bcl-2 family prior to mitochondria outer membrane perme-
abilization (MOMP) [33–35,51–53]. (d) Modeling studies with main focus on intrinsic
apoptosis and caspase inhibition [54–58].
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tein (BAR) [59], and caspase-8 and -10-associated RING proteins (CARPs) [60] play
a central role for establishing bistability.
Bistability on the ligand/receptor level was proposed upon theoretical considera-
tions of a positive feedback in receptor oligomerization reactions [47]. These were
motivated by new insights into the structure and function of CD95 (APO-1/Fas)
molecules [61]. Protein crystallization experiments on receptor/FADD-clusters had
shown that receptors in the absence of ligands favor a closed form where FADD
cannot bind. Upon ligand binding an open form is favored, allowing FADD binding,
DISC formation and signal progression. The conformation of open receptors leads
to the mutual stabilization of the receptors in their open state, which may cause
receptor oligomerization and positive feedback amplification. An ODE model was
formulated in a continuum approximation where molecule numbers were treated as
local protein concentrations [47]. At high receptor densities, which could be poten-
tially induced locally inside lipid rafts, reactions can take place where several open
receptors stabilize each other. In the model these events could be approximated by
higher order reactions. Rate equations for reactions that contain terms with an order
of three or larger can have two stable steady states and one unstable steady state in
between, which causes bistable behavior. Therefore, depending on the local receptor
densities, reversible or irreversible bistability can result. This leads to an all-or-none
response on the level of DISCs, resulting in a gradual response, integrated over all
clusters on the cell level.
Intrinsic apoptosis pathway The theoretical study by Bagci et al. [40] addressed
origins of bistability on the level of mitochondrial outer membrane permeabilization
(MOMP) and apoptosome formation. Two positive feedback mechanisms contribute
to bistability: First, caspase-3 cleaves and inactivates the MOMP inhibitor Bcl-2,
and thereby amplifies its own production. A second feedback arises from the cleav-
age of the MOMP inducer Bid by caspase-3; thus Bid cleavage, initially triggered
by caspase-8, can be enhanced by caspase-3. Their mass-action model describes
oligomerization of Apaf-1 bound to cytochrome c to the heptameric complexes of
apoptosomes. As this cooperative oligomerization process leads to higher order
terms in the corresponding rate equation, the positive feedback interactions can re-
sult in bistable regimes corresponding to either survival or apoptosis. As the model
of Bagci et al. [40] does not consider reactions upstream of initiator caspases, ini-
tial doses of caspase-8 and caspase-3 serve as stimulus. Their considerations were
motivated by experimental studies that had shown a survival mechanism of cancer
cells based on elevated Bax degradation [62], decreased Bax expression in human
breast cancers [63] or overexpression of Bcl-2 [64]. In the model of Bagci et al.,
bifurcation points in the caspase-3 activity were investigated, that are dependent
on the production or degradation of Bax and their relation to inhibitory Bcl-2 pro-
teins. Above a certain threshold for the degradation rate of Bax or below a certain
threshold for the Bax production rate, the bistable behavior is changed into a monos-
table survival state. In this state an initiator caspase stimulus cannot trigger the
apoptosome-mediated feedback anymore.
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Current studies on Bcl-2 family members show even more complicated relations
on the level of mitochondria among proteins that act as sensitizers (as Bad, Noxa or
Puma), activators (Bid, Bim) or effectors (Bax, Bak). To characterize the vulnera-
bility of tumors to apoptosis effectors, the impacts of different Bcl-2 family members
on mitochondria isolated from tumor samples were investigated [65, 66]. For more
detailed reviews see [67–69].
Recently, models of intrinsic cell death were applied to predict the responsiveness
of patient tumors to chemotherapies [53, 70, 71]. Two studies applied a model de-
scribing activation of caspase-9 and caspase-3 after MOMP, cytochrome c and Smac
release and inhibition of XIAP, which was originally developed based on experiments
in common lab cell lines [55]. Measurements of Apaf-1, XIAP, Smac, procaspase-3
and -9 levels in patient tumor samples of colorectal cancers [70] and glioblastoma
multiforme brain tumors [71] were used as initial concentrations for model simula-
tions. In the study on colon cancer samples, model simulations were used to predict if
effector caspases activity could be effectively evoked by applying chemotherapy, and
model predictions were significantly correlated with observed clinical outcomes [70].
Similarly, the study on brain tumor samples showed that model simulations were cor-
related with progression free survival durations in patients [71]. A model describing
interactions between pro- and anti-apoptotic Bcl-2 family members was developed
by Lindner et al. to predict responses of colon cancers to chemotherapy with 5-FU
and oxaliplatin, based on the quantification of Bak, Bax, Bcl-2, Bcl-xL and Mcl-1
in tumor samples compared to normal tissue [53]. Similar to the study focused on
signaling species downstream of MOMP, knowledge of Bcl-2 family member levels
facilitated model predictions of responses to chemotherapy that were highly corre-
lated with observed clinical outcomes. Furthermore, their model enabled predictions,
which patients may be successfully co-treated with BH3-mimetic drugs as ABT-263,
ABT-737 or ApoG2 that mimic natural inhibitors of anti-apoptotic Bcl-2 family
members [72].
Taken together, models of intrinsic cell death could successfully reveal mecha-
nisms of interactions between pro- and anti-apoptotic Bcl-2 family members and
show promising results with regard to chemotherapy optimization.
Implicit feedback mechanisms in the intrinsic apoptosis pathway In the mod-
eling studies summarized so far, the positive feedback mechanisms known from the
biomedical literature and their contribution to bistability were analyzed. Addition-
ally, mathematical modeling can provide valuable insights into non-obvious, hidden
feedback loops that arise from the topology of the apoptosis network. This phe-
nomenon has been referred to as implicit positive feedback regulation. The interplay
of caspase-3, caspase-9 and inhibitors of apoptosis (IAPs) in the mitochondrial pro-
apoptotic pathway was investigated in a model by Legewie et al. [54]: Cytochrome
c released from mitochondria, triggers activation of caspase-9, which in turn cleaves
procaspase-3 into active caspase-3. Both caspase-3 and caspase-9 are inhibited by
XIAPs to prevent auto-reactive activation. Interestingly, an implicit positive feed-
back loop arises from the dual inhibition of both caspases by XIAPs: Once active
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caspase-3 is generated, it can bind to XIAPs, thus sequestering XIAPs away from
caspase-9. This sequestration effect enhances caspase-9 activation, resulting in auto-
amplification of caspase-3 cleavage. In the model by Legewie et al., the dependency
of the concentration of active caspase-3 as the response to an Apaf-1 concentration
shows different characteristics of either monostable, bistable reversible or bistable
irreversible behavior. The authors concluded that implicit positive feedback alone
brings a very small range of bistability; however, implicit feedback synergizes with
other feedback mechanisms to establish a broad bistable range and irreversibility in
the life-death decision.
The studies of Chen et al. [33, 51] combined ODE, stochastic and cellular au-
tomaton modeling to further understand signaling processes that potentially lead
to MOMP. In these studies interactions between pore forming effectors (Bax, Bak),
activators and enablers (tBid and several others), and inhibitors (Bcl-2 amongst
others) that lead to or prevent mitochondria outer membrane permeabilization are
analyzed. After translocation to mitochondria, inactive Bax and Bak are catalyzed
to their active form by an activator. Subsequently, activated Bax and Bak lead to
membrane pore formation and cell death. In the study of Cui et al. [52] models in-
volved in the bistability of MOMP were further developed. Questions on the possible
model topology led to hierarchical considerations in the studies of Chen et al. [33,51]
as well as Cui et al. [52]: Do activators and enablers indirectly induce apoptosis by
sequestering Bcl-2 away from Bax, or are activators directly pro-apoptotic by cat-
alyzing the reaction of Bax to its active form that can cause pore formation and
cytochrome c release? This question led to an indirect model recapturing the inhibi-
tion of Bcl-2 by activators and topologies describing direct Bax activation. Inhibitors
as Bcl-2 in the indirect topology interfere by inhibiting Bax and thereby preventing
its oligomerization at the pores. In direct topologies they inhibit activators from cat-
alyzing Bax activation. Direct topologies were favored in this study, as they involve
two possible feedback mechanisms that could contribute to a bistability in Bax ac-
tivation. These considerations were motivated by experimental studies that showed
a bimodal distribution of cells that had low or high amounts of activated Bax and
Bak monitored by flow cytometry [73–75]. The first described feedback mechanism
is facilitated by activated Bax that can sequester Bcl-2, leading to an increase of
free activators and thereby providing increased Bax activation. This mechanism is
similar to the role of XIAP as discussed in the study of Legewie et al. [54], since
Bcl-2 acts as a dual inhibitor of upstream activators and their downstream effector
Bax. Furthermore, the model of Cui et al. [52] considers a feedback mechanism, in
which activated Bax itself provides further Bax activation. In their study the signal
response behavior is characterized by the dependency of active Bax and Bcl-2 steady
state levels as dependent on the production rate of activators. In a model contain-
ing both feedback mechanisms the interval of activator production rates that lead to
bistability of active Bax and Bcl-2 concentrations is significantly enlarged compared
to a variant with only one feedback mechanism. Therefore, the combination of both
feedback mechanisms would provide a higher robustness for the bistable behavior of
Bax activation and mitochondria pore formation.
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Origins of a robust all-or-none behavior - Switching and threshold mechanisms
other than bistability Biochemical signaling networks may exhibit switching mech-
anisms other than bistability arising from positive feedback. In such cases, the sys-
tem exhibits a single steady state which increases in a steep, non-linear manner with
increasing input concentration. Such sigmoidal, all-or-none dose-response behavior
has been termed ultrasensitivity. One ultrasensitivity mechanism with particular
relevance to apoptosis is inhibitor ultrasensitivity: here, a protein inhibitor strongly
binds to its target, implying that the target remains completely inactive unless the
total concentration exceeds the total inhibitor concentration [76]. Thus, the stoi-
chiometry between inhibitor and target determines the system behavior, explaining
why the mechanism is also known as stoichiometric switch.
The critical roles of c-FLIPL and c-FLIPS, which potentially act as stoichiometric
inhibitors in the death-inducing signaling complex, were investigated in a model
of Bentele et al. [41]. The dependence of the ligand concentration threshold on
the concentrations of both splicing variants of c-FLIP was characterized, and it
was concluded that c-FLIPs establish a stoichiometric switch. A large scale model
comprising DISC assembly, caspase activation, MOMP, interference from caspase
inhibitors, and degradation processes was derived. The model could be fitted to
quantitative western blot data (caspase-8, -2, -7, -3, -9, Bid, PARP) representing
population measures of protein concentrations under different ligand concentrations
using hierarchical parameter estimation. By a global sensitivity analysis clusters of
modeled signaling proteins with high mutual sensitivities of protein concentrations
were defined, which lead to functional subsystems. By disregarding parameters
that had low sensitivities to parameters in one cluster the dimensionality of the
parameter estimation problem could be decreased. Predictions of the reduced model
were subsequently verified experimentally. Most importantly, it could be shown that
the threshold ligand concentration was highly sensitive to the c-FLIP concentration
which is consistent with a stoichiometric switch mechanism. A refined version of
the Bentele model was presented in the theoretical study of Toivonen et al. [77]
which took into account fast turnover of c-FLIP variants that could be relevant for
their anti-apoptotic effect. It could be shown that the concentration of c-FLIP at
the time of ligand addition is central to apoptosis timing. Recently, accumulation
of c-FLIP due to proteasome inhibition was investigated in a study by Laussmann
et al. [50]. As a direct effect, c-FLIP overexpression delays caspase-8 activation.
Changes in apoptosis kinetics, however, were not intuitive as proteasome inhibition
simultaneously caused TRAIL receptor 2 accumulation. Therefore, pro- and anti-
apoptotic effects of proteasome inhibition were investigated by a kinetic model.
Another ultrasensitivity mechanism with potential relevance to apoptosis is pro-
tein dimerization. For protein dimerization the steady state of the active dimer
depends on the total protein concentration in a quadratic manner. Thus, weak in-
put signals controlling the concentration of the monomer species can be suppressed,
while stronger inputs are transmitted. This phenomenon, known as multistep ultra-
sensitivity, was analyzed by Würstle et al. [49] as described in the following.
In the absence of death receptor ligands, the amplification loop from active
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caspase-8 to caspase-3, from activated caspase-8 to caspase-6 and back to caspase-8,
has to be silenced to prevent apoptosis induction at low levels of active caspase-8.
Würstle et al. compared different model variants to understand how efficient suppres-
sion of the amplification loop can be achieved [49]. First, they analyzed the role of
well-known caspase inhibitors such as the caspase-8 inhibitor BAR and the caspase-
3 inhibitor XIAP. Second, they took into account that only caspase-8 dimers are
catalytically active, and considered de-dimerization of caspase-8 complexes released
from the DISC. In this context, it had been shown experimentally that the caspase-8
dimerization equilibrium favors the formation of caspase-8 monomers [78]. A core
model describing the activation loop only was extended by either one of these three
inhibiting mechanisms. Time series of caspase activation and substrate cleavage by
caspase-3 caused by mild initial stimuli of caspase-8, -3 or -6, were calculated for each
model variant, using experimentally measured kinetic constants for caspase activi-
ties and caspase-8 dimerization. Subsequently, time courses of the model variables
were calculated under various initial concentrations of procaspases-3, -6 and -8, BAR
and XIAP to assess the sensitivity of the system towards each inhibitory mechanism
in a time interval of 24 hours, respectively. Each parameter constellation leading to
less than 20% substrate cleavage was classified as non-apoptotic, while more than
80% substrate cleavage was considered as effective apoptosis. Thereby model vari-
ants could be compared regarding their potential to prevent apoptosis. A model
was considered as more preventive if it caused weak cleavage in a larger fraction of
the randomly chosen parameter sets than other model variants. As a result of an
initial stimulus of caspase-8 the numbers of parameter constellations leading to hypo-
thetic survival were slightly higher in the XIAP model than for the de-dimerization
model, while the number was highest for the de-dimerization model in response to
stimuli of caspase-3 or caspase-6. The apoptosis-preventing effect of the low affin-
ity in a caspase-8 dimer becomes evident when considering that caspase-6 can only
cleave monomers of procaspase-8 in absence of a dimerization inducer as the DISC.
Because of the low affinity in the caspase-8 dimer the system is especially stable
against a stimulus of caspase-8 monomers. Consequently, all three inhibitory mech-
anisms were included into one model to assess thresholds of the maximal caspase-8
stimulus strength that could be compensated. Threshold changes upon removal of
one of the mechanisms were determined that showed again the strong perturbation
resistance by caspase-8 dimerization and dissociation [49]. Thus, it was concluded
that the caspase-8 dimerization equilibrium efficiently prevents accidental cell death
initiation.
Another monostable model of the apoptosis threshold was introduced in the the-
oretical study of Stucki and Simon [56]. However, these authors did not focus on
the mechanism of ultrasensitivity, but represented all-or-none caspase-3 activation
phenomenologically using a Heaviside function in the caspase-3 production term.
The major focus of the study was to analyze how the caspase-3 activation threshold
could be modulated by the caspase-3 inhibitory XIAPs, the XIAP antagonist Smac,
and Smac binding anti-apoptotic proteins such as survivin [79]. The potentially
limiting role of caspase-3 degradation was addressed, and it was concluded that XI-
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APs efficiently suppress apoptosis by triggering the degradation of caspase-3 in a
non-linear manner.
Models characterized by a timing switch Steady states, bistable switches and
ultrasensitivity govern long-term decision making within biochemical signaling net-
works. However, in the context of apoptosis, it is also important that the time
course of effector caspase activation is abrupt. Such temporal switching ensures
complete and coherent initiation of cellular demise. Single cell measurements using
GFP-tagged cytochrome c and caspase FRET probes confirmed that mitochondrial
permeabilization and subsequent effector caspase activation indeed occur in a tem-
porally abrupt manner [80, 81]. Accordingly, a more recent study concluded that
the apoptosis timing in single cells consists of a variable lag time followed by the
sudden switch-like effector caspase activation [82]. While the lag time varies within
the range of one to several hours, dependent on the stimulus strength, the sudden
switching time was shown to be relatively invariant around 30 minutes. This ro-
bustness of sudden switching can be interpreted as necessary to prevent from states
of partial destruction that could cause genomic instability. The lag time is length-
ened by proteins upstream of activated Bax, as c-FLIP, BAR or cytosolic Bcl-2, and
shortened by TRAIL receptors, caspase-8, Bid and Bax. Moreover, the robustness
of the switching time is determined on the level of Bax-Bcl-2 interaction leading to
mitochondria pore formation [82]. Thus, most modeling studies characterizing the
temporal dynamics of apoptosis initiation in type II cells employing the mitochon-
drial pathway were focused on regulation at the level of caspase-8 or Bcl-2. In the
following the systems biological literature on the temporal dynamics of apoptosis
initiation will be reviewed.
In the study of Hua et al. [43] different topologies reflecting possible interactions
of Bcl-2 with Bid, tBid or Bax were compared regarding their role in controlling the
kinetics of caspase-3 activation and preventing apoptosis. Four topologies, including
Bcl-2 binding to Bid, tBid or Bax only, or to tBid and Bax, were implemented into a
large scale model describing extrinsic apoptosis from ligand binding to caspase-3 acti-
vation. Specifically, their model describes DISC assembly, caspase-8 activation, Bid
cleavage and subsequent mitochondrial reactions (i.e. binding reactions of Bcl-2, Bax
oligomerization, Smac release, cytochrome c release and apoptosome formation). By
comparing experimental data from wild type and Bcl-2 overexpressing cells with sim-
ulated trajectories of the model variants, model discrimination was possible: Their
experimental data supported a mechanism where the caspase-3 time course reacts
very sensitively to Bcl-2 overexpression, and the model suggested that this can only
be realized if Bcl-2 can simultaneously inhibit both tBid and Bax. A global sensitiv-
ity analysis on initial concentrations of the model variables gave insight into effects
of overexpression or suppression. In this context it was interesting that in the model
of Hua et al. suppression of Bcl-2 under its basal level did not accelerate apopto-
sis, which could be experimentally verified [43]. This indicates that Bcl-2 inhibitors
could selectively sensitize Bcl-2 overexpressing tumor cells to apoptosis [83], while
not affecting non-transformed cells expressing Bcl-2 at moderate levels. The sensi-
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tivity analysis by Hua et al. showed further asymmetric effects of overexpression or
suppression: In some proteins an overexpression does not affect apoptosis timing,
while their suppression causes significant changes (e.g. death receptors). Taken to-
gether, the model was able to predict dynamics of caspase-3 activation with high
accuracy and provided insights into mechanisms of Bcl-2 action.
Albeck et al. [39] presented a refined model which exhibits similar complexity
as the Hua et al. [43] model, but was based on a large body of data, mostly at the
single-cell level. Specifically, the model was trained against population data acquired
with flow cytometry and western blotting as well as single cell imaging data. These
were measured at various TRAIL concentrations and under several conditions of
overexpression or depletion of signaling proteins. In the study of Albeck et al. [39] it
was shown experimentally that MOMP timing and the kinetics of Smac/cytochrome
c release were only dependent on the upstream signaling network controlling caspase-
8 activation, while the contribution of positive feedback was negligible. Specifically,
a role of three putative positive feedback mechanisms from caspase-3, caspase-6 or
caspase-9 could be excluded. This suggests that some of the bistability mechanisms
discussed above do not account for the temporal dynamics of apoptosis initiation at
least in HeLa cells. In contrast to other apoptosis models the cell death decision was
not dependent on bistability but explained apoptosis by the monostable trans-critical
process of MOMP. The interaction of Bcl-2 family members with tBid and Bax, the
process of Smac release followed by the reduction of effector caspase inhibition by
XIAP, and the mitochondria membrane pore formation dynamics were identified
as critical stages of the all-or-none behavior of effector caspase activation. Signal
transduction from MOMP to effector caspases apparently proceeds in a redundant
manner through Smac inactivating XIAP and apoptosome formation causing XIAP
sequestration and activation of caspase-3. In conclusion, the study by Albeck et
al. currently represents the most comprehensive and realistic large-scale model of
apoptosis.
In a combined experimental and theoretical study, Rehm et al. analyzed the ki-
netics of temporally switch-like effector caspase activation downstream of mitochon-
dria [55]. In particular, they focused on the control of effector caspase activation
by XIAP. Their model described apoptosis signaling following MOMP induced by
the drug staurosporine. The agent tetramethylrhodamine methylester (TMRM) was
used to experimentally measure changes of the mitochondria membrane potential to
monitor the occurrence of MOMP. In their model, Smac and cytochrome c released
from mitochondria served as stimuli. Subsequent events in the model include apopto-
some formation, caspase-9 as well as caspase-3 activation and caspase inhibition by
XIAP. Their modeling analyses focused on the inhibition of caspase-9 and caspase-
3 auto-amplification loops by XIAP, and model predictions were confirmed using
single cell experiments with cells stably expressing FRET probes that contained a
cleavage site for caspase-3. Specifically, their model prediction, that a reduction of
XIAP levels would not affect apoptosis timing, while an XIAP overexpression would
significantly delay effector caspase activation, could be experimentally verified in
HeLa cells and in MCF7 cells which are completely devoid of caspase-3. Similarly,
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another prediction that interference on the level of Smac has only weak influences
on apoptosis timing was verified. In conclusion, the study of Rehm et al. provided
detailed insights into the regulative function of XIAP on the timing of effector cas-
pase activation [55]. Recently, the model was successfully applied to explain lack of
effector caspase activation after MOMP in different cancer cell lines as a result from
cell death impairing combinations of Apaf-1, procaspase-9, XIAP and procaspase-3
levels [84]. Huber et al. combined approaches from metabolic engineering with the
model of Rehm et al. to study the crosstalk between reactions of the respiration
chain and the intrinsic apoptosis pathway [58]. Their model quantitatively charac-
terized how an increased glucose level that increases cytosolic ATP production can
stabilize the transmembrane potential, a mechanism that may support the cell death
evasion of cancer cells.
It can be expected that future research will provide much more detailed insights
into the kinetics of apoptosis initiation, since various tools are now available to
monitor apoptosis on several signaling levels at the single-cell level: FRET reporters
consisting of two fluorescent proteins linked with a cleavage sequence for caspase-
8 or caspase-3 were used to monitor the activity of initiator and effector caspases
[55, 81, 82, 85]. In the study of Albeck et al. a GFP-tagged form of Bax was used
to measure the translocation of Bax into mitochondria upon Bid activation [82].
Furthermore, a reporter protein that contains the mitochondria import sequence
of Smac and thus accumulates in the mitochondria inter-membrane space (IMS-
RP) was used to indicate MOMP in single cells. Simultaneous and quantitative
description of multiple signaling levels will be a major challenge for future modeling
studies.
Modeling the ambiguity between cell death and survival Experimental studies
by Nair et al. suggested that the mechanisms of cell death and survival can be mu-
tually exclusive [23]. The behavior of a population of cells upon an oxidative stress
(H2O2) stimulus was observed. While some cells underwent apoptosis, others clearly
showed a successful overcoming of the stress stimulus and a proliferative response.
However, the paradigm of mutually exclusive cell death or survival processes was
challenged in the subsequent experimental and theoretical studies described in this
section.
To understand the double-edged role of CD95 (APO-1/Fas) activation in apopto-
sis as well as in NF-êB activation, models describing the role of c-FLIP on both cell
fates were established [46,48]. A focus of the models is the balance between caspase
activation and inhibitory processes at the DISC. Cleavage of homodimers of the two
main procaspase-8 isoforms, procaspase-8a and b (p55 and p53), bound to FADD
can result in two forms that possess catalytic activity: an intermediate form p43/p41
that remains bound to the DISC as a homodimer, and the completely processed form
p18 that dissociates from the DISC as p182-p102 heterotetramers [86,87] (Figure 1.2).
Three splicing variants of the cellular FADD-like interleukin-1β-converting enzyme
inhibitory protein (c-FLIP), c-FLIP short (c-FLIPS), c-FLIP long (c-FLIPL) and
c-FLIP Raji (c-FLIPR) can heterodimerize with a monomer of procaspase-8 bound
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to a FADD molecule at the DISC and interfere with caspase-8 activation. The two
variants c-FLIPS and c-FLIPR block procaspase-8 autoprocessing in a heterodimer
and therefore inhibit propagation of the apoptosis signal. In contrast, c-FLIPL can
facilitate procaspase-8 cleavage to p43/p41 but not to p18. Therefore, c-FLIPL
leads to heterodimers with p43/p41 at the DISC, and these complexes have a cer-
tain catalytic activity. While the two forms c-FLIPS and c-FLIPR clearly inhibit
signal propagation, it was not obvious if c-FLIPL promotes or also inhibits apopto-
sis [88–90].
DED DED p18 p10 p53/p55 
p43/p41 p30 
p26/p24 
p10 + + 
p18 p10 + + 
caspase-8 
DED p20 p12 c-FLIPL 
c-FLIPS 
DED 
p18 p10 DED DED p18 
DED DED 
c-FLIPR 
DED DED 
DED DED 
DED p20 p43-FLIP DED 
DED p22-FLIP DED 
c-FLIP 
p17 p12 p32 
p20 p17 p12 
p17 
+ p12 
+ caspase-3 
Figure 1.2. Forms of caspase-8, c-FLIP and caspase-3. For caspase-8 activation the
two isoforms of procaspase-8, p55 and p53, are cleaved to p43/p41 plus p18 or p26/p24
plus p30. The death effector domains (DEDs) of procaspase-8 can bind to FADD, to
other procaspase-8 monomers or to the similar DEDs of c-FLIP proteins. These
are c-FLIPL, c-FLIPS, c-FLIPR, and the two cleaved forms p43-FLIP and p22-FLIP,
containing catalytically inactive caspase-like domains p20 and p12 [46,91]. Caspase-3
exists as a pre-formed dimer and is activated by cleavage to p17 and p12.
To resolve this question, a study of Fricker et al. on the signaling function of
c-FLIPL combined experiments and modeling, and showed an ambiguous function
of the protein as dependent on the stimulus strength [46]. Their model considered
the formation of homodimers of procaspase-8 or heterodimers of procaspase-8 and
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c-FLIP variants at the DISC and either termination of further reactions or process-
ing to caspase-8 or p43-FLIP by other active homo- or heterodimers. The model
was trained against immunoblot data of procaspase-8 (p55), the intermediate form
p43/p41 and caspase-8 (p18 in p182-p102) at a given ligand concentration. The
model predicted that at a low ligand concentration a twenty-fold overexpression of
c-FLIPL would lead to a significant reduction of caspase-8 activity. Contrarily it
was predicted, that at high ligand concentration, the same overexpression would lead
to an acceleration of cell death. The authors could confirm these predictions with
time lapse imaging of cells moderately overexpressing c-FLIPL. As the processing of
procaspase-8 is relatively fast, and c-FLIPL overexpression therefore can only cause
small accelerating effects, Fricker et al. tested their model subsequently in conditions
of c-FLIPS or c-FLIPR overexpression. As these c-FLIP variants inhibit caspase-8
activation, an even stronger activating effect of c-FLIPL was predicted. Again the
predictions were verified, confirming the predicted ambiguous effect of c-FLIPL be-
ing anti-apoptotic at low and pro-apoptotic at high stimulus strengths. The study
by Neumann et al. investigated in detail how NF-êB is activated by CD95L, and
how this process is modulated by c-FLIP and caspase-8 [48]. The different pos-
sibilities of DISC formation of activated receptors, FADD, procaspase-8, c-FLIPL
and c-FLIPS and their processed forms were described in their model: (i) DISCs
containing at least two procaspase-8 molecules give rise to p43/p41 dimers and subse-
quently mature caspase-8. (ii) At DISCs that contain at least one procaspase-8 and
one c-FLIPL molecule a heterodimer of p43/p41 and c-FLIPL is created. Besides,
several other DISC constitutions preventing further processing were considered. By
immunoprecipitation experiments, it was shown that interaction of p43-FLIP with
IKKα leads to the phosphorylation of IêB (NF-êB·IêB·P). Phosphorylation of IêB
was previously shown to trigger degradation, thereby promoting NF-êB activation.
The subsequent translocation of NF-êB into the nucleus after IêB·P degradation
was monitored in live cell experiments. The model matched the dynamics of these
processes and the model complexity was iteratively reduced by summarizing or dis-
regarding variables and modeled reactions. The simplification was supervised by
means of the fitting accuracy in iterative parameter estimations. The balance be-
tween c-FLIPL and procaspase-8 was shown to be responsible for proliferative or
apoptotic effects of CD95 stimulation. Regimes of predominant NF-êB activation
or caspase-3 or of both processes could be predicted.
Systems biological studies on the ambiguity towards cell death or survival path-
ways revealed close interlinks between both processes. A more complicated overall
image results when considering connections to other cellular signaling processes.
Within the process of cell growth and mitosis, cell cycle regulatory mechanisms can
determine pro- or anti-apoptotic conditioning as investigated in the cell cycle model
of Pfeuty et al. [92]. Further interlinks exist between cell cycle repair mechanisms
leading to cell cycle arrest or apoptosis execution [57]. Additionally, the apoptosis
sensitivity is modulated by other cellular stress responses as theoretically analyzed
in recent modeling studies [77, 93].
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Understanding cell-to-cell variability Several new experimental techniques and
theoretical approaches were developed to investigate the origins and the role of
cellular variability in cell death signaling. In several modeling studies, the effects of
randomly choosing initial protein concentration sets from probability distributions
to estimate consequences of variable initial protein concentrations were investigated
[39,45,49,77].
In general, it is not clear whether cell-to-cell variability in cell signaling mainly
arises from stochastic dynamics in biochemical reactions (intrinsic noise) or from
the variability of initial protein levels (extrinsic noise). Combining modeling and
single cell experiments, it could be shown that heterogeneous apoptosis timing in a
population of cells has its origin in the variable initial levels of apoptotic proteins [94].
In single cell experiments using FRET reporters for initiator and effector caspase
activity and the MOMP reporter protein IMS-RP, after cell divisions pairs of cells
were observed. While the time of apoptosis was highly correlated in the first hours
after cell division, correlation in cell death timing ceased in pairs of older sister
cells. This correlation was sustained over a longer period of time by inhibition
of protein synthesis. Thereby it was demonstrated that the variability of protein
levels arising from noise in gene expression is responsible for cell-to-cell variability
in apoptosis timing rather than genetic mutations or epigenetic differences that
occur on a larger time scale. By combining single cell experiments with the model
of Albeck et al. it was verified that the time of apoptosis is dependent on the
concentrations of several signaling proteins upstream of MOMP [39]. Thus, the
control of apoptosis timing appears to be distributed over many protein expression
levels. Only when overexpressing single signaling proteins as Bid, the dependency
of single protein concentration increases. Based on the same model, Gaudet et al.
simulated the effects of protein level changes on the variability of cell fates. Their
study characterized to which degree variability in cell fate decisions dependents on
the levels of involved signaling proteins, and how variances of initial protein levels
and covariances between protein levels impact on the variability of characteristic
features as the time of MOMP or the time when half of the effector caspase substrate
PARP is cleaved [95]. In particular, it was pointed out that altering the initial level
of a certain model species can strongly change the influence of the variability of
involved signaling species on cell death kinetics, termed contextual sensitivity.
As an alternative approach to link the possible behavior of heterogeneous single
cells to their population level measures at certain time points of a dynamic process,
Hasenauer et al. developed methods based on parameter probability densities [96].
These were demonstrated on a synthetic data set for a simple model of tumor necrosis
factor (TNF) signaling [97]. The original parameter densities could successfully be
estimated from simulated flow cytometric data.
Taken together, cell-to-cell variability is an inherently complex phenomenon that
can only be tackled by quantitative approaches. ODE modeling combined with
sensitivity analysis and stochastic modeling became valuable tools in this field of
apoptosis research.
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Conclusions and future perspective of cell death modeling Apoptosis is a well-
characterized biological process amenable to mathematical modeling. Mechanistic
models provided valuable insights into nonlinear phenomena such as all-or-none
switching and irreversible decision making. Modeling reconciled apparently contra-
dictory observations at the single-cell and population level, and was employed to
identify molecular mechanisms controlling whether a cell enters death via the type
I or type II pathway of apoptosis [42–44, 98]. In particular, the study by Hua et al.
verified corresponding model predictions experimentally, and showed that the anti-
apoptotic influence of Bcl-2 is completely lost in type II cells in the case of procaspase-
8 overexpression [43]. Lyapunov coefficients served as a tool to predict under which
conditions changes in initial protein concentrations cells shift from a type I to a
type II apoptosis behavior. Specifically, this method showed that the ratio between
caspase-3 and XIAP determines the type of cell death [98]. Non-intuitive feedback
loops arising implicitly from the apoptosis network structure could be identified by
simulation analysis [52,54]. The crosstalk between cell death and survival signaling
is much less understood; here, modeling was mostly restricted to top-down and qual-
itative approaches owing to crosstalk complexity. However, quantitative modeling
and sensitivity analysis are required to predict effective co-treatment strategies for
cancer cells that often harbor combined mutations in interdependent growth factor
and apoptosis networks. Currently, a major limitation is our incomplete understand-
ing of autophagy (’self eating’) which shares many molecular components with the
apoptosis machinery (e.g. Bcl-2 family members) [99, 100]. Depending on the cell
type, autophagy protects cells from death by removing damaged organelles or it trig-
gers another form of cell death, further complicating the apoptosis survival network.
Another limitation of current models is that they mainly focus on extrinsic apopto-
sis induced by death ligands. However, most pharmacologically relevant responses,
e.g., during chemotherapy, proceed via the intrinsic mitochondrial pathway. The
intrinsic pathway includes another layer of complexity, as it requires transcriptional
regulation, e.g., of Bcl-2 protein family regulators (Puma, Noxa). Quantitative gene
expression profiling and chromatin immunoprecipitation (ChIP) studies combined
with systematic molecular perturbations are required to quantitatively model gene
regulatory networks controlling intrinsic apoptosis. Antagonists inhibiting the In-
hibitor of Apoptosis (IAP) proteins appear to be promising therapeutics, as they
selectively kill cancer cells in the absence of further stimulation. Apoptosis models
taking into account basal state signaling are required to understand and to optimize
such therapeutic approaches. Live-cell imaging and flow cytometric approaches led
to insights into apoptosis at the single cell level, and revealed principles of cell-to-
cell variability [55,94]. Further experimental and theoretical analyses are required to
understand how complete eradication of tumor cell populations can be achieved. In
principle, it might be possible that nonlinear phenomena such as bistability give rise
to tumor cell sub-populations that are completely insensitive to therapy. Moreover,
single cells may differ in the apoptosis pathways they employ, implying that com-
binatorial inhibition of multiple pathways is required for elimination of the whole
tumor. This requires the development of new parameter estimation tools which
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take into account cell-to-cell variability, and integrate population-based as well as
single-cell measurements.
1.3. Biochemical basics of erythropoietin receptor
signaling
The glycoprotein hormone erythropoietin (Epo) regulates the production of red
blood cells by binding to the Erythropoietin receptor (EpoR) at the plasma mem-
brane of hematopoietic precursor cells in the bone marrow [101]. It is used to treat
renal anemia, tumor anemia, and is applied as an adjuvant therapeutic agent in
anemia resulting from chemotherapy induced bone marrow depression [102]. Non-
erythropoietic effects of Epo, as protection of neurons after stroke or cardiomyocytes
after cardiac infarction, are the subject of current research [103].
The signal transduction mechanism of EpoR is similar to other cytokine receptors,
in which a ligand stimulus is translated to a response on the level of gene transcrip-
tion. After binding to dimeric EpoR, associated Janus kinase 2 (JAK2) enzymes
are brought into proximity and can phosphorylate each other (Figure 1.3). Auto-
activated JAK2 then phosphorylate tyrosyl residues at EpoR, which allows binding
of STAT5 monomers that are subsequently phosphorylated by JAK2 [104]. Phos-
phorylated STAT5, after being released from EpoR, dimerizes and is then actively
transported to the nucleus where it binds to its consensus sequences and induces
the transcription of specific genes [105]. After dephosphorylation, STAT5 re-enters
the signaling cycle [106]. On the level of transcription, STAT5 activation stimu-
lates the differentiation of erythroid progenitor cells and inhibits their apoptotic
demise [107–109].
The signal transduction cascade from an Epo stimulus to a transcriptional re-
sponse is an example for the general physiological principle of receptor signaling
in cells. General questions in research on ligand-receptor signaling address mecha-
nisms, by which cells shape the response towards a certain ligand stimulus that can
be translated to a specific cellular fate:
(i) How does receptor shuttling between the intracellular pool and the mem-
brane, the internalization of active receptors and receptor recycling influ-
ence the signal response dynamics of a cytokine? Cells can adapt to a cer-
tain stimulus and translate a continuous stimulus to a transient response
by negative feedback, a mechanism termed “perfect adaptation” [110], as
it is the case for cytokine receptors of the immune system [111]. Contrar-
ily, a pulse stimulus can be translated to a constant response due to a
bistable switch, which can result from the combination of positive feed-
back and cooperativity, as it is the case for TGFβ [112] or progesterone
signaling [113]. The cellular response towards epidermal growth factor
(EGF) is a classic example for adaptation to a cytokine stimulus by in-
ternalization and subsequent degradation of activated receptors, which
effectively reduces the fraction of receptors contributing to signal trans-
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Figure 1.3. EpoR activated JAK-STAT signaling. Upon Epo binding, JAK2 is au-
tophosphorylated and phosphorylates tyrosyl residues at EpoR, thus enabling STAT5
activation and a specific transcriptional response.
duction [114]. In this example, receptor trafficking effectively modulates
signal transduction [115,116].
(ii) How is receptor signaling regulated by mechanisms involving post-trans-
lational modifications? In the example of EpoR, besides the direct in-
volvement of kinases and phosphatases in signaling, other modifications
were found to take influence on signal transduction. EpoR phosphory-
lation was found to be responsible for receptor internalization mediated
by the PI3K subunit p85, which is impaired in patients with primary
familial and congenital polycythemia [117]. Ubiquitinylation was shown
to trigger internalization and degradation of EpoR, dependent on which
lysyl residues of the EpoR are targeted [118].
(iii) Which receptor traffic processes should be targeted by modifying the
properties of an Epo mimetic drug in order to optimize the therapeutic
effect towards a heterogeneous population of target cells? Due to variabil-
ity, in some cells adaptation mechanisms could lead to a weak response,
while only in a fraction of cells a therapeutic effect will be achieved. In
this context, understanding sources of cell-to-cell variability might help
to optimize therapeutic applications with respect to heterogeneity in the
dynamics of receptor traffic.
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1.4. Mathematical models of erythropoietin receptor
signaling
Studies on EpoR signaling that were based on mathematical models mainly focused
two processes, either the dynamics of EpoR traffic or the STAT induced transcrip-
tional responses. The JAK-STAT signaling pathway, which links receptor activation
of several cytokine receptors at the plasma membrane to transcriptional responses,
was extensively characterized by ODE models [119, 120]. Because of the high rele-
vance of Epo for clinical applications, Epo models were motivated by the develop-
ment of new strategies for optimizing its efficiency, and by defining a therapeutic
window for stimulating hematopoiesis but not tumor growth [121].
Several Epo mimetic drugs were developed to enhance the therapeutic effect of
stimulating erythropoiesis [122]. Amongst them, NESP is a hyperglycosylated Epo
variant, which has, compared to Epo, a lower affinity to the EpoR and a higher
dissociation rate. Nevertheless, NESP can more efficiently stimulate erythropoiesis.
A modeling study by Gross and Lodish, based on surface bound and internalized
amounts of radioactively labeled ligand in a population of cells, showed that only
differences in NESP and Epo with regard to receptor binding and unbinding were
responsible for the higher efficiency of NESP [123]. However, other processes as
internalization, resecretion or degradation of the ligand, were equally fast for both
ligands. Compared to Epo, NESP yielded higher efficiency, as a smaller fraction
is internalized and degraded due to its faster unbinding. An important aspect of
EpoR signaling is the large intracellular receptor pool compared to a small receptor
fraction at the membrane. The study of Becker et al. showed that the fast cycling
between the plasma membrane and the intracellular pool in combination with an
accelerated internalization of active membrane bound EpoR, facilitates signaling
over a broad dynamic range of ligand concentrations [124]. As a result, the time
integral of active EpoR after ligand addition is linearly dependent on the ligand
concentration in the medium. Therefore, the EpoR system functions as a linear
integrator over a large interval of Epo concentrations. The kinetic behavior of the
induced STAT5 activation and its nuclear translocation was addressed in the study
by Swameye et al., which showed that the steps of nuclear import and export are the
most sensitive processes in the Epo system towards external perturbations [106]. A
further modeling study addressed regulatory mechanisms that modulate the induced
STAT5 response, which was based on western blot measurements of STAT5 and
JAK-STAT signaling regulators [125]. Inhibitory effects from the two relevant JAK-
STAT regulators CIS and SOCS3 were quantitatively characterized and linked to
the cellular survival supporting effect of STAT5 activation. While CIS provided
an effective negative feedback at low Epo concentrations, due to direct interference
with STAT binding to active EpoR, negative feedback from SOCS3, which inhibits
both STAT5 dimerization and interference with STAT5 binding to EpoR, became
predominant at high Epo concentrations.
In summary, the dynamics of EpoR traffic and Epo induced transcriptional re-
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sponses were accurately characterized by ODE modeling studies on the level of cel-
lular populations. So far, no study addressed cell-to-cell variability in Epo signaling,
which motivated for the project described in part II.
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The cell ensemble models of apoptosis initiation and Epo receptor traffic described
in this thesis were calibrated with experimental data at the single-cell and cell pop-
ulation level. The single-cell behavior was characterized using confocal microscopy.
Population-based assays included western blotting and fluorescence activated cell
sorting (FACS). This chapter describes basic principles underlying these experimen-
tal techniques, and explains the experimental procedures in detail (sections 2.1 and
2.2). Section 2.3 describes how mathematical models were fitted to experimental
data and how the model parameters were estimated. Section 2.3 contains parts of
the book chapter by Kallenberger et al. in Computational Systems Biology [2], and
section 2.2 contains parts of a submitted manuscript by Kallenberger et al. [126].
2.1. Confocal fluorescence microscopy
Confocal microscopy
The basic principle of confocal microscopy is that the excitation source and the
detector system are focused on the same optical plane, while a pinhole allows only
light from a small region of the optical plane to be passed to the detector (Figure
2.1) [127]. For this purpose, contrary to conventional widefield microscopy, not the
whole sample but only a small focus spot is illuminated. To record an image from
a fluorescent object the microscopic sample is illuminated point-wise, typically by
employing the collimated light of a laser. The principle of confocal microscopy was
originally developed by the mathematician and neuroscientist M. Minsky to optimize
imaging of neurons [128]. As the pinhole prevents that light from other regions than
the focus spot reaches the detector, planes at defined depths can be imaged, and
the signal-to-noise ratio is significantly improved compared to conventional widefield
microscopy.
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Figure 2.1. Principle of a confocal microscope. A laser beam is expanded, passes a
dichroic mirror and is focused by the microscope objective to a point at the fluorescent
sample. On the same optical path, light from the sample is reflected by the dichroic
mirror and passes the pinhole, which excludes light from other locations than the focal
spot. An image is recorded by iteratively moving the focal spot with the turning mirror
to an array of positions in the focal plane. The figure was modified after [129,130].
The resolution of a microscope objective is limited by the wavelength λ and the
optical properties of the objective due to diffraction. A point in the plane of an object
in the distance dobj from the lens with radius R is imaged to an Airy pattern in the
distance dim from the lens. The first minimum of the Airy pattern is located at the
angle θ from the center of the diffraction pattern, with sin θ = 0.61λ/R, according to
the first zero of the intensity distribution that contains a first-order Bessel function.
This results in the radius
rdiff ≈ 0.61λdim/R (2.1)
of the inner disk-shaped area of the diffraction pattern. To be able to distinguish
two nearby diffraction disks from two image points, they have to be in a distance
larger than the diffraction disk radius rdiff , which can be translated to a minimal
distance ∆x of two points in the plane of the imaged object that can still be resolved.
Using the relation between the object and image sizes for a lens and Equation 2.1,
the minimal resolvable distance reads ∆x = rdiff dobj/dim = 0.61λdobj/R ≈ 0.61λf/R,
assuming dobj ≈ f as the object is close to the focus plane in the distance f from
the lens. For the object the maximal angle of aperture is 2α, with 2 sinα = 2R/f.
Using this relation the minimal resolvable distance, i.e. the lateral resolution rlateral,
reads rlateral ≡ ∆x = 0.61 λsinα . To increase the resolution, immersion oil between the
object and the lens is used to decrease the wavelength according to the diffraction
index n ≈ 1.5 to λ0 = λ/n. The product n sinα, termed numerical aperture NA,
describes the optical properties of an objective and had a value of NA = 1.4 in the
used setup. The lateral resolution then reads
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rlateral = 0.61
λ0
n sinα = 0.61
λ0
NA
. (2.2)
In a confocal microscope the pinhole size is measured in Airy units AU . A size
of 1AU accords to the size of the diameter of the central Airy disk in the plane of
the pinhole. The intensity distribution of the diffraction pattern in the image of a
point is termed point spread function (PSF). In a simple microscope consisting of
two lenses the PSF is given by an Airy pattern. At small pinhole sizes, as described
in [127], the total PSF can be approximated by the product of the PSFs for the
excitation light path and for the detection light path,
PSFconfocal ≈ PSFexcitation · PSFdetection. (2.3)
In an epi-fluorescence microscope, as shown in Figure 2.1, the total PSF is equal
to the squared PSF of the objective, as it is simultaneously used for excitation and
detection. The inner disk between the maximum and the first minimum of an Airy
pattern can be well approximated by a Gaussian function I(r) = I0 exp ((r−r0)2/2σ2).
Therefore, the total PSF for an epi-fluorescence confocal microscope can be approx-
imated by a Gaussian with the smaller standard deviation σ˜ = σ/
√
2. For this
reason, the lateral resolution in a confocal microscope is decreased, compared to a
widefield microscope, by a factor of approximately
√
2, which results in an improved
lateral resolution of
rlat,confocal = 0.43
λ0
NA
. (2.4)
The axial resolution is equivalent to the full width at half maximum (FWHM) of
the PSF, and can be approximated by the term
raxial ≡ FWHMaxial ≈ 0.88λ0
n−√n2 −NA2 , (2.5)
which is valid for pinhole sizes around 1AU [127, 131]. In the microscope that
was used for live-cell imaging experiments the lateral resolution was about rlateral ≈
144nm and the axial resolution raxial ≈ 0.5µm. Single cell measurements were
conducted with a spinning disk confocal microscope that was optimized for fast
image recording, weak photobleaching and low phototoxicity for cells.
Spinning disc microscopy
To improve the velocity of image acquisition, microscopy techniques were invented, in
which larger areas of an object can be imaged simultaneously. A widened laser beam
is subdivided by an array of holes and is focused on an array of spots the object plane.
The pattern of focus spots is arranged in a way that the magnified image of the spot
pattern accords to the pixel array of a CCD camera for recording the fluorescence
intensity from each spot. A spinning disk microscope uses a Nipkow disk, which is
a rotating disk with spirals of equally sized holes that has been used for displaying
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images on early cathode ray screens [132]. Each hole of one spiral covers a radial
interval ∆r to record the image of a sector part between two circles (rmax−rmin)∆ϕ
in one disk rotation. The employed setup makes use of the Yokogawa technique,
in which a first disk of 20.000 microlenses focuses laser light on the corresponding
pinholes in the second disk (Figure 2.2) [133].
Figure 2.2. Principle of a spinning disk confocal microscope. A rotating microlens
disk focuses coherent blue light (in the case of imaging GFP) to an equally oriented
pinhole disk that simultaneously collimates green light from focus spots in the object
plane, which is transmitted by a dichroic mirror to the detector, modified after [127].
The disk contains 12 spirals, which means that rotation by 30° is required to
record one image, resulting in a typical speed of one frame per millisecond at 5000
rotations per minute. The image is projected on a CCD camera that is synchronized
with disk rotation.
In the absence of a microlens disk the pinhole disk blocks a large amount of laser
light. The transmission factor T = (D/S)2, calculated from the pinhole diameter D
and the distance S between adjacent pinholes, quantifies the fraction of the excita-
tion light that is used for imaging [127]. For conventional confocal microscopes the
transmission factor is around 50%, while spinning disk microscopes without a mi-
crolens disk would have a transmission factor of around 5% only. Using a microlens
disk, a transmission factor of about 40% can be achieved [133].
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Figure 2.3. Employing fluo-
rescent proteins for microscopy.
(A) Emission and excitation
spectra for eGFP and mCherry
(mCh) (data were taken from
http://spectra.arizona.edu). For live-
cell experiments GFP was excited
at 488nm and mCherry at 591nm
(dotted vertical lines). (B) Jablonski
diagram indicating electronic exited
states (thick lines) with vibrational
modes (thin lines) and transition
rates in an ensemble of molecules
(kex: excitation rate, kf : fluores-
cence rate, kn: rate of non-radiative
relaxation, kisc: interstate conver-
sion rate, kp: phosphorescence rate,
kbleach: bleaching rate, relaxation
from vibrationally excited to ground
states are fast and can be seen
in equilibrium compared to other
transitions), modified after [134].
Basics of fluorescence
Fluorescent molecules as GFP or mCherry that are used for confocal microscopy
of cells can be excited by absorbing a photon with the energy hνexc according to
their excitation spectra (Figure 2.3A). Then, the molecule switches to an excited
electronic state implicating the transition of an electron to an unoccupied orbital
that is separated by the absorbed energy amount. This transition can be visualized
in a Jablonski diagram, in which the rotational, vibrational and electronic energies of
a molecule are added in order to simultaneously show the different energetic states.
Figure 2.3B shows three electronic states, which are two singlet states S0 and S1
with equal antiparallel spins and a triplet state T0 with parallel spins. Electronic
states are visualized as thick horizontal lines, while nuclear vibrational levels for each
state are symbolized by thin lines. When a molecule in the state S0 absorbs a photon
with hνexc the molecule changes to a vibrationally excited state S1 and rapidly
relaxates to the vibratial ground state of S1. Then, the molecule can change back
either by fluorescence or non-radiative internal conversion. Fluorescence implicates
that a photon with the energy hνem is emitted, and the molecule typically changes
to a vibrationally excited S0 mode, which can relaxate to its ground state. As
the molecule quickly relaxates from vibrationally excited to ground modes in S1
before fluorescence, and in S0 after fluorescence, the frequency of the emitted photon
νem = (νexc − Erel/h) is red-shifted due to possible energy losses Erel in these non-
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radiative transitions, termed Stokes shift, which results in the red-shifted emission
spectrum (Figure 2.3A). Besides fluorescence, the molecule can change from S1 to S0
by internal conversion, without emitting a photon, due to distributing the absorbed
energy by other processes. The third possibility, termed intersystem conversion,
implies a non-radiative transition occurring with a spin-flip of the electron to a triplet
state T0. For the transition from this state back to S0 the spin multiplicity has to
be changed as it requires a spin-flip, and is therefore kinetically unfavored, which
leads to a long half-life of the state T0. Such a metastable state is the requirement
for phosphorescence, which denotes the delayed relaxation to S0 and the emission
of a photon with a larger wavelength compared to the excitating photon. Due to
the long half-life of T0, which can be in the range of milliseconds to hours, the
chance for photochemical destruction of the molecule, termed photobleaching, is
increased in this state. When describing an ensemble of fluorescent molecules, the
transitions between different states can be described with rates that are proportional
to the transition probabilities for single molecules (Figure 2.3B). From the rates for
fluorescence (kf ), non-radiative internal conversion (kn) and interstate conversion
(kisc), the quantum efficiency
QE = kf
kf + kn + kisc
(2.6)
can be calculated, which is proportional to the number of photons emitted by flu-
orescence divided by the number of absorbed photons [134]. For variants of the
fluorescent protein GFP, the quantum efficiency is in the range between 0.65 and
0.72 [135].
2.2. Biochemical experimental methods
Cell lines and cell culture
For apoptosis modeling (part I) stable cell lines were generated from wild type HeLa
cells. CD95R-HeLa and the HeLa cell lines stably expressing procaspase-8-mGFP
were described in [136]. From HeLa wt and CD95R-HeLa cells, probe or GFP fusion
expressing cell lines were selected with 0.8mg/ml G418 (Sigma-Aldrich, Taufkirchen,
Germany).
For erythropoietin receptor modeling (part II) stable cell lines were generated
from EpoR-GFP-H838 cells, stably expressing EpoR-GFP, which were obtained
from the group of Prof. Ursula Klingmüller at the German Cancer Research Cen-
ter in Heidelberg. A cell line that stably expressed fusions of the myristoylation-
palmitoylation (MyrPalm) with mCherry (MyrPalm-mCh) was generated by trans-
fection of EpoR-GFP-H838 cells and selection with 0.8mg/ml G418.
Cell lines were maintained in DMEM (Invitrogen, Darmstadt, Germany) contain-
ing 10% fetal calf serum (Biochrom AG, Berlin, Germany), 100µg/ml penicillin and
streptomycin (Invitrogen), stably transfected cell lines additionally with 0.2 mg/ml
G418 or 0.2µg/ml puromycin (Sigma-Aldrich). Cells were transfected with Fugene
30
2.2. Biochemical experimental methods
6 (Roche, Basel, Switzerland). For microscopy, cells were maintained in 8-well Lab-
Tek chambers (Thermo Scientific, Asheville, NC, USA) with a density of 40.000/well,
for western blot experiments in 2-well Lab-Tek chambers at the same density as for
single cell experiments (204.000/well).
Antibodies and reagents
For apoptosis modeling (part I), caspase-8 was detected by C-15 antibody [137],
which was a kind gift of Peter Krammer. Furthermore, anti-FADD (Cell Signaling),
anti-BID (Cell Signaling, Danvers, MA, USA), anti-5F8 (Chromotek) and anti-GFP
(Roche Diagnostics) antibodies were used. Horseradish peroxidase-conjugated sec-
ondary antibodies (Southern Biotech, Birmingham, AL, USA) were used for detec-
tion. For flow cytometry secondary antibodies coupled to Alexa Fluor 488, goat
anti rabbit or goat anti mouse (Invitrogen) were used. Cell death was induced with
T4-CD95 ligand (Apogenix, Heidelberg, Germany) in all experiments, except for the
combined FRET and NES probe cleavage experiment (Figure 4.4), and prodomain
probe cleavage experiments (Figures 7.11 and 7.12), where LZ-sCD95 ligand [138]
was used that was expressed in 293T cells as described in [136].
For erythropoietin receptor modeling (part II), Cy5.5 stained Epo was obtained
from Roche Diagnostics GmbH (Penzberg, Germany).
DNA constructs
The ER-anchored probe from the calnexin-LQTDG-YFP was built as described
in [136] by replacing the ELQTDG cleavage sequence by GIETDS and by shortening
the luminal domain of Calnexin by removing residues 25 to 462. For the NES probe
used in live-cell experiments to generate single cell observables for model fitting, the
NES sequence MNLVDLQKKLEELELDEQQ was fused to the cleavage sequence
GIETDS (caspase-3), followed by a linker and mCherry (NES-GIETDS-mCh) as
described in [136]. Furthermore, NES probes containing the part C164 to K231
of the caspase-8 prodomain linker with cleavage sites D210, D216 and D223 as
cleavage sequence, or containing the not cleavable sequence DEVA were created. The
Calnexin construct was cloned in the pEGFP N1 vector (BD Biosciences, Franklin
Lakes, NJ, USA) and the NES sequence, its promoter region and its polyadenylation
signal were cloned into the Calnexin construct on the other side of the enhancer
region of the CMV to generate a bidirectional CMV promoter.
FADD was fused to mGFP [139] with the linker PRARDPTSGGGGGPVAT and
cloned in the pIRES-Neo3 vector (BD Biosciences). BID was fused to mGFP C-
terminally and mCherry N-terminally with the linkers GSIAT and RSRG respec-
tively and cloned in the PEGFP N1 vector. Myristoylation-palmitoylation (Myr-
Palm) probes were constructed as described in [136]. The MyrPalm domain was
fused to a spacer of snap tags, alternative cleavage sequences and either mCherry
or mGFP. Cleavage sequences were either MTISDS (caspase-8 prodomain, D210),
PREQDS (caspase-8 prodomain, D216), PVETDS (caspase-8 enzymatic subdomain
linker, D374) or ELQTDG (BID).
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Analysis of total cellular lysates and protein quantifications
Western blot samples were lysed with lysis buffer (20mM Tris/HCl, pH 7.5, 150mM
NaCl, 1mM phenylmethylsulfonyl fluoride (Sigma-Aldrich), protease inhibitor cock-
tail, 1% Triton X-100 (Serva, Mannheim, Germany), and 10% glycerol). Lysates
were analyzed using SDS PAGE gels (Invitrogen). The different time points were
loaded in a random manner to avoid quantification bias (Figures A.8 and A.9). Pro-
teins were transferred to PVDF membrane (Millipore, Billerica, MA, USA) using
wet blotting. Detection was performed using the Pico Chemiluminescent Substrate
from Thermo Scientific and a CCD camera (Intas, Göttingen, Germany).
In probe expressing CD95-HeLa and HeLa wt cell lines that were used for time
series experiments we quantified endogenous FADD, p55 and BID levels with help
of calibrated GFP fusion proteins (Figures A.10-A.12). First, GFP fusion protein
lysates were calibrated to recombinant eGFP (BioVision, Mountain View, CA, USA).
Therefore, we loaded different amounts between 0.1 and 30ng of GFP mixed with
equal amounts of cell lysate of non-transfected cells together with lysates of fusion
protein expressing cells to western blot gels. Then calibrated fusion protein lysates
were loaded at different amounts to western blot gels together with lysates from the
cleavage probe expressing cell lines that were used for time series experiments.
Flow cytometry
To estimate the numbers of surface CD95 receptors and parameters µ and σ for log-
normal distributions LN (µ, σ) of initial protein concentrations by flow cytometry,
we used QIFIKIT calibration beads (Dako, Glostrup, Denmark) with five differ-
ent antibody epitope numbers per bead, according to the manufacturers’ protocol
(Figure A.13). To obtain parameters σ for lognormal distributions of initial pro-
tein concentrations for FADD, p55 and BID, we used a protocol for intracellular
immunostaining of fixed permeabilized cells (Figure A.14). For each experiment,
5 × 105 cells were washed in blocking buffer (0.04M sucrose, 1x PBS, 1% BSA),
fixated with 4% PFA before primary and secondary antibody staining in 1x PBS
with 1% BSA. Between each step, cells were washed three times with 0.04M su-
crose in 1x PBS, respectively. Samples were measured on a modified flow cytometer,
FC500/MPL (Beckman Coulter, Brea, CA, USA) at 488nm with a 20mW solid
state laser (Coherent Inc., Santa Clara, CA, USA). For estimations of distribution
parameters the FACS events were gated for narrow forward scatter and side scatter
intensity intervals to include cells with similar volumes.
Live-cell imaging and simultaneous western blot sample preparation
Live-cell experiments were performed in a 37°C, 5% CO2 incubation chamber on a
Yokogawa spinning disk confocal on a Nikon Ti inverted microscope equipped with
63x Plan Apo NA 1.4 objective lens and the Perfect Focus System for continuous
maintenance of the focus, using MetaMorph 7 software (Nikon, Tokio, Japan). GFP
(Calnsh-GIETDS-mGFP) fluorescence was excited at 491nm with a 100mW solid
state laser and collected with a 525/50 emission filter (Chroma Technology Corp,
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Bellows Falls, VT, USA) and an exposure time of 70ms. Cherry (NES-GIETDS-
mCh) fluorescence was excited at 561nm with a 200mW solid state laser and collected
with a 620/60 emission filter (Chroma Technology Corp). A binning of 4x4 pixels
was used. At the beginning of each experiment a z-Stack with 20 slides at 0.7µm
step size was recorded, followed by recording single slides in the stack center every
two minutes (CD95-HeLa cells) or three minutes (HeLa wt cells).
Western blot samples were obtained from 2 · 105 cells in two well Lab-Tek cham-
bers for each time point, kept inside a microscope incubation chamber to obtain
equivalent experimental conditions as for the imaged single cells. For every time
point Lab-Teks were instantly transferred on an ice-cooled metal block, washed in
ice-cooled 1× PBS before treatment with ice-cooled lysis buffer, and harvested with
cell scrapers (BD Biosciences).
2.3. Mathematical modeling with systems of ODEs
Parameter estimation in ODE models
In a biochemical system, knowledge on interactions between signaling species can
be translated to a system of coupled ordinary differential equations
d~x
dt
= f(~x, ~p, u) (2.7)
that describe the dynamics of concentrations ~x of n model species, kinetic param-
eters ~p and an external stimulus u. The observables
~y = g(~s, ~x) + ~ε, (2.8)
which link the model variables to time series of experimental measurements, are
functions of concentrations ~x, scaling factors ~s, and a noise term ~ε. Usually, ob-
servables yj with j = 1, ...,m are linearly dependent on single variables xi or linear
combinations of variables. To then estimate the parameters ~p, ~x0 and ~s, the distance
between experimental data y˜jk for dj time points with k = 1, ..., dj and correspond-
ing observable values yjk(~p, ~x0, ~s) for a given set of parameters is minimized. For
this purpose, usually the weighted sum of residuals
χ2(~p, ~x0, ~s) =
m∑
j=1
dj∑
k=1
(
y˜jk − yjk(~p, ~x0, ~s)
σj,k
)2
, (2.9)
with measurement errors σj,k for each time point serves as objective function,
which is iteratively minimized [140–142]. Therein, the errors σj,k are assumed to be
normally distributed. Minimizing χ2 is equivalent to maximizing the logarithmic
likelihood that the data set y˜jk plus or minus a certain deviation ∆y occurs for the
observables yjk(~p, ~x0, ~s) of a certain model [140]. The likelihood function for the
data set of with normally distributed measurement errors reads
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L(y˜jk) =
m∏
j=1
dj∏
k=1
exp
−12
(
y˜jk − yjk
σj,k
)2
∆y
 . (2.10)
Accordingly, the log-likelihood for the total number of data points N =
m∑
j=1
dj,
with Equation 2.9 reads
lnL = N ln ∆y − 12χ
2. (2.11)
Therefore, minimizing χ2 = const.−2 lnLmaximizes the corresponding log-likelihood.
The following paragraphs describe strategies that are employed to minimize χ2.
Strategies for parameter fitting
To minimize the residual function and find and optimal set of parameters, gradient
based optimization algorithms are employed that either directly following gradients
of the residual function (line search algorithms) or employ a model that approxi-
mates the residual function in a certain region of the parameter space (trustregion
algorithms).
In general, for a function f(~r) of ~r ∈ Rn, which in the case of χ2 minimization
contains the set of parameters (~p, ~x0, ~s), the problem
f(~r) = min!
has to be solved.
Line search methods
In line search methods a series of points
~rk+1 = ~rk + αk ~dk
is calculated, moving to the iteratively updated directions ~dk by the step width αk,
such that f(~rk+1) < f(~rk) until a certain criterion as ∇f(~r) < c with a small c ∈ R
is fulfilled, as described in [143]. A simple approach is the steepest gradient method,
in which the direction accords to the steepest gradient ~dk = −∇f(~rk) and the series
to ~rk+1 = ~rk − αk∇f(~rk). A faster converging approach is the Newton method. At
a point ~rk the function f(~r) is approximated by the second order Taylor series
m(~r) = f(~rk) + (~r − ~rk)T∇f(~rk) + 12(~r − ~rk)
TH(~rk)(~r − ~rk), (2.12)
in whichH(~rk) is the Hessian matrix containing second partial derivatives ∂
2f(~rk)
∂ri∂rj
.
The direction of an optimization step is defined by the minimum ofm(~r) at∇m(~r) =
0, which exists if H(~rk) is positive definite. Then, the direction ~dk = ~rk+1 − ~rk for
m(~rk+1) becomes ~dk = −H−1(~rk)∇f(~rk), according to
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0 = ∇m(~rk+1) = ∇f(~rk) +H(~rk)~dk.
As the calculation of H is computationally extensive, common variants of the
Newton method use approximated Hessians [143].
Trust region strategy
In trust region approaches, instead of directly minimizing f(~r), a model mk(~r) is
approximated to a certain region of f(~r) and iteratively minimized [144]. Usually,
again, a quadratic approximation of f(~r) in ~rk is defined by
mk(~d) = f(~rk) + ~dT∇f(~rk) + 12
~dTB(~rk)~d,
in whichB(~rk) is an approximation of the Hessian at ~rk [145]. The problemmk(~d) =
min! is now solved to obtain the step ~dk for each iteration within a subregion of f(~r),
which is limited by the radius ∆k > 0. The radius defines the trust region by {~d |∣∣∣~d∣∣∣ ≤ ∆k}. In this region the modelmk(~d) can be trusted, as it approximates, at least
in small regions around ~rk, f(~r) sufficiently well. Now, the predicted reduction of by
ξ = mk(0)−mk(~dk) can be compared with the actual reduction ζ = f(~rk)− f(~rk+1).
Certain parameters cl with l = 0...4 are chosen in the ranges 0 < c3 < c4 < 1 < c1,
0 ≤ c0 ≤ c2 < 1, with c2 > 0, to decide if the position will be changed to ~rk+1 =
~rk+~dk or stays at ~rk+1 = ~rk. Furthermore it is decided according to these parameters
if the radius ∆k will be reduced or enlarged [145]. If the criterion ξ/ζ < c1 is fulfilled,
the next step starts from ~rk + ~dk, otherwise from the old position ~rk. The radius for
the next step is chosen according to
∆k+1 ∈

[
c3
∣∣∣~dk∣∣∣ , c4∆k]
[∆k, c1∆k]
if ξ/ζ ≤ c0
if ξ/ζ > c0
before the optimization problem mk+1(~d) = min! is solved for the following itera-
tion step. The step-wise optimization proceeds until a stop criterion |∇f(~rk)| ≤ ε
with a small ε > 0 is fulfilled. When using B = H the optimization strategy is
denoted as trust region Newton method.
ODE models of biochemical signal transduction networks
Applying ODE models in biochemical signaling networks often consists of a sequence
of work steps, in which biochemical hypotheses are translated to ODE models and
tested by experimental data. After having experimentally validated a certain model
topology, the model can be further analyzed to quantitatively investigate character-
istic properties of the system and to plan strategies for therapeutic interventions.
Figure 2.4 illustrates the process of working with ODE models that are calibrated
with experimental data, as it is typically applied in studies on biochemical signaling
networks. Conflicting hypotheses on biochemical mechanisms that are translated to
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Figure 2.4. Overview of ODE modeling used in several apoptosis modeling studies.
Biochemical knowledge on a signal transduction network can be translated to a system
of coupled ODEs with variables ~x, parameters ~p and an external stimulus u, which
could be a cell death ligand or drug concentration. Conflicting mechanistic hypotheses
can be translated to alternative model topologies. By model fitting to experimental
data represented by observables ~y with experimental errors ~ initial concentrations x0,
parameters ~p and scaling factors ~s are estimated. After fitting of model variants, a
model selection can be carried out based on methods as the likelihood ratio test or
the Akaike information criterion (AIC). Identifiability of estimated parameters can
be analyzed and experiments can be predicted for model validation or further model
discrimination. To characterize kinetic properties of the underlying biochemical signal
transduction network a sensitivity analysis can be conducted. Direct Lyapunov expo-
nents (DLE), calculated from the maximum eigenvalue λmax of a matrix containing
derivatives of the variables ~x against initial values ~x0, can be used to characterize the
dependency of model trajectories on initial concentrations [98,146].
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2.3. Mathematical modeling with systems of ODEs
alternative model topologies can be tested by assessing, which model variant can
explain a set of experimental data sufficiently well. Kinetic parameters and initial
protein concentrations are estimated, as well as scaling factors between model vari-
ables and experimental data, by fitting an ODE model to experimental data. An
identifiability analysis can show if estimated parameters can be successfully deter-
mined from the given set of experimental data or are unidentifiable [141,142,147]. An
unidentifiable parameter can have different values without reducing the fit quality,
eventually being correlated with another unidentifiable parameter, which decreases
the predictive power of the model. For model validation, observable trajectories
under different starting conditions as in the experimental data set (e.g. changed
protein levels by knock-down or overexpression), can be predicted and tested by
recording further experimental data under these conditions. After fitting alterna-
tive model variants, the most likely model can be determined by comparing values
of the log-likelihood estimator χ2, using methods as the likelihood ratio test or the
Akaike information criterion (AIC) [148, 149]. It might be that a model variant, in
which a reaction was omitted, can explain the experimental data equally well as
a larger model, indicating that a certain reaction is irrelevant. For this purpose,
the AIC accounts for the model size and penalizes the number of parameters, so
that a more parsimonious model will be preferred. It is a practical estimator of the
expected relative Kullback-Leibler information [150], as it simply depends on the
difference between the number of parameters k and the logarithmic likelihood lnL,
AIC∗ = 2k − 2 lnL = 2k − 2
(
c− χ
2
2
)
= 2k − 2c+ χ2, (2.13)
using Equation 2.11 with c = N ln ∆y. In this context, the Kullback-Leibler infor-
mation
I(f, g) =
ˆ
f(x) ln
(
f(x)
g(x | p)
)
dx (2.14)
denotes the loss of information by approximating the function f by the model g with
parameters p [151]. Minimization of I(f, g) can be directly related to maximizing
the likelihood of the model g(x | p) as described in [150]. While the nominator of
the logarithmic term in Equation 2.14 is a constant
C =
ˆ
f(x) ln f(x)dx,
the denominator, which corresponds to an expectation value for the relative loss of
information
Ef [ln g(x | p)] =
ˆ
f(x) ln g(x | p)dx = C − I(f, g), (2.15)
has to be optimized by model fitting. To obtain a model selection criterion based
on the Kullback-Leibler information, Akaike showed that the expectation value
EyEx [ln (g(x | pˆ(y)))], which contains the expectation value described in Equation
2.15 with the maximum likelihood estimate pˆ(y) of parameters p for the data y, can
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be well approximated by the difference lnL − k, as detailed in [148]. To obtain a
direct relation to χ2, the AIC was defined with the additional factor −2 as in Equa-
tion 2.13. As the differences of AIC values for model variants are relevant, rather
than exact values, the expression
AIC = χ2 + 2k (2.16)
is normally used, omitting the constant c in Equation 2.13. At large values of k
compared to N , in particular if n/k ≤ 40, the corrected Akaike information criterion
AICcorr = AIC +
2k(k + 1)
N − k − 1 (2.17)
is preferred [152].
Using this criterion, a preferred model variant can be selected, which explains the
experimental data sufficiently well with the smallest possible number of parameters.
If clear discrimination between alternative models is not possible, experimental con-
ditions can be chosen, in which predictions from different candidate models differ
the most. After having validated a model, its kinetic properties can be analyzed by
a sensitivity analysis. The relevance of model reactions on the concentration of a
model species at a certain time point can be determined by calculating derivatives
to kinetic parameters, as applied in different apoptosis modeling studies [41, 47,48].
Furthermore, direct Lyapunov exponent (DLE) analysis has been used in apopto-
sis models to characterize functional roles of signaling species. By this method,
trajectory changes of model species due to changes in initial concentrations of in-
volved signaling proteins can be determined to analyze consequences for cellular
fates [98, 146].
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ICellular heterogeneity determined by variable
protein levels: cell ensemble model of apoptosis

A manuscript based on the content of this part has been submitted to the journal
’Science Signaling’ [126]. The study described in this part was supervised by Dr.
Stefan Legewie (IMB, Mainz) and Dr. Joel Beaudouin (German Cancer Research
Center, Heidelberg). Basic ideas of this part had their origin in the master thesis of
Juliane Claus that was supervised by Dr. Stefan Legewie [153]. Parts of the project
were accomplished during the stay of Stefan Kallenberger in the lab of Prof. Peter
Sorger at Harvard Medical School.
3. Introduction
A fundamental problem of cancer chemotherapies is fractional killing. After ap-
plying a cell death inducing chemotherapy protocol, a small fraction of the tumor
cell population survives, in which apoptosis could not be induced. Fractional killing
can be explained by variability of apoptotic signaling protein concentrations. The
question arises, which combinations of protein levels are decisive for survival and
the variability of cell death timing. Extrinsic apoptosis, which is targeted by thera-
peutically used cell death ligands, is initiated by the activation of caspase-8, which
subsequently causes the activation of effector caspases that dismantle the cell. A
part of the tumor cell population might, for example, survive due to a too low num-
ber of cell death receptors in combination with a certain too low level of caspase-8
at a given cell death stimulus. This part describes an approach that links the vari-
ability of apoptotic signaling protein levels with the variable cell death kinetics in a
heterogeneous cancer cell population.
For this purpose, a technique was developed to record time series of caspase activ-
ities, resulting from a cell death stimulus, in single cells that is described in chapter
4. Then, a novel modeling approach was developed in order to describe a heteroge-
neous cancer cell population with a cell ensemble model that combines time series
from single cells with population data (chapter 5). Based on the current biochemical
knowledge on apoptosis, ODE model variants were developed, which are described
in chapters 6 and 7, in order to investigate the mechanism of apoptosis initiation,
its temporal control and to simulate cell populations. A minimal model variant was
found and experimentally validated, in which prodomain cleavage sites are cleaved
within dimers and enzymatic domain sites are cleaved between dimers. The model
of caspase-8 activation indicates mechanistic similarities to caspase-9 activation at
apoptosomes, and that caspase-8 acts as molecular timer, which terminates its own
cleavage activity after a certain active period. Obtaining a valid model to simulate
cell death of heterogeneous cancer cell populations is motivated by the optimization
of chemotherapeutic treatments: Conditions can be predicted that maximize the
fraction of apoptotic cells. To this end, a multivariate log-normal joint distribution
was estimated by fitting a model simultaneously to a heterogeneous population of
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cells (chapter 8). This multivariate joint distribution was used for further simula-
tions of “random cells” and effects of taking influence on the start concentrations
of involved signaling proteins. As discussed in chapter 9, a model topology was
found that effectively contributes to pathway branching between non-apoptotic sig-
naling pathways at weak cell death stimulus strengths and an efficient induction of
apoptosis at higher stimulus strengths.
Initiation of extrinsic apoptosis by caspase-8 activation
Extrinsic apoptosis is initiated by extracellular death ligand and by formation of
the Death Inducing Signaling Complex (DISC) [6] that serves as a platform for the
activation of initiator caspases, caspase-8 and -10. These enzymes cleave and acti-
vate effector caspases, caspase-3 and -7, and cleave the pro-apoptotic Bcl2 family
member BID to tBID, which induces mitochondria outer membrane permeabiliza-
tion (MOMP). MOMP irreversibly triggers effector caspases activation by releasing
further pro-apoptotic proteins. In so-called type I cells, initiator caspases activity is
sufficient for direct activation of effector caspases, while type II cells require indirect
activation via BID cleavage and MOMP [98,154]. Despite extensive characterization
of caspase-8/10 activation, cleavage and other posttranslational modifications, little
is known on how their cellular activity is effectively generated and controlled over
time, and how it allows cells to decide between death and survival.
DISCs contain clustered CD95/Fas death receptors bound to the adaptor pro-
tein FADD on their cytosolic domain, on which dimers of procaspase-8 are assem-
bled [5, 155]. The two main procaspase-8 isoforms, procaspase-8a and b (p55 and
p53), consist of a prodomain (p26/24), which interacts with FADD, and an enzy-
matic domain with two subunits, p18 and p10. The prodomain and the enzymatic
subdomains are connected with linkers that can be cleaved by caspase-8 itself. Cleav-
age at D374 and D384 between the catalytic subunits generates p43/41 and p10,
which typically appear first after activation [7, 156]. Cleavage at D210 and D216,
between the prodomain and the catalytic subunits, leads to the formation of p26/24
and p30 if cleavage occurs on p55/53, or to the formation of p26/24, p18 and p10
if cleavage occurs on p43/41 [86]. Fully cleaved caspase-8 is released from the DISC
to the cytosol as the hetero-tetramer p182-p102.
Uncleaved procaspase-8 dimers can cleave themselves and a restricted group of
local DISC bound proteins [157, 158], while cleavage to p43/41 leads to a “sub-
strate switch” allowing the cleavage of downstream effectors of apoptosis as BID or
procaspase-3 [87]. Proximity induced activation of caspase-8 is attributed to dimer-
ization, while cleavage of the inter-subunit linker in procaspase-8 dimers is thought
to stabilize the dimeric conformation [159,160] and is required for caspase-8 cleavage
activity towards downstream substrates, as it is the case for p43/41 [87, 161]. Two
active caspase-8 pools are constituted from this activation process, a membrane pool
represented by p43/41, and a cytosolic pool of p18/caspase-8.
As procaspase-8 is at the same time enzyme and substrate its cleavages can occur
in three ways: by an intramolecular process, an intermolecular process within dimers,
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or an interdimeric process. Contradictory results have been obtained concerning
the intra- vs. intermolecular cleavage of caspase-8: Chen et al. proposed that the
first cleavage event in caspase-8 auto-processing is intramolecular [162]. Moreover,
structural studies proposed that the cleavage sites in the catalytic subunits may
access the active site inside the same molecule and favored intra-dimer processing
[163, 164]. However, active, processed caspase-8 and other proteases can cleave
dimeric procaspase-8 via an interdimeric process [78,156].
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4. Quantifying enzyme activities by a
confocal imaging based method
This chapter describes a new method to quantitatively observe compartmentalized
caspase-8 cleavage activity in single cells. Cleavage probes containing fluorescent
proteins were expressed in cells. While uncleaved probes are kept in the cytosol,
after cleavage, the fluorescent proteins can enter the nucleus. Time series of nuclear
fluorescence intensities were recorded by confocal microscopy under various exper-
imental conditions. From these intensity time series, enzyme activities, which are
proportional to single cell concentrations of active forms of caspase-8, were calcu-
lated that can be used to calibrate ODE models of extrinsic cell death as it will
be described in the subsequent chapters. Finally, the method was compared with
a previous approach that employs fluorescence resonance energy transfer (FRET)
cleavage probes.
Caspase-8 substrates such as caspase-3 and BID can be cleaved by the caspase-8
intermediate p43/p41 (later referred to as p43) at the plasma membrane and its final
product p182-p102 (later referred to as p18), which is released to the cytosol, but not
by p55/p53 (later referred to as p55) or p30 [87,161]. Here, two compartmentalized
caspase-8 specific cleavage probes were used, to distinguish the cleavage activities
of the p43 and p18 intermediates. These cleavage probes are targeted to differ-
ent cellular compartments by fusing fluorescence proteins to localization domains
through a short cleavage sequence of amino acid residues IETD (Isoleucine - Glu-
tamic Acid - Threonine - Aspartic Acid), recognized specifically by caspase-8. Upon
caspase-8 activation, the linker is cleaved and the fluorescent protein released from
its localization domain allowing the fluorescent proteins to equilibrate over the entire
cell [136]. Dynamic changes in nuclear intensity measured by time-resolved confo-
cal microscopy imaging, served as readout for enzymatic activity. To distinguish
the cleavage activity of caspase-8 at the plasma membrane and within the cytosol
Calnexin, which localizes at the surface of the endoplasmic reticulum (ER) [165],
was fused to mGFP through the cleavage sequence IETD. This probe monitors the
activity of the cytosolic form of caspase-8 (p18) away from the plasma membrane.
The other cleavage probe employs a nuclear export signal (NES), which causes its ac-
tive transport out of the nucleus [166] and restricts its localization to the complete
cytosol. Therefore, the NES probe can be used for reporting cleavage activity of
caspase-8 at both the plasma membrane (p43) and within the cytosol (p18 , Figure
4.1).
The degree of probe cleavage reflects the integrated activity of caspase-8 over
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Figure 4.1. Observation of single cell caspase-8 trajectories with cleavage probes.
Schematic representation of CD95 signaling: Subsequently to CD95 ligand binding to
CD95 death receptors and FADD binding, dimers of procaspase-8 (p55) are assembled
that can be cut at two cleavage sites (drawn in red). Cleavage in the catalytic domain
generates p43, which is further processed in the prodomain to p18 that enters the
cytosol. Prodomain linker cleavage in p55 produces catalytically inactive p30. While
the cytoplasmic probe can be cleaved by p43 and p18, the ER probe is cleaved by p18
only.
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Figure 4.2. Quantification of caspase-8 enzyme activities. (A) Live-cell imaging of
probe cleavage (red channel – mCherry/cytosolic probe, green channel – mGFP/ER
probe). In two marked cells time series of nuclear fluorescence intensities (C) were
measured and transformed to concentrations of uncleaved probes (D) or p43 and p18
(E) using equations 4.5 and 4.6.
time, but not the caspase-8 activity at a certain time point. A mathematical model
was developed to derive the enzymatic activities of p18 and p43 from the imaging
based cleavage data (Figure 4.2).
The model assumes that enzyme saturation in caspase-8 mediated probe cleavage
can be neglected. The cleavage rate of a probe ˙[Pr] is then proportional to the
concentration of the uncleaved probe [PrF ] and of caspase-8 [C8] multiplied by the
kinetic constant kprobe
˙[Pr] = kprobe[C8][PrF ] ⇔ kprobe[C8] =
˙[Pr]
[PrF ] . (4.1)
The caspase-8 activity profile can thus be calculated by extracting ˙[Pr] and [PrF ]
from the data. To this end ˙[Pr] and [PrF ] will be expressed as functions of average
probe intensities in the nucleus Incl and in the total cell Itot because these intensities
can be extracted most reliably from single-cell measurements. Alternatively, the
averaged probe intensities in the nucleus Incl and in the cytosol Icpl could be used
as described in the following.
Upon stimulation, the number of uncleaved probes NPrF reacts to NPr cleaved
probe molecules and NF = NPr fluorescent protein molecules. The fluorescence
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intensity in the nucleus Incl = cNF/Vc, reflects the number of fluorescent protein
molecules NF in the cell volume Vc, multiplied by a scaling factor c. The total
concentration of cleaved probes [Pr] is higher than the concentration of fluorescent
protein molecules by the ratio of the cytoplasmic volume Vcpl and the total cellular
volume
[Pr] = NPr
Vcpl
= NF
Vcpl
= Vc
cVcpl
Incl. (4.2)
The concentration of the uncleaved probes [PrF ] can be either determined by
additionally measuring the average intensity inside the whole cell Itot = c(NPrF +
NF )/Vc or the fluorescence intensity inside the cytosol Icpl = c(NPrF/Vcpl +NF/Vc)
as
[PrF ] = NPr
Vcpl
= 1
c
(Icpl − Incl) = Vc
cVcpl
(Itot − Incl). (4.3)
Thereby, estimates of the amount of active caspase-8 multiplied by the cleavage
constant
kprobe[C8] =
Vc
Vcpl
˙Incl
Icpl − Incl =
˙Incl
Itot − Incl (4.4)
are obtained, eliminating the scaling factor.
The ER-anchored cleavage probe PrERF1 can only be accessed by the soluble,
cytoplasmic form p18. Based on the approach described in Equations 4.1-4.4, the
activity from cytoplasmic [p18]
˙[PrER] = kprobe[p18][PrERF1] ⇔ kprobe[p18] =
˙I1,ncl
I1,tot − I1,ncl (4.5)
can be calculated using I1,tot the trajectories for I1,ncl. The activity of the active mem-
brane bound intermediate p43 cannot be calculated directly, because no membrane-
specific cleavage probe is available. The total concentration of active casepase-8
equals the sum of soluble and membrane-bound forms ([C8tot] = [p18] + [p43]).
For simplicity, it was assumed that probe cleavage by p43 and p18 is of similar
magnitude, and can be described with the same kinetic constant kprobe. Then, the
membrane-bound activity can be calculated based on the difference between terms
for cytosolic and ER probe cleavage (PrcplF2 and PrERF1, respectively)
˙[Prcpl] = kprobe ([p43] + [p18]) [PrcplF2] ⇔
kprobe[p43] =
˙I2,ncl
I2,tot − I2,ncl −
˙I1,ncl
I1,tot − I1,ncl . (4.6)
In the case of this study F1 is mGFP and F2 is mCherry. Automated image
analysis was employed to estimate amounts of cleaved and uncleaved probes. The
total cellular and the nuclear fluorescence intensities were extracted by segmentation.
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MatLab scripts (The Mathworks, Natick, MA, USA) and the software ImageJ (NIH,
Bethesda, MD, USA) were used for segmentation and analysis of cell shapes and
intensities from stack data and of nuclear intensities from slide data for every time
point. NES-probe signals were used to segment inner and outer cytoplasm and
nucleus borders. Volumes were calculated by voxel numbers and voxel volumes of
0.427×0.427×0.7µm3 while cell surface areas were calculated by adding faces areas
of polygon meshes (Table A.4).
Equations 4.1-4.6 require that slopes of probe cleavage can be estimated from
time course data with limited sampling rate. To improve the robustness of slope
estimation, temporal derivatives in equations 4.5 and 4.6 were calculated over longer
time intervals, in which several intensity measurements were averaged. For each
single cell quantity, values were calculated in eight equidistant time intervals. This
relatively small number was chosen to obtain a reasonable signal-to-noise ratio in
p43 and p18 activities, which limited the propagated error from noisy intensity
measurements. Optimizing model fitting performance was a further reason to keep
the number of data points for each cell low.
Smoothing splines were fit to the nuclear intensity trajectories. The errors ∆I1,ncl
and ∆I2,ncl were estimated as standard deviation of the difference between the
smoothing spline and experimental data. For I1,tot and I2,tot an error of 10 percent
was assumed. Figure 4.3 shows trajectories of estimated total caspase-8 activities in
single CD95-HeLa and HeLa wt cells at different death ligand concentrations. CD95-
HeLa cells underwent apoptosis in the range between 40 minutes and around two
hours. In these cells, at a ligand concentration of 10000 ng/ml caspase-8 trajecto-
ries and cell deaths are slightly delayed compared to the trajectories at 5000 ng/ml.
Caspase-8 trajectories for HeLa wt cells that undergo apoptosis in the range of one
to twelve hours show a more pronounced saturation behavior of caspase-8 activity
and cell death kinetics at increasing ligand concentrations. While highest caspase-8
activities are obtained at 2000 ng/ml, caspase-8 activity decreases and cell death is
delayed at higher concentrations.
In few cells, almost the total amount of cytoplasmic cleavage probes was cleaved
before apoptosis. Then nuclear fluorescence intensity that indicates the concentra-
tion of cleaved off fluorescent protein approximates the cytosolic fluorescence inten-
sity representing the sum of uncleaved and cleaved probe concentrations. As soon
as the nuclear intensity Incl was equal or larger than 90% of the average intensity
of the whole cell Incl ≥ 0.9 · Itot further calculating of caspase-8 observables was
stopped. When further calculating caspase-8 observables, flattening of observable
trajectories can be observed due to probe depletion.
Caspase-8 activation is known to be significantly enhanced by caspase-3 mediated
feedback cleavage, which is activated after MOMP in the last six to eight minutes
before apoptosis [82,167]. Recently it was shown that before MOMP, most caspase
activity seen from the probes indeed comes from caspase-8 [136]. As this study was
focused on the primary dynamics of caspase-8 autoprocessing, the last 10 minutes
prior to bleb appearance from analysis were excluded. The kinetics of probe cleavage
was recorded in HeLa wt and in CD95-HeLa cells, which stably overexpressed CD95
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Figure 4.3. Single cell caspase-8 trajectories. Observable trajectories for C8tot (sum
of p43 and p18 observables) in CD95-HeLa (A) and HeLa wt (B) cells at indicated
CD95 ligand concentrations show decreased caspase-8 activity and delayed cell death
at high ligand concentrations (error bars: propagated errors in observable calcula-
tions). Cell fates are indicated by symbols at the trajectory ends: In most cells
apoptosis (stars) could be monitored. When starting cell division (circles), the com-
partmentalization of the NES probes was lost, and no further data could be obtained
in mitotic cells undergoing apoptosis. In few cells, almost the total amount of cy-
toplasmic cleavage probes was cleaved before apoptosis (diamonds) and caspase-8
trajectories could not be further determined.
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Figure 4.4. Live-cell confocal microscopic images for an exemplary cell that expresses
NES- and FRET-cleavage probes. After cleavage of the nuclear export signal (NES)
probe, the fluorescent protein mCherry enters the nucleus (top row). Cleavage of the
FRET-probe separates the two fluorescent proteins CFP and YFP. The loss of FRET
is measured in the quotient of the intensities ICFP /IY FP (bottom row).
by 10-fold. At different ligand concentrations more than 100 cells were analyzed in
each cell line. Time of death, visually estimated as the time of apoptotic membrane
blebbing, was between 1 and more than 12 hours for HeLa wt and between 40 to 120
minutes for CD95-HeLa cells. A representative result for quantitative estimation of
model-based caspase-8 activity is shown in Figure 4.2. Activity of probe cleavage
is low in the beginning, and is strongly enhanced in the second half of the time
course (Figures 4.2A and 4.2B). Temporal profiles were experimentally confirmed
with fluorescence resonance energy transfer (FRET) cleavage probes simultaneously
expressed with NES cleavage probes as described in the following paragraph.
Comparison of caspase-8 activity profiles in FRET- and NES-probe measure-
ments Currently two methods are available to monitor caspase-8 activity in single
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cells. Several studies used FRET-reporters that consist of a pair of fluorescent pro-
teins, usually CFP and YFP, connected with a cleavage sequence that is specific
for caspase-8 [81, 82, 85]. Probe cleavage is indicated by loss of FRET effect, which
resembles an energy transfer from the donor fluorophore CFP to the acceptor fluo-
rophore YFP [168]. The energy transfer underlies the dipole-dipole coupling between
donor and acceptor. The alternative excited-state relaxation competes with photon
emission of the donor. Small changes between donor and acceptor molecule distance
R can be detected as decay of the FRET efficiency
EFRET =
R60
R60 +R6
,
in which the Förster radius R0 denotes the molecule distance at a FRET efficiency
of 50% [169].
Here, both methods were compared and their equivalence was shown. Figure 4.4
shows microscopic image data from exemplary cells that after transient transfection
simultaneously express FRET and NES cleavage probes and were stimulated with
CD95L. Cleavage of the NES-probe containing the cleavage site for BID (top panel,
NES-ELQTDG-mCherry) can be measured by an increase of the nuclear fluorescence
intensity ImCherry,ncl, while FRET probe (CFP-ELQTDG-YFP) cleavage is indicated
by an increase of the ratio
ICFP
IY FP
= I˜CFP − ICFP,bg
I˜Y FP − IY FP,bg
of background subtracted intensities of CFP and YFP (bottom panel).
The single cell trajectories (Figures 4.5A and 4.5B) of cells that simultaneously
express both probes show high correlation coefficients (Figure 4.5C).
Fluorophore intensities were processed such that uncleaved probe levels are di-
rectly comparable (Figure 4.2C). Calculated enzyme activity trajectories (Figure
4.2D) were very similar between individual cells, confirming the robustness of the
method. Membrane cleavage activities (p43) showing a steep increase after the cer-
tain latency period largely exceeded the cytosolic cleavage activities (p18), which
showed a delayed set off and a more gradual increase.
Taken together, employing cleavage probes for calculating caspase activities in
single cells has proven to be a robust and reproducible method to obtain insights to
variable cell death kinetics in an ensemble of single cells. The approach of generating
quantitative protease activity trajectories could be transferred to similar systems of
intracellular proteases as cathepsins, serine proteases, secretases or HIV-protease to
obtain mechanistic insights to involved signaling pathways.
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Figure 4.5. Single cell trajectories for NES- and FRET-probe cleavage related to
caspase-8 activity. (A) Fluorescence intensity trajectories of all measured cells (n=33)
were determined in ROIs within cross sections of the nuclei. (B) FRET signal trajec-
tories of all measured cells. The quotients of the fluorescence intensities for CFP and
YFP were measured in ROIs of whole cell cross sections, respectively. The NES probe
and FRET probe trajectories of three representative cells are highlighted in green,
blue or red. (C) Correlation coefficients ρ between FRET- and NES-probe signal tra-
jectories for each cell dependent on the time of cell death tapt. The blue bars represent
the numbers of cells that underwent cell death in a certain time interval. Correlation
coefficients ρ (indicated by gray dots) are lower for cells with smaller tapt, which can
be explained by a lower number of data points at equal noise levels.
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5. Integrating single cell and
population data in a cell ensemble
model
Mathematical models of signal transduction are typically fitted to cell population
data that have two main disadvantages: they hide cell-to-cell variability and smoo-
then, as they represent population averages, the kinetics that would be seen in indi-
vidual cells. In a situation, where single cells show steep and switch-like trajectories
with variable temporal delay population observable trajectories will show a grad-
ual response, which hides the kinetics of the underlying biochemical process. This
chapter describes how different experimental data were simultaneously described
by cell ensemble models, which combine the advantages of different experimental
techniques, integrate information of different qualities and describe heterogeneous
populations of cells. The subsequent chapters 6 and 7 will describe the model com-
ponents that are based on this approach.
Single cell observables that were obtained with help of cleavage probes as de-
scribed in chapter 4 were restricted to catalytically active caspase-8 forms. In
contrast, also inactive enzyme intermediates and other cleavage products can be
quantified by the conventional population based method of western blotting. The
dataset of single cell observables was enriched by population-based western blot mea-
surements of p55, p43, p30, p18, as well as BID and tBID in CD95-HeLa cells at 50
and 500ng/ml (Figures 7.6, A.8 and A.9). Flow cytometric measurements further
allowed restricting the cell-to-cell variability of signaling protein concentrations to
a physiologically relevant range (Table 5.3, Figures A.13 and A.14). Experimen-
tal data obtained by several techniques, providing information of different qualities,
were integrated in a multi-scale modeling approach (Figure 5.1). To simultaneously
describe a heterogeneous cell population an ensemble of single cell models was cre-
ated, in which each cell is described with equal sets of ODEs and the same kinetic
parameters, but by different initial protein concentrations, thus introducing cell-to-
cell variability. The ensemble of single cell models was fitted to single cell observables
for uncleaved probes, yPrERF1 and yPrcplF2 , as well as yp43 and yp18, from an ensemble
of cells. Simultaneous to fitting of individual parameters, ensemble averages were
fitted to western blot data (Figure 5.1).
Setting boundary conditions for model fitting by quantifying mean protein levels
and variances In order to define appropriate starting conditions for the estimation
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Figure 5.1. Representation of data from different experimental techniques in the
model. Single cell models were fitted to single cell measurements −→yn. Population
based measurements −→Y for caspase-8 intermediates, BID and tBID are represented
by sums of single cell variables xn weighted by cellular volumes Vn. Distribution
parameters σ from flow cytometry and mean initial protein levels from western blot
were not directly fitted but used to constrain parameter limits.
of initial protein concentrations of involved signaling species in single cells, mean
protein levels were measured with calibrated western blots and by fluorescence acti-
vated cell sorting (FACS) using calibration beads. Furthermore, FACS was applied
to measure variances of protein levels and thereby define lower and upper allowed
boundaries for estimated protein levels in single cells to constrain the mathematical
model of caspase-8 processing.
To determine average protein levels, in the first step GFP fusions to FADD, p55,
and BID were calibrated with recombinant GFP of known concentration by western
blot. In the second step, these calibrated GFP fusions were blotted simultaneously
with cell lysates of cleavage probe expressing HeLa wt and CD95-HeLa cells (Tables
5.1, Figures A.10-A.12). For this purpose, cell lines stably expressing FADD-GFP
or p55-GFP were generated from HeLa wt cells. The same cell line was used to tran-
siently express BID-GFP-mCherry. The concentrations of FADD-GFP, p55-GFP
and BID-GFP-mCherry in fusion protein lysates were estimated by a calibration
curve that was obtained by simultaneously blotting fusion protein lysates together
with different doses of recombinant GFP, and immunostaining of GFP. Endogenous
levels of FADD, p55, BID and cytosolic cleavage probes (NES-GIETDS-mCherry)
were determined by blotting different doses of fusion protein lysates together with
lysates of probe expressing CD95-HeLa and HeLa wt cells, and immunostaining
with antibodies against FADD, p55, BID and mCherry (Figures A.10-A.12). Aver-
age levels of the ER probe (Calnexin-GIETDS-mGFP) could be directly measured
by blotting lysates of probe expressing cell lines together with known doses of recom-
binant GFP (Figure A.12). The order of samples was shuﬄed to avoid biases from
gel and blotting inhomogeneities [170]. Employing the method of calibrated western
blots to determine average protein concentrations yielded relatively large standard
deviations but served to estimate the orders of magnitude of protein levels and were
sufficient for defining start values in the parameter fitting procedures. Estimates of
FADD and p55 had the same magnitude order as in the study of Fricker et al. [46]
(NFADD ≈ 200.000/cell compared to 130.000/cell, and NFADD ≈ 320.000/cell com-
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CD95R-HeLa (mean ± SD) HeLa wt (mean ± SD)
FADD 200843 ± 31549 229583 ± 31073
procaspase-8 334075 ± 143428 324431 ± 164643
BID 509926 ± 48462 571555 ± 108848
cytosolic probe 2093323 ± 759296 4852343 ± 1514532
ER probe 11137085 ± 4103493 8428324 ± 4495411
Table 5.1. Estimates of protein numbers in CD95R-HeLa and HeLa wt cells from
calibrated western blots (means ± SD, nsamples = 4).
N (c. i.)
HeLa wt 12085 (11807, 12363)
CD95R-HeLa 157087 (155607, 158580)
HeLa wt, with probe expression 63425 (53014, 73892)
CD95R-HeLa, with probe expression 330269 (322410, 338155)
Table 5.2. Estimates of receptor numbers in probe expressing and native CD95R-
HeLa and HeLa wt cells by calibrated FACS measurements.
pared to 250.000/cell). In this study, FADD and p55 levels of similar magnitude in
probe expressing CD95-HeLa and HeLa wt cells were measured.
Mean levels of CD95 receptors and variability of CD95 receptors, FADD, p55
and BID were determined in probe expressing or not probe expressing HeLa wt and
CD95-HeLa cells by immunostaining followed by flow cytometry (Table 5.2, Figures
A.13 and A.14). The absolute concentration of CD95 receptors was estimated with
help of calibration beads carrying defined epitope numbers for secondary antibodies
(Figure A.13). CD95 receptors on the surface of cells are bound by primary anti-
bodies under saturation conditions, i.e. where it can be assumed that all receptors
are bound to primary antibodies. Then, beads and cells with bound primary anti-
bodies were stained with fluorescently labeled secondary antibodies. Cells that were
incubated with the secondary but without the primary antibody served to measure
the background fluorescence intensities. The measured intensities were at the upper
limit of the intensity range of the calibration beads. Therefore the calibration error
was rather large in the probe expressing cells. To initialize the parameter estimation
a receptor concentration start value was used, which lay between measures for the
native and the probe expressing cells according to N ≈ 30000 receptors for probe
expressing HeLa wt cells and N ≈ 250000 receptors for probe expressing CD95R-
HeLa cells (see Table 5.3) that were as well consistent with earlier studies on these
cell lines [46,48].
FACS distributions were used to restrict the variability of initial protein concen-
trations for CD95R, FADD, p55 and BID in the model to physiologically reasonable
levels. To measure variability of protein levels independent from cell size, FACS
events were filtered for cells of similar volumes by gating for narrow front scat-
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ter and side scatter intervals. To correct intensity measurements for background
fluorescence, medians of normal distribution function fits to intensities of control
measurements were subtracted. The lognormal distribution parameters µ and σ for
initial concentration distributions were determined by fitting the probability density
function
f(ζ) = 1
ζσ
√
2pi
exp
(−(ln ζ − µ)2
2σ2
)
to rescaled and background corrected FACS signal ζ. Compared to the immunos-
taining of membrane bound receptors, intracellular staining of FADD, p55 and BID
cannot be assumed to achieve saturation with primary antibodies and mean levels
will be underestimated by FACS. Therefore, the variance measured in FACS exper-
iments was combined with mean levels from the more accurate calibrated western
blots to obtain lognormal probability density functions of initial protein concentra-
tions. In order to restrict initial protein concentrations in the model, 5% and 95%
percentiles were calculated and combined with mean signals from western blots to
set lower and upper limit for parameter fitting, respectively (Table 5.3).
Coefficients of variation in the range of V arK =
√
exp(σ2)− 1 = 0.8 . . . 1.1 were
obtained, which are rather large compared to studies on the variability of protein
levels [171, 172], probably due to additional variability from intracellular antibody
staining and FACS measurements. For this reason, the obtained 5% percentiles
were used as lower and 95% percentiles as upper allowed boundaries for estimations
of initial protein concentrations in each cell. Cellular volumes that were used to
calculate average protein concentrations in Table5.3 from protein numbers per cell
as well as surface areas were determined by segmentation from confocal microscopic
image stacks (Table A.4). For the ER-anchored and cytosolic probes the initial val-
ues were directly determined in individual cells by combining single cell observables
yPrERF1 and yPrcplF2 from live-cell experiments with the average value from western
blot measurements. Therefore, it was not required to define upper and lower limits
for initial cleave probe concentrations.
Combining single cell with population observables The experimental data set
comprised measurements at the single-cell and population levels. Single-cell models
were directly fitted to single-cell measurements, and variability was introduced by
allowing the initial signaling protein concentrations to vary between individual cells.
Population-based measurements were represented in the model by ensemble averages
of multiple single-cell models. In the following, it shall be described in detail how
model variables were fitted to observables from single cell and population based
experiments.
Single cell observables ~ynof cells for the uncleaved probe concentrations, yPrERF1,n
and yPrcplF2,n, as well as observables for effective caspase-8 concentrations yp43,n and
yp18,n were used for model fitting. The model variables were linked to observables by
using scaling factors s that were estimated from the data. At four different ligand
concentrations, ten cells were included respectively. In total data from 80 cells was
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CD95R-HeLa HeLa wt
cˆ u5% u95% cˆ u5% u95%
CD95R 116 34 396 12 2,4 58
FADD 93 21 405 90 22 372
procaspase-8 155 36 671 127 37 434
BID 236 59 943 224 47 1060
cˆ cmin cmax cˆ cmin cmax
cytosolic probe 973 n.d. n.d. 1909 n.d. n.d.
ER probe 5178 n.d. n.d. 3316 n.d. n.d.
Table 5.3. Initial values, lower and upper limits for estimations of initial concentra-
tion. The values for CD95R correspond to estimates from calibrated FACS measure-
ments, whereas the values for FADD, procaspase-8 and BID correspond to the median
protein numbers obtained from calibrated western blots and FACS experiments. For
CD95R, FADD, procaspase-8 and BID, 5% and the 95% percentiles u5% and u95% were
estimated by fitting lognormal probability density functions to FACS signals. Lower
and upper limits were not defined for the cytosolic and the ER probes as probe concen-
trations were directly determined by combining single cell observables from individual
cells with the mean values from western blot experiments.
included. When fitting a model topology to data from 80 cells, more than 2560
residuals were minimized (80 cells × 4 observables × 8 time points).
To include population data into the parameter fitting procedure and link popula-
tion observables with model variables for single cells population observables Y were
introduced. A population observable was assumed to be proportional to the sum of
the corresponding single cell variables xn, weighted by the cellular volumes Vn that
were segmented from microscopic data. The total amount of caspase-8 and BID,
estimated from the band intensities, did not significantly change over time. Single
cell observables
~yn(ti) =

yp43
yp18
yPrERF1
yPrcplF2
 =

sC8[p43]n(ti) + p43
sC8[p18]n(ti) + p18
sF1[PrERF1]n(ti) + PrERF1
sF2[PrcplF2]n(ti) + PrcplF2
 = ~s ~xn(ti) + ~ (5.1)
of each cell n included in the model were related to the model variables ~x with
entries[p43]n to [PrcplF2]n multiplied by scaling factors ~s with entries sC8 for caspase-
8 species, as well as sF1 and sF2 for the two fluorescent proteins F1 and F2 with
experimental errors ~ for each species. Population observables Y were related to nor-
malized ensemble averages of corresponding single cell variables that were weighted
with cell volumes Vn, respectively. The absolute values for western blot intensities
and variables for each caspase-8 species (p55, p43, p30 and p18) and the two forms of
BID (BID and tBID) were normalized by the respective sums of intensities caspase-8
or BID intensities
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IC8,tot = Ip55 + Ip43 + Ip30 + Ip18 (5.2)
or
IBID,tot = IBID + ItBID (5.3)
and sums of concentrations
SC8 =
∑
n
Vn ([p55]n + [DISCp55]n + [p43]n + [p18]n + [p18i]n) (5.4)
or
SBID =
∑
n
Vn ([BID]n + [tBID]n) . (5.5)
The expression for the population observables at time points tk reads
~Y (tk) =

Ip55(tk)/IC8,tot(tk)
Ip43(tk)/IC8,tot(tk)
Ip30(tk)/IC8,tot(tk)
Ip18(tk)/IC8,tot(tk)
IBID(tk)/IBID,tot(tk)
ItBID(tk)/IBID,tot(tk)

=

∑
n
Vn ([p55]n(tk) + [DISCp55]n(tk)) /SC8 + ∆p55∑
n
Vn[p43]n(tk)/SC8 + ∆p43∑
n
Vn[p30]n(tk)/SC8 + ∆p30∑
n
Vn ([p18]n(tk) + [p18i]n(tk)) /SC8 + ∆p18∑
n
Vn[BID]n(tk)/SBID + ∆BID∑
n
Vn[tBID]n(tk)/SBID + ∆tBID

= ~Xp(tk) + ~∆. (5.6)
Therein, ~Xp denotes derived population variables with errors ~∆. By using west-
ern blot band intensity fractions instead of absolute intensities the introduction
of another scaling factor was avoided. Furthermore, fractions of western blot in-
tensities were used in order to avoid errors from small differences in total protein
amounts within western blot samples for different time points that result from the
experimental procedure of sample preparation.
While the single cell observable yp18,n for p18 reflected the corresponding single
cell variable [p18]n of active p18, the western blot observable Yp18 derived from the
western blot intensity Ip18 reflected the sum of active p18 as well as the inactive
species p18i and was related to the sum of single cell variables [p18]n and [p18i]n.
Thereby, combining single cell and western blot data facilitated estimating the sta-
bility of p18.
By parameter fitting, the kinetic model parameters were globally estimated, i.e.
they were assumed to be equal for each cell. Furthermore, initial concentrations
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for CD95R, FADD, p55, BID and the two cleavage probes were locally estimated
for each included cell. The function of residuals R, which was be minimized during
parameter estimations, comprised three parts: a weighted sum of single cell residuals
Rsc, a residual term for the population observables Rp and another residual term
Rx¯0 to minimize the distance of initial concentration averages and experimentally
determined mean protein concentrations
R = Rsc +Rp +Rx¯0 (5.7)
with
Rsc =
∑
i,j,n
sjxjn(ti)− yjn(ti)
ijn
, (5.8)
Rp = N
∑
k,l
(Yl(tk)−Xl(tk)) (5.9)
and
Rx¯0 =
∑
s
∣∣∣∣∣∣∣∣∣∣∣∣∣
1
Ns

∑
ns
Vns [CD95R]ns(t0)∑
ns
Vns [FADD]ns(t0)∑
ns
Vns [p55]ns(t0)∑
ns
Vns [BID]ns(t0)
−

CD95RFACS
FADDWB
p55WB
BIDWB

∣∣∣∣∣∣∣∣∣∣∣∣∣
. (5.10)
Equation 5.8 weights the difference between model observables sjxjn(ti) for cell n
and single cell data yjn(ti) by the experimental errors ijn for each time point i that
was obtained by error propagation for single cell observable calculations as described
in chapter 4. In Equation 5.9 the residuals Rp for population observables Yj were
weighted by the number of cells N included in the model rather than weighting by
the experimental error of each western blot sample. This procedure is equivalent
to choosing an error model with a certain relative error, and had turned out to be
more robust for parameter fitting. In Equation 5.10 the single cell model averages
for initial CD95R, FADD, p55 and BID concentrations in HeLa wt or CD95-HeLa
cells were compared with experimentally determined averages, from FACS or west-
ern blot experiments, respectively. This penalty term should assure that single cell
models, which were fitted to data of cells at different ligand concentrations, had the
same mean initial concentrations. Therefore, differences were calculated for experi-
mental sets of data s that comprised a group of ns = 1 . . . Ns cells with N =
∑
s
Ns
treated at the same ligand concentration, respectively. Single cell data of two cell
lines were recorded at four ligand concentrations, respectively, which results in a
total number of eight datasets. It was tested, if further penalty terms that represent
additional boundary conditions are beneficial for parameter estimations and accel-
erate the convergence of model fits. Tentatively, a penalty term was included in R
for deviations between of lognormal distributions of estimated initial concentrations
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and the corresponding distributions from FACS experiments. However, as experi-
mentally determined variability was unrealistically large, distribution penalty terms
were not further employed.
For parameter estimations, the squared residuals in Equation 5.7 were minimized,
employing a trustregion algorithm. While the squared single cell residuals corre-
spond to a χ2 estimator, the two additional residual terms represent artificial bound-
ary conditions to comply with physiological circumstances.
Taken together, the described procedure represents a substantial extension of
previous apoptosis models that took into account cell-to-cell variability. So far, no
other model of cellular signal transduction networks was calibrated with the combina-
tion of time resolved single cell and population observables. The study of Albeck et
al. [39] that was applied in further studies on cell-to-cell variability [94,95] combined
population observables from western blot and FACS experiments with distributions
of time points of certain cellular events as the time when mitochondria outer mem-
brane permeabilization or apoptosis occurred. Kinetic parameters were manually
adjusted until model simulations from randomly sampled initial conditions reflected
experimentally measured distributions. It will be the aim of further work to opti-
mize model calibration with combined single cell and population data regarding the
convergence behavior of fitting procedures, and to characterize the value of different
boundary conditions for parameter identifiability [141,142,147]. Within this context
it will be of interest, which advantages can be gained by including further boundary
conditions as probability density functions of initial protein concentrations. The
following chapters 6 and 7 address the implementation of two separate parts of the
model that was fitted to the combination of single cell and population observables.
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6. Explaining the inverse bell-shape
of cell death kinetics by receptor
oligomerization models
To investigate the quantitative dynamics of caspase-8 activation, kinetic models were
developed that comprise two parts, one describing receptor oligomerization and one
describing subsequent caspase-8 activation mechanisms. In this chapter, the first
part of the model will be described.
To characterize caspase-8 processing and identify potential non-linearities, a dose
response analysis was performed with soluble CD95 ligand fused to the T4 domain
(T4-CD95L), which stabilizes the ligand in its trimeric form [173], ranging from
50ng/ml to 10µg/ml. Interestingly, it was discovered that at high CD95 ligand con-
centrations cell death is decelerated relative to intermediate levels (Figure 6.1). This
inverse bell-shaped dose-response profile was found in HeLa wt, and to a weaker ex-
tent as tendency in CD95-HeLa cells. As a similar inverse bell-shaped dose-response
behavior was observed for probe cleavage kinetics (Figures 7.5B and 4.3, decreasing
caspase-8 activity and delayed apoptosis at high CD95 concentration in HeLa wt,
and with less extent in CD95-HeLa cells), it was hypothesized that this characteris-
tic behavior emerges early in the signaling cascade, upstream of caspase-8 activation,
possibly at the receptor level.
In the following, mathematical models of ordinary differential equations (ODEs)
based on known features of CD95 receptor-ligand binding will be described, which
reflect mechanisms underlying the inverse bell-shaped dose-response profile of cell
Figure 6.1. Median cell
death times (squares) for
HeLa wt and CD95-HeLa
cells. Error bars represent
standard deviations from
medians in different micro-
scopic fields.
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Figure 6.2. Illustration of
the mechanism of inverse bell-
shaped behavior. At high lig-
and concentrations most bound
ligands are connected to recep-
tors in a 1:1 stoichiometry, re-
sulting in a low number of
oligomerized receptors capable
of caspase-8 activation.
death. Possible model topologies shall be based on the following premises: (i) CD95
receptors oligomerize and may exist as pre-formed oligomers in the absence of stim-
ulation [174–176]. (ii) Only oligomerized receptors bound to extracellular ligand
are biologically active and serve as a platform for procaspase-8 activation. (iii) The
T4-CD95 ligand used in this study is a highly pure and stable trimer [173] that effi-
ciently induces receptor oligomerization by simultaneously binding to three receptor
monomers [177–180].
These features of receptor signaling can explain the inverse bell-shaped dose-
response profile: Each monomeric receptor binds with 1:1 stoichiometry to a trimeric
ligand if the ligand is in large excess over the receptors, which represents the state of
maximal entropy. The system is thus shifted towards biologically inactive one-to-one
complexes of receptors and ligands upon strong stimulation, whereas intermediate
concentrations of the trimeric ligand efficiently oligomerize and activate the receptor
(Figure 6.2).
Two possible models of multivalent ligand binding to oligomerizing receptors will
be discussed, a simple model of dimerization and a more complex trimer model. Us-
ing further assumptions, a steady state solution based on a simplified trimerization
model will be derived that facilitated parameter fitting, and providied an explana-
tion of the observed cell death kinetics with a similar dose response relation. The
assembly of active death receptor complexes has been shown to take place within a
few minutes after ligand addition [6], and is a rapid process compared to caspase-8
activation. Therefore time scale separation of both processes was applied, and it
was assumed that the receptor-ligand binding was at steady state for mathematical
modeling.
Model of receptor dimerization A key assumption is that only oligomerized recep-
tors bound to a multimeric ligand are active receptor species that can bind FADD
and form death inducing signaling complexes. This assumption alone, independent
from the required number of oligomerized receptors in an active receptor complex,
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Figure 6.3. Receptor oligomerization models. (A) Model of receptor dimerization,
in which receptors R reversibly dimerize, and complexes of two receptors bound to a
ligand L represent the active receptor speciesRact. (B) Model of receptor trimerization,
in which three receptors bound to one ligand represent active receptors Ract.
can explain the observed inverse bell-shaped cell death kinetics. Therefore, a suf-
ficient minimal model is a model of receptor dimerization, in which receptors re-
versibly dimerize and a ligand molecule can bind up to two receptors (Figure 6.3A).
In the following equations, r and r2 denote concentrations of monomeric receptors
[R] and receptor dimers [RR], while c1 and c2 denote concentrations of ligand bound
monomeric receptors [RL] and ligand bound receptor dimers [RRL] ≡ 1/2[Ractive].
The ligand concentration [L], denoted as l, is assumed to be constant, representing
the experimental condition where ligand is in large excess. Kinetic constants for
receptor binding and unbinding are kr+ and kr−, for ligand binding and unbinding
kl+ and kl−, respectively.
r˙ = −kr+r(2r + c1) + kr−(2r2 + c2)− kl+lr + kl−c1 (6.1)
r˙2 = kr+r2 − kr−r2 − kl+lr2 + kl−c2 (6.2)
c˙1 = −kr+rc1 + kr−c2 + kl+lr − kl−c1 (6.3)
c˙2 = kr+rc1 − kr−c2 + kl+lr2 − kl−c2. (6.4)
Equations 6.1 to 6.4 contain the simplification that binding of the second receptor
to LR (“crosslinking”) has the same kinetic parameters kr+ and kr− as binding of
the first receptor. The set of non-linear ordinary differential equations can be solved
in a steady state where r˙ = r˙2 = c˙1 = c˙2 = 0. The polynomial that results
from combining the equations and denoting the total receptor pool with r0 = r +
c1 + 2(r2 + c2) has one experimentally reasonable zero. After collecting the kinetic
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parameters for binding and unbinding in the dissociation constants KDR = kr−/kr+
and KDL = kl−/kl+ the solution for active receptor concentration reads
1
2[Ractive] ≡ c2 =
l
8KDL(KDL + l)
[
KDRl +KDL(KDR + 4r0)
−
√
KDR(KDL + l)(KDLKDR +KDRl + 8KDLr0)
]
. (6.5)
It is plotted for comparison together with other model solutions in Figure 6.4.
Model of receptor trimerization Using the more realistic assumption that ligands
can bind up to three receptors, and that ligand bound receptor trimers represent
the active receptor species, an analogous set of rate equations can be formulated.
Two further species, receptor trimers and ligands bound to three receptors, have to
be considered. Here, r3 denotes the concentration of receptor trimers [RRR], and c3
the concentration of ligands bound to three receptors [RRRL] ≡ 1/3[Ractive] (Figure
6.3B).
r˙ = −kr+r(2r + r2 + c1 + c2) + kr−(2r2 + r3 + c2 + c3)− kl+lr + kl−c1 (6.6)
r˙2 = kr+r(r − r2) + kr−(r3 − r2)− kl+lr2 + kl−c2 (6.7)
r˙3 = kr+rr2 − kr−r3 − kl+lr3 + kl−c3 (6.8)
c˙1 = −kr+rc1 + kr−c2 + kl+lr − kl−c1 (6.9)
c˙2 = kr+r(c1 − c2) + kr−(c3 − c2) + kl+lr2 − kl−c2 (6.10)
c˙3 = kr+rc2 − kr−c3 + kl+lr3 − kl−c3 (6.11)
Solving the equation system according to the dimer model would lead to a complex
cubic equation. Below, an alternative expression for active receptor levels will be
derived based on further simplifying assumptions in order to avoid terms as the
square root in Equation 6.5 that strongly increase the numerical effort for each step
of an optimization process. The steady state solutions of this simplified model will
be compared to the more exact dimer (Eqs. 6.1 to 6.4) or trimer model (Eqs. 6.6
to 6.11).
Simplified model of receptor trimerization summarizing different oligomeric
states The solution of a simplified trimerization model was derived in order to de-
crease the computational effort of parameter fitting. Therein, ligand bound oligomer
forms will be summarized in rl,tot and free receptor forms in rf,tot, assuming the same
binding kinetics for different receptor oligomerization states.
The overall concentration of receptors consists is
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rtot = rf,tot + rl,tot. (6.12)
The steady state concentration of receptor/ligand complexes depends on the lig-
and concentration l and the ligand dissociation constant KDL
KDL =
kl−
kl+
= rf,totl
rl,tot
. (6.13)
Including Equation 6.12 yields
rl,tot = rtot
l
l +KDL
. (6.14)
Now it shall be further assumed that active receptors Ract with the concentration
ract are a subspecies of ligated and not ligated receptors, independent from steady
states of ligand binding, and result from the reaction of one ligand bound with two
free receptor species, leading to the steady state equation
(rl,tot − ract)(rf,tot − ract)2 = KDRract (6.15)
with the dissociation constant KDR for active receptors. To avoid a cubic term in
ract and simplify Equation 6.15, it is further assumed that the concentration of free
receptors rf,tot is little influenced by the amount of active receptors. However, the
concentration of ligated receptor is assumed to be dependent on the amount of active
receptors. The simplified form
(rl,tot − ract)rf,tot2 −KDRract = 0 (6.16)
can be combined with Equations 6.12 and 6.14 to(
rtotl
l +KDL
− ract
)(
1− l
l +KDL
)2
r2tot −KDRract = 0. (6.17)
The solution of this polynomial eqation reads
ract =
K2DLr
3
totl
(KDL + l)(KDRK2DL + r2totK2DL + 2KDRKDLl +KDLl2)
. (6.18)
The cell death kinetics observed in experimental data could be sufficiently well
explained by using this equation as shown in the subsequent chapters. The charac-
teristics of the simplified trimer model were compared with the more exact dimer
and trimer models. Figure 6.4 shows active receptor fractions Ractive/Rtot that were
calculated using the exact trimer model. Solutions of the exact dimer model (Eq.
6.5) and the simplified trimer model (Eq. 6.18) were fit to these trajectories. The
bell shape of active receptors is more pronounced in the simplified trimer model
and very similar in exact dimer and trimer oligomerization models. However, as
experimental data were only recorded at four different ligand concentrations, all
model versions could be used to explain the experimentally observed death kinetics
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Figure 6.4. Active receptor
fractions in different oligomer-
ization models. Fits of the so-
lutions of the simplified trimer
model (Eq. 6.18, green lines)
and the dimer model (Eq. 6.5,
blue lines) to numeric solutions
of the exact trimer model for
CD95-HeLa (dotted lines) and
HeLa wt cells (solid lines) that
were calculated the exemplary
values KDR = 0.5nM and
KDL = 5nM .
Figure 6.5. Variability of ac-
tive receptor fractions for CD95-
HeLa, and HeLa wt cells. Mean
fractions (lines) and areas for 1σ
confidence intervals for single
cells with different receptor lev-
els (shaded areas). Simulations
were calculated with Equation
6.18 using kinetic parameters
from model fitting and model
estimations of receptor numbers
in a cell population.
sufficiently well. Obtaining one fit of the whole cell ensemble model on a cluster
node using the simplified trimer model solution opposed including the trimer model
ODEs (Eqs. 6.6 to 6.11) reduced the time compared to the from about three hours
to twenty minutes. More detailed insights into the oligomerization dynamics and
a better discrimination between possible models could be facilitated by recording
data at more densely sampled ligand concentrations.
Equation 6.18 was implemented to calculate the amount of active receptors at
the beginning of each parameter optimization step in the full model that takes
into account caspase-8 autoprocessing (see chapter 7). The initial concentrations
of receptors rtot in an ensemble of cells, the constants KDL and KDR were then
estimated by model fitting to experimental data. Corresponding model simulations
show peaks of the active receptor fractions at intermediate ligand concentrations
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(Figure 6.5), which corresponds to the fast apoptosis kinetics at intermediate ligand
concentrations in cell death measurements.
The model furthermore explains the observed phenomenon that CD95-HeLa cells
show saturated cell death kinetics at higher ligand concentrations than HeLa wt
cells, as these have about ten times less CD95 receptors. Variability in receptor lev-
els causes variable inverse bell-shaped active receptor profiles and saturation levels.
This variability can have a pro-survival effect and increases apoptosis time variabil-
ity in a cellular population with variable receptor levels: At low receptor numbers
the oligomerization mechanism prevents DISC formation. Increasing ligand levels
towards the saturation levels in cells with low receptor numbers enlarges cell death
variability: In cells with small receptor numbers death kinetics is decelerated, while
in cells with higher receptor levels cell death is further accelerated.
To conclude, the observed inverse bell-shape in caspase-8 activity can be explained
based on the dynamics of receptor oligomerization. The association of active recep-
tors and subsequent reaction steps were assumed to be slow compared to receptor-
ligand binding, and thus implemented as ODEs as described in the following chapter.
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7. Modeling shows a combined
cis/trans cleavage mechanism of
caspase-8 activation
7.1. Alternative mechanisms of caspase-8 activation
Activation of caspase-8 at death inducing signaling complexes, which are assembled
after activation of death receptors at the plasma membrane of cells, is an initial
event of the signaling cascade that leads to apoptosis. Several mechanisms have
been proposed for caspase-8 autocleavage [8]. From the perspective of information
processing, two classes of mechanisms are of particular interest: the ones that re-
sult in apparent intradimeric (’cis’) mechanisms and the ones that cause apparent
interdimeric (’trans’) mechanisms (Figure 7.1). Both would potentially lead to differ-
ent response characteristics: cis mechanisms can be seen as unimolecular reactions
with kinetics independent from input strength, while trans mechanisms introduce
bimolecular reactions, implying accelerated activation with increased input strength.
In this chapter, section 7.2 describes the formulation of alternative caspase-8 acti-
vation model variants, which include the above described receptor activation model.
By fitting these models to experimental data, discrimination between intra- and
interdimeric processing modes was possible, and a minimal model variant could be
selected and experimentally validated (section 7.3). Model selection showed that
interdimeric cleavage is essential for caspase-8 activation, which implies that death
receptor clustering at the plasma membrane is mechanistically required. In section
7.4, a Monte Carlo method is applied to intuitively understand consequences of dif-
ferent cleavage mechanisms on cleavage kinetics. Section 7.5 adresses the finding
that caspase-8 acts as a ’molecular timer’ similar to caspase-9 activation in apopto-
somes. Expressions for reaction rates and ODEs of two model versions, which were
implemented as described in the following, are listed in Tables A.1 and A.2.
Modeling shows a combined cis/trans cleavage mechanism of caspase-8 activation
Figure 7.1. Intra- vs. inter-
dimeric cleavage mechanisms:
active centers (stars) in
procaspase-8 can cleave do-
main linkers (red lines) within
procaspase-8 dimers (’cis’), or
between neighboring dimers
(’trans’).
7.2. Model implementation
Mass-action based ODEs were employed to describe DISC formation, p55 binding,
the activation, release and deactivation of caspase-8, as well as substrate cleavage
(Figure 7.2). The steady state solution of the receptor activation model that was
described in chapter 6 served as the input for the caspase-8 auto processing model.
In the following, several assumptions are described that were made to limit the
complexity of the model but can be assumed to be sufficiently realistic with regard
to biochemical processes.
DISC formation: In the model, DISC formation involved ligand, receptor, FADD
and procaspase-8. C-FLIP proteins can influence caspase-8 activity [46, 48], but as
their level was not perturbed in our experiments and was low, in the range of a
few hundred compared to 3× 105 procaspase-8 molecules per cell [46,48], they were
not explicitly included in the model, and likely appeared implicitly in some kinetic
parameters. Procaspase-8 autoprocessing can only occur in a dimer configuration
where two (pro)caspase-8 molecules are in close vicinity. The trimeric CD95 receptor
must therefore recruit two or more FADD and procaspase-8 molecules, which then
need to remain bound until autoprocessing is completed.
Single monomer binding: To avoid combinatorial complexity, several assump-
tions were made for describing the dimer dynamics by a simplified reaction scheme
with monomeric reaction steps (Figure 7.2). It was assumed that FADD and p55
binding are highly cooperative processes. Cooperativity implies that a second p55
or FADD monomer rapidly binds to the receptor complex, once the first monomer
has been recruited. Then, binding of two monomers is mechanistically equivalent to
one bimolecular reaction, and can be described by a single reaction step.
Effectively monomeric reactions: Procaspase-8 needs to be bound to the DISC
in a dimeric configuration to death receptors to be capable of auto-processing.
Procaspase-8 auto-cleavage is to some extent a random-ordered process and may
thus proceed in two alternative routes: In processing of p55 via p43 to p18 cleavage
between the enzymatic subdomains precedes cleavage between prodomain and en-
zymatic domain. The inverse order of cleavage events results in the reactions from
p55 via p30 to p18. It was not explicitly distinguished between different homo- and
heterodimeric configurations of caspase-8 at the DISC, and instead, the behavior of
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Figure 7.2. Graph of the caspase-8 activation model. Arrows represent reaction
fluxes that were described in ODEs. A steady state solution for the receptor oligomer-
ization model was combined with the visualized model, in which active receptors Ract
serve as platform for DISC formation and procaspase-8 cleavage reactions. Here, the
’cis/cis’ variant is represented, where cleavages of the prodomain and enzymatic do-
main sites are described as unimolecular reactions. In other variants shown in Figures
7.3 and A.1 the part in the grey area is replaced by an alternative set of reactions.
p55, p43, p30 and p18 within dimers was described as monomers. This is justified
when assuming that the cleavage activity of a procaspase-8 dimer is independent of
the respective dimer partner molecule. This implies for example that the activity of
p43 in p43-p43 homodimers contributes to the catalytic activity of the model species
p43 to the same extent as p43 in the heterodimers (p55-p43, p30-p43).
Cleavage reactions: The subsequent caspase-8 auto-processing occurs at five
cleavage sites, two of which are located in the enzymatic domain of procaspase-8
(D374 and D384), whereas the remaining ones lie between the prodomain and the
enzymatic domain (D210, D216 and E201) [8,87] (Figure 1.2). These groups of neigh-
boring cleavage sites are located in close vicinity, suggesting that the corresponding
cleavage products show very similar biological activity. It was therefore assumed
in the model that caspase-8 autoprocessing involves only two cleavage events, one
between the prodomain and the enzymatic domain (p55→p30 and p43→p18), and
one between the enzymatic subdomains (p55→p43 and p30→p18). The kinetic pa-
rameters for each cleavage reaction can be regarded as collective parameters for
any prodomain site or enzymatic site cleavage, respectively. The active center of
caspase-8 is reversibly open in the forms p55 and p30, while it is permanently open
and accessible for substrates in p43, due to cleavage of the intersubunit linker that
otherwise could cover the active center [8]. Therefore, different trans cleavage activ-
ities were assumed for p55 and p30 than for p43.
Binding and unbinding: The prodomain of procaspase-8 allows for high-affinity
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Figure 7.3. Schematic representation of model variants. The enzymatic domain
sites and the prodomain sites are potentially cleaved in cis, in trans or both in cis and
trans. Here, the maximal variant ‘cis+trans/cis+trans’ and two minimal variants are
symbolized: a pure cis and the ‘cis/trans’ topology.
binding to the FADD-receptor complex. The species p55 and p43 contain the
prodomain, and are therefore assumed to be located to the receptor complex [87].
Unbinding of these species was neglected, assuming that unbinding is slow compared
to the subsequent cleavage reactions. The prodomain is cleaved off in p18 and p30,
suggesting that these species can dissociate into the cytosol. It was assumed in the
model that p18 is immediately released from the DISC, as only weak traces of p18
are measured in DISC immunoprecipitates [87]. The p30 intermediate is assumed
to be retained at the DISC in the model, as it is only transiently formed in little
amounts: The vast majority of p30 is thus expected to form heterodimers with p55
or p43, and therefore remains bound to the DISC via the dimer interface. Probe
cleavage was implemented as described above and BID cleavage was modeled like
the NES probe cleavage.
Intra- and interdimeric modes of caspase-8 autoprocessing could be discriminated
by fitting different model variants (Figures 7.3 and A.1) to experimental data. The
model variants differ in the cleavage kinetics of the caspase-8 auto-processing reac-
tions: cis cleavage reactions are reflected by a unimolecular reaction, whereas trans
cleavage reactions are reflected by a bimolecular reaction.
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In the following, model variants are abbreviated by the cleavage modes, cis, trans
or cis+trans, of the two linkers. For example, ’cis/trans’ means that the prodomain
linker cleavage can be described as unimolecular and the catalytic linker can be
described as bimolecular trans reaction. As cis and trans mechanisms of each linker
cleavage are not mutually exclusive, three topologies are possible for each linker,
generating a total of nine different topologies (Figure 7.3 shows three of them, all are
illustrated in Figure A.1). Expressions for reaction fluxes and ODEs of the complete
’cis+trans/cis+trans’ model and the ’cis/trans’ variant are shown in Tables A.1 and
A.2. Model parameters were unknown and determined by fitting to experimental
data. The MatLab toolbox PottersWheel was used for parameter estimations for
each model variant [181] employing the trustregion method. Model analysis and
simulations were performed with custom MatLab scripts.
Together with cleavage reactions for the cytosolic probe, the ER-anchored probe
and BID, the models contain 11 species, between 14 and 26 reactions, and 12 to 16
kinetic parameters. The maximum single cell dataset that was used for model fitting
comprised ten cells at four different ligand concentrations, for HeLa wt and CD95-
HeLa cells. This leads to a total number of Ncells ·Nconcentrations ·Ncell lines ·Nspecies =
10 · 4 · 2 · 11 = 880 ODEs in each model variant, and a total number of 493 to
497 estimated parameters. Using the maximum dataset, 2560 single cell residuals
and 80 population residuals, as defined in Equations 5.8 to 5.10, were minimized.
Under these conditions, one fit that started from a random choice of values for
initial concentrations ~x0 for each cell, kinetic parameters ~p and scaling factors ~s
took around twenty minutes on a cluster node. The following section will describe
the model fitting results.
7.3. Model fitting, model selection and experimental
validation
Ensemble models of different caspase-8 auto-processing scenarios were fitted to exper-
imental data to discriminate between alternative hypotheses on cis or trans mecha-
nisms. First, the capacity of the four smallest models, ’cis/trans’, ’cis/cis’, ’trans/cis’
and ’trans/trans’, to fit the data was compared with the model that contains the
highest degrees of freedom, namely ’cis+trans/cis+trans’. As a measure for the
goodness of fit, the quotient χ2sc/N was used, i.e. the sum of weighted model-data
differences for single cell observables, divided by the number of single cell observ-
able data points N . Therein, the term χ2sc of the residual function was the dominant
remaining part in the residual function at the end of a model fit, and the only com-
ponent that could be clearly defined as χ2-estimator. A value of χ2sc/N smaller than
one indicates that a model topology fits the experimental data well as the distance
between model and data is smaller than the experimental standard error. Strikingly,
the two minimal models that constrain the cleavage in the catalytic domain to a cis
mechanism could not reproduce the data (Figure 7.4).
In contrast, the minimal model variants ’cis/trans’ and ’trans/trans’ could ex-
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Figure 7.4. Model discrimination between cis and trans cleavage variants. Color
coded χ2/N values, indicating goodness of fit, for the 1% best of n = 1000 fits are
shown for model topologies that were fit to experimental data of increasing complexity,
and box plots for fits to the full experimental dataset, in which box colors indicate
median χ2/N values. Models with χ2/N > 1 were regarded as not being able to
explain experimental data.
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plain the data well (min(χ2sc,cis/trans/N)= 0.81, min(χ2sc,trans/trans/N)= 0.85). More-
over, extended model variants did not significantly improve the fit quality (Figure
A.2) demonstrating that the minimal models ’cis/trans’ (Figures 7.5 and 7.6) and
’trans/trans’ are sufficient to explain the data.
One might ask, if other common indicators as the corrected Akaike informa-
tion criterion (AICcorr) that take into account the numbers of estimated model
parameters could improve model selection: Here, differences in parameter num-
bers k of different model variants (kcis/cis = 493, kcis+trans/cis+trans = 497) con-
tribute much less to AICcorr values than differences in log-likelihood after model
fitting to data (LL1%best fits,cis/cis = −4093 . . .−3868, LL1%best fits,cis+trans/cis+trans =
−3419 . . . − 3277), i.e. all evaluated models are about equally parsimonious with
regard to parameter numbers. In this case, AICcorr values are approximately propor-
tional to χ2, justifying the use of χ2/N as criterion for comparisons between model
variants. Kinetic parameter estimates can be found in Table A.3.
Figure 7.7 shows two exemplary cells that were marked in Figure 7.5A to clarify
why a pure cis mechanism is insufficient for explaining the single cell observables:
The accelerated increase in p43 activity after a phase of low activity can be explained
by the ’cis/trans’ model but not by the ’cis/cis’ variant that would require a rather
gradual increase of enzyme activities.
To test whether the combination of single cell and population data was required
for model discrimination, it was tested if reduced amounts of experimental data
would have be sufficient. To this end, model variants were calibrated with western
blot data only. In this case, a single set of ODEs for each model variant was used
instead of the ensemble of single cell models, in accordance to previous models
that were based on population data [41, 48]. As population data was not recorded
at extremely high ligand concentrations, in this case, the receptor oligomerization
model defined by Equation 6.18 was replaced with a simple equation for receptor
binding Ract = R · L/(KDL + L). As the population models were not based on
probe cleavage data, they were reduced by the two ODEs describing probe cleavage,
compared to the single cell models. Therefore, the population data based model
variants comprised 9 ODEs and 10 to 14 kinetic parameters, which results in a total
number of 16 to 20 estimated parameters. The population model variants were fitted
to 60 western blot data points.
Interestingly, neither the western blot data alone nor the single cell data for HeLa
wt cells alone were sufficient for model discrimination (Figure 7.4, left column). As
expected, model fits to western blot data alone did not show clear differences between
model variants as the western blot trajectories showed rather gradual increases of
active caspase-8 compared to the corresponding single cell data. Therefore, the
combination of single-cell and population data from CD95-HeLa, or from both HeLa-
wt and CD95-HeLa, was required for model discrimination.
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Figure 7.5. Fits of the ensemble of single cell ’cis/trans’ models after calibrating
with single cell data of 80 cells (2 cell lines × 4 ligand concentrations × 10 cells per
condition) and western blot data (best 0.5% of n = 103 fits). For clarity, only fits and
data at two of four concentrations are shown. Experimental data (points) and model
fits (lines) for cleavage probes, p43 and p18 for CD95-HeLa (A) and HeLa wt (B) cells.
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Figure 7.6. Western blot data for CD95R-HeLa cells for caspase-8 intermediates,
BID and tBID and model fits.
Figure 7.7. Model fits to trajectories from two exemplary CD95-HeLa cells, indicated
in (A) at [L] = 5000ng/ml. The ’cis/cis’ version fails to fit the data, especially for
p43 and p18, while the ’cis/trans’ model explains the switch like increase with delay
seen in single cell trajectories.
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Flux analysis shows transition from ’cis+trans/cis+trans’ to ’cis/trans’
The largest model variant essentially behaved like the minimal ’cis/trans’ variant
indicating that the ’cis+trans/cis+trans’ version over-fitted the experimental data,
which could be learned from analyzing fluxes in cleavage reactions.
Fluxes were calculated by multiplying caspase-8 intermediate concentrations with
the kinetic parameters of involved cleavage reactions. To distinguish between rele-
vant and irrelevant cleavage reactions, fluxes were integrated until median apoptosis
times tˆapt. In the full ’cis+trans/cis+trans’ model each of the four reactions from
p55 to p43 or p30, and from p43 or p30 to p18, is described with unimolecular (’cis’)
or bimolecular (’trans’) kinetics, which results in eight model reactions (model equa-
tions are listed in Table A.2). For example, the equation for integrated fluxes in the
reactions p55→p43, which depends on the kinetic parameters for enzymatic domain
site cleavage, reads
Ip55→p43 = Ip55→p43,tr,p43 + Ip55→p43,tr,p55+30 + Ip55→p43,cis =
ktr,D374,p43
tˆ
t0
[p55][p43]dt+ ktr,D374,p55/p30
tˆ
t0
[p55]([p55] + [p30])dt
+ kcis,D374
tˆ
t0
[p55]dt. (7.1)
Therein, the two first terms describe trans cleavage of p55 either by p43 or by
the sum of p55 and p30 while the third term reflects the contribution from the cis
cleavage reaction. In Equation 7.1, the integrated fluxes, as well as concentration
trajectories are functions of death ligand concentrations, respectively. In the same
manner, reaction flux integrals for reactions were calculated for the other cleavage
reactions.
Figure 7.8 shows integrated fluxes in the ’cis+trans/cis+trans’ model for reac-
tions of caspase-8 intermediates in CD95-HeLa and HeLa wt cells at different ligand
concentrations, which were calculated starting from the median estimated initial con-
centrations in the cell ensemble model until median cell death times, respectively.
Furthermore, fractions of initial p55 levels that were processed by a certain cleav-
age reaction between ligand addition and the median time of apoptosis were calcu-
lated (Figure 7.9). Following the example in Equation 7.1, the left bar graphs in
Figure 7.9 visualize the fractions
Ip55→p43,cis(tˆapt)
[p55](t0)
,
Ip55→p43,tr,p43(tˆapt)
[p55](t0)
and Ip55→p43,tr,p55+p30(tˆapt)[p55](t0)
.
Analyzing processed p55 fractions shows that certain cleavage reactions have small
contributions, which can be neglected. Strikingly, the largest amount of p55 is
processed in trans by p43 to p43, whereas trans cleavage by p55 plays a minor
role. Contributions from cis reactions for the enzymatic domain cleavage reactions
(p55→p43, p30→p18) are negligibly small. However, in prodomain cleavage reac-
tions (p43→p18, p55→p30), fluxes for cis reactions are significantly larger than
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Figure 7.8. Integrated fluxes for caspase-8 cleavage reactions in the
’cis+trans/cis+trans’ variant. (A, B) Solid lines represent mean trajectories and
shaded areas standard deviations for the 1% best of n = 103 fits. (A) In CD95-
HeLa cells, the largest amount of initial p55 is processed in the reaction p55→p43,
whereas minor amounts are processed from p43 to p18 and from p55 via p30 to p18.
Changing ligand concentrations has the strongest effect on the reaction from p55 to
p43, due to weaker positive feedback from trans cleavage by p43. (B) Integrated fluxes
for HeLa wt cells as in (A). As in CD95-HeLa cells, the reaction from p55 to p43 has
the largest fluxes, whereas the relative difference to the other cleavage reactions is
smaller. Compared to reactions in CD95-HeLa cells, larger amounts of p18 relative to
p43 are generated before undergoing apoptosis.
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Figure 7.9. Fractions of initial p55 levels processed in cleavage reactions of the
’cis+trans/cis+trans’ model. (A) Processed p55 fractions in CD95-HeLa cells. Error
bars represent standard deviations for the best 1% of n = 103 model fits. (B) Processed
fractions of initial p55 levels in HeLa wt cells as in (A). Similar to CD95-HeLa cells,
trans cleavage of p55 by p43 is the strongest contributing reaction. Again, fluxes for
cis cleavage of the enzymatic domain and for trans cleavage of the prodomain are
negligible, which supports model simplifications to the ’cis/trans’ topology.
trans reactions. Therefore, model simplification by rejecting enzymatic domain cis
cleavage and prodomain trans cleavage is justified, which results in the ’cis/trans’
model.
For the less contributing prodomain trans cleavage reactions larger fluxes are
estimated for trans cleavage by p55 than by p43, opposite to the trans cleavage
reactions of the enzymatic site, where p43 has larger trans cleavage activity. In this
reaction, kinetics of trans cleavage by p55 is rather similar to the kinetics of p55
cis cleavage than p55 trans cleavage by p43. Therefore it is made more difficult to
discriminate between cis cleavage of p55 with a reaction rate proportional to [p55]
and trans cleavage of p55 by p55 where the reaction rate is proportional to [p55]2.
Additional experiments supported further discrimination between model variants as
described in the following section.
To obtain intuitive insights in the timing of caspase-8, momentary half-life times
of caspase-8 intermediates were calculated for parameter estimates of different model
variants. For example, momentary half-lives of p55 and of p43 were calculated for
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Figure 7.10. Predicted half-life times of caspase-8 intermediates for the ’cis/trans’
(blue) and the ’cis+trans/cis+trans’ (cyan) models in CD95-HeLa and HeLa wt cells.
Both variants show very similar half-life estimates for caspase-8 intermediates, in
particular for p18 and p43 (τ1/2,p18 ≈ 10′ and τ1/2,p43 ≈ 100′, solid lines: means,
shaded areas: standard deviations for the best 1% of n = 1000 fits).
the ’cis+trans/cis+trans’ model by
τ1/2,p55,′cis+trans/cis+trans′ = ln 2 [(ktr,D216,p43 + ktr,D374,p43)[p43]+
(ktr,D216,p55/p30 + ktr,D374,p55/p30)([p55] + [p30]) + kcis,D216 + kcis,D374]−1
and
τ1/2,p43,′cis+trans/cis+trans′ =
ln 2
ktr,D216,p43[p43] + ktr,D216,p55/p30([p55] + [p30]) + kcis,D216
.
For the ’cis/trans’ model, half-lives were analogously calculated by
τ1/2,p55,′cis/trans′ =
ln 2
ktr,D374,p43[p43] + ktr,D374,p55/p30([p55] + [p30]) + kcis,D216
and
τ1/2,p43,′cis/trans′ =
ln 2
kcis,D216
.
Half-lives of p30 and p18 were calculated in the same manner. Figure 7.10 shows
that estimated half-lives of caspase-8 intermediates for the ’cis+trans/cis+trans’ and
the ’cis/trans’ topologies are in an equivalent range.
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In comparison to the ’cis/trans’ topology, fit quality to experimental data was
slightly worse for the ’trans/trans’ model variant, which describes prodomain site
and the enzymatic domain site are cleaved by interdimeric cleavage reactions (Fig-
ure 7.4). Clear discrimination between these two variants was not possible by model
fitting. However, model analysis for the best fits of the ’trans/trans’ model showed
clear deviations from predictions of the complete ’cis+trans/cis+trans’ model (Fig-
ures A.5, A.6 and A.7). The ’trans/trans’ model could be finally excluded by addi-
tional experiments, which will be described in the following paragraph.
Taken together, analyzing reaction fluxes in caspase-8 cleavage reactions and
half-lives of caspase-8 intermediates shows that simplifying the complete ’cis+trans/-
cis+trans’ topology leads to the ’cis/trans’ variant rather than other minimal model
topologies. Trans cleavage reactions potentially cause positive feedback or feedfor-
ward: in the ’cis+trans/cis+trans’ variant, p55, p43 and p30 catalyze their own
processing in a feedforward manner. Furthermore, p43 and p30 amplify their own
production by positive feedback to p55 cleavage. The flux analysis shows that trans
cleavage reactions rather establish a positive feedback than a feed forward activation,
especially for the reaction catalyzed by p43. The most important positive feedback is
involved in trans cleavage of p55 by p43 to p43 while other trans reactions only have
minor contributions. This feedback of p43 on its own generation is mechanistically
important, as estimated parameters showed about eight times higher trans-cleavage
activity for p43 than for DISC-bound p55 or p30 (Table A.3). Half-lives indicate
that the active intermediate p43 is relatively stable compared to the short-lived final
product p18. This principle, which was denoted as ’molecular timer’, will be further
addressed in section 7.5.
Experimental validation: cleavage probes containing caspase-8 autoprocessing
sites support a ’cis/trans’ mechanism
The experimental data described in this paragraph were obtained from Dr. Joel Beau-
douin (German Cancer Research Center, Heidelberg).
Model fitting to single cell and population data favored trans kinetics for cleavage
of the enzymatic domain site and a cis reaction for prodomain site cleavage (Figure
7.4). However, the ’trans/trans’ variant, in which both sites are cleaved with trans
mechanisms, could not unequivocally be rejected by model fitting to experimental
data. In order to provide independent experimental support for ’cis/trans’ cleavage
reactions, cleavage probes containing caspase-8 auto-processing sites were designed
and their cleavage kinetics was analyzed. A cleavage probe containing the prodomain
linker sequence requires a bimolecular reaction step to be cleaved by caspase-8. By
localizing this probe with a myristoylation-palmitoylation (Myr-Palm) domain on
the plasma membrane a caspase-8 trans auto-cleavage scenario could be mimicked.
Cleavage probes contained cleavage sequences of amino acid residues MTISDS
(caspase-8 prodomain, D210), PREQDS (caspase-8 prodomain, D216), PVETDS
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Figure 7.11. Discrimination experiments with cleavage probes. (A) Averaged nor-
malized intensities from nuclear ROIs (white dotted lines) recorded in n = 21 HeLa wt
cells expressing MyrPalm-(BID site)-mCherry (top row, red channel) and MyrPalm-
(D210 site)-YFP (bottom row, green channel) probes. (B) Averaged nuclear intensi-
ties from n = 16 HeLa wt cells expressing MyrPalm-(BID site)-mCherry (top row, red
channel) and MyrPalm-(D216 site)-YFP (bottom row, green channel) probes. Trajec-
tories in panels (A) and (B) indicate that at half-times tBID,50% only small amounts
of prodomain site probes are processed (error bars: standard deviations, scale bars:
10µm).
(caspase-8 enzymatic subdomain linker, D374) or ELQTDG (BID) and a fluorescent
protein. Furthermore, cleavage probes linked to a nuclear export signal (NES) were
used that either contain all prodomain cleavage sites (D210, D216 and D223), the
sequence DEVA (non-cleavable for caspase-8), or ELQTDG (BID) and a fluorescent
protein. Cells simultaneously expressed probes with the BID cleavage sequence
bound to mCherry and probes containing one of the other cleavage sequences bound
to YFP, to use BID probe cleavage kinetics as reference, respectively.
After probe cleavage the, fluorescent protein entered the nucleus whereas un-
cleaved probes were exclusively localized at the plasma membrane. After ligand
addition, fluorescence intensity in nuclear regions of interest was measured to mon-
itor probe cleavage, similar as for probe cleavage experiments to generate single
cell observables for active caspase-8 as described in chapter 4. Here, the leucine
zipper-soluble CD95 ligand (LZ-sCD95L) [138] was used as described in [136] to
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stimulate apoptosis. To compare between groups of signal trajectories, nuclear in-
tensity trajectories were normalized to the time of apoptosis, which was indicated by
membrane blebbing, and to the average signal of the complete cell (Figures 7.11A,
7.11B and 7.12A) or to the saturation limit indicating cleavage of the total amount
of probes (Figure 7.12B). Average trajectories therefore approximate the value one
if the nuclear intensity is equal to the average intensity of the cell.
In line with the predicted cis mechanism, it was found that probes using the
aminoacid sequences REQD (prodomain cleavage site D210) and TISD (prodomain
cleavage site D216) as cleavage linkers showed no significant cleavage before cell
death (Figures 7.11A and 7.11B). Similar results were obtained with probes contain-
ing a more complete caspase-8 prodomain linker (Figure 7.12A). In contrast, the
model clearly predicted trans cleavage of the enzymatic domain linker. Therefore,
it was expected that a probe with the aminoacid sequence VETD, corresponding to
the enzymatic domain cleavage site D374, is efficiently cleaved. According to this
prediction, it could be observed that the VETD probe is fully cleaved at the time
of cell death, comparable to an LQTD probe containing the cleavage sequence of
BID (Figure 7.12B). Furthermore, cytosolic NES probes showed that trajectories of
probes with all prodomain cleavage sites were similar to trajectories of probes with
non-cleavable sites (Figure 7.12A). This validates the hypothesis that prodomain
site cleavage is a cis mechanism within procaspase-8 dimers rather than a trans re-
action between neighbored dimers.
Taken together, these data provide independent support for the model-predicted
’cis/trans’ cleavage mechanism of caspase-8 autoprocessing. Next, it was investi-
gated why a trans cleavage of the enzymatic domain was required in the model to
explain the experimental data. As can be seen in Figure 7.7, a cis mechanism for the
cleavage of the catalytic domain linker fails to reproduce the switch-like increase in
the p43 trajectories after a certain delay of low enzymatic activity. A similar conclu-
sion could be drawn by analyzing the qualitative features of ’cis/cis’ and ’cis/trans’
models using simulations with randomly chosen kinetic parameters in a Monte Carlo
approach, as described in the following.
7.4. Monte Carlo modeling reveals qualitative
differences in ’cis/cis’ and ’cis/trans’ topologies
Model fitting suggested that trans-cleavage is required for caspase-8 activation, but
did not provide intuitive explanations why the pure cis mechanism fails to fit the
data. Fits of the ’cis/cis’ and ’cis/trans’ models were systematically compared to
understand how the two mechanisms differ. It could be observed that the ’cis/cis’
mechanism fails to explain the switch-like accumulation of the catalytically active
p43 intermediate observed in single-cell measurements (Figure 7.7). This indicated
the requirement of trans cleavage, which results in a positive feedback loop that
amplifies the signal and thereby induces a more rapid caspase-8 activation and cell
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topologies
Figure 7.12. The enzymatic domain cleavage site, but not the prodomain site, is
cleaved in trans. (A) Averaged nuclear intensities from n = 16 HeLa wt cells express-
ing NES-(caspase-8 prodomain sites)-YFP, n = 23 cells expressing MyrPalm-DEVA-
YFP, and n = 39 cells expressing MyrPalm-(BID site)-mCherry probes. Probes with
caspase-8 prodomain sites are not efficiently cleaved compared to probes with the
cleavage sequence of BID. Trajectories with prodomain sites show only slightly higher
cleavage for the probe with prodomain sites than for the DEVA probe, which cannot be
cleaved by caspase-8. (B) Averaged normalized intensities from nuclear ROIs recorded
in n = 20 HeLa wt cells expressing the two probes MyrPalm-(BID site)-mCherry and
MyrPalm-(D374 site)-YFP. At tBID,50% when half of BID probes was cleaved, about
the same amount of enzymatic domain probes was processed.
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fast reactions, k ∈ [10, 104] slow reactions, k ∈ [10−3, 1]
parameters
in both
variants
kon,CD95L, koff,CD95L,
kon,FADD, koff,FADD, kon,p55
kp18,inactive, kcl,probe
’cis/cis’
kcis,D216 (prodomain cleavage),
kcis,D374 (enz. domain cl.)
’cis/trans’
kcis,D216 (prodomain cl.),
ktr,D374,p55/p30 (enz. domain cl.),
ktr,D374,p43
Table 7.1. Kinetic model parameters and sampling intervals.
death.
An exhaustive analysis of the whole parameter space for ’cis/cis’ and ’cis/trans’
models was performed based on a Monte Carlo approach to show more rigorously
that switch-like caspase-8 activation can only be observed in a ’cis/trans’ mecha-
nism. The kinetic parameters of the models where 104 times randomly sampled,
and simulations were performed for each parameter set. Kinetic parameters were
sampled from uniform distributions within two interval sizes, one for fast bind-
ing reactions of CD95L, FADD and p55 (k ∈ [10, 104]), and one for slow reac-
tions (k ∈ [10−3, 1]). For simplicity, the receptor oligomerization model component
was replaced by a simple bimolecular reaction describing monomeric ligand bind-
ing to monomeric receptors. This was sufficient in this case, as it was intended
to simply obtain a wide range of active receptor amounts for simulating caspase-
8 activation kinetics under variable conditions. The ligand concentration values
[CD95L] ∈ [10−2, 3 · 10−2, 0.1, 0.3, 1, 3, 10, 102] · KDL and experimentally measured
average initial protein concentrations were used as initial conditions for simulations
with each randomly chosen set of kinetic parameters.
The simulation results were systematically analyzed to show that ’cis/cis’ and
’cis/trans’ models differ in the switch-like behavior of the time courses. Trajectories
resulting from different parameter sets were temporally normalized by the time t5%
when 5% of the probes are cleaved, and normalized in amplitude by the total probe
concentrations [PrcplF2], respectively. In general, ’cis/trans’ trajectories can show a
steeper time course for cytosolic probe cleavage than ’cis/cis’ trajectories, especially
in CD95-HeLa cells (Figure 7.13): In these, cytosolic probe cleavage switched from
5% to 50% during a less than two-fold increase in time for the ’cis/trans’ mech-
anism (blue trajectories), while trajectories were shallower for the ’cis/cis’ model
simulations (red trajectories).
This complementary approach can further support discrimination between ’cis/cis’
and ’cis/trans’ topologies by trajectory shape attributes. To this end, the times
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Figure 7.13. Monte Carlo simulations of cytosolic probe cleavage kinetics support
discrimination between ’cis/cis’ and ’cis/trans’ topologies. (A) Model fits of ’cis/cis’
and ’cis/trans’ versions to data of two exemplary cells as in Figure 7.7. In the left plot,
times until 5% or 50% cytosolic probe cleavage, t5% and t50%, are indicated. (B, C) Cy-
tosolic probe cleavage trajectories from random parameter simulations illustrate that
the ’cis/trans’ variant can explain steeper and switch-like probe cleavage trajectories
than the ’cis/cis’ topology for CD95-HeLa (B) and HeLa wt cells (C). Trajectories
were obtained by randomly sampling kinetic rate constants (Nsamples = 104) from
large parameter intervals (shaded areas: space between 5% and 95% percentiles, solid
lines: medians).
89
Modeling shows a combined cis/trans cleavage mechanism of caspase-8 activation
Figure 7.14. Monte Carlo modeling of cytosolic probe cleavage supports discrimina-
tion between ’cis/cis’ and ’cis/trans’ topologies. Combinations of normalized t5% and
t50% experimental values for CD95-HeLa cells fit into the space for t5%-t50% combina-
tions of simulated ’cis/trans’ trajectories but not into the space of simulated ’cis/cis’
trajectories. However, for HeLa wt cells a direct discrimination by the t5% and t50%
measures is not possible as most of the experimental values are compatible with simu-
lated values from the ’cis/trans’ as well as the ’cis/cis’ versions. Time points extracted
from simulated trajectories are shown as dots. Solid lines mark borders of dot densi-
ties that include 99% of simulated values. To obtain a collective timescale, time points
were normalized by the mean of t5% values for HeLa wt cells (tˆ5%,HeLa)
until 5% or 50% cytosolic probe cleavage were determined to describe two major
trajectory characteristics, a delay period of low cleavage activity (t5%) and a period
of accelerated cleavage between t5% and t50%, which is indicated in Figure 7.13A.
Figure 7.14 shows combinations of the cytosolic probe cleavage times t5% and t50%
for simulations and experiments that were normalized by mean t5% of HeLa cells,
respectively.
To display areas of possible t5% and t50% combinations for ’cis/cis’ and ’cis/trans’
models, dot densities ρ = 1/NsamplesNij, in which Nij is the number of t5% and t50%
combinations in the area i∆t5%j∆t50% in a grid defined by coordinates i and j, were
calculated. Areas that contain 99% of the integrated density of simulation results
are surrounded by solid lines for the two model variants. Experimental combinations
(t5%,t50%) for CD95-HeLa cells (Figure 7.14, left plot) lie within the valid area for
the ’cis/trans’, but outside the area for the ’cis/cis’ model, which does not support
relatively low ratios of t50% to t5%. Contrarily, most of the experimental measures
for HeLa wt cells (Figure 7.14, right plot) lie within valid areas of both topologies.
Here, in accordance to the model fitting results, again CD95-HeLa cells support
mechanistic discrimination, while both topologies are tolerable for data from HeLa
wt cells. By decreasing the level of death receptors, the trajectories become less
switch-like: Comparing between the mean t5% and t50% for CD95-HeLa and HeLa
wt cells shows, that tenfold less receptors cause a stronger decrease in t50% than for
t5%.
90
7.5. Caspase-8 operates as a molecular timer
In conclusion, simulating trajectories by a Monte Carlo approach confirmed that
’cis/trans’ models were able to generate switch like trajectories, especially in CD95-
HeLa cells, in contrast to ’cis/cis’ models. A trans mechanism is required to explain
the experimental data on the kinetics of cytosolic probe cleavage and to establish a
switch-like initiation of apoptosis.
7.5. Caspase-8 operates as a molecular timer
Combining single cell and western blot data, it could be concluded that caspase-8 is
activated by a combined ’cis/trans’ mechanism. This section addresses an interesting
finding with regard to the deactivation kinetics of caspase-8 that shows a parallel to
the kinetics of caspase-9 activation at apoptosomes.
Effective half-lives of the different caspase-8 cleavage products during the time
course of apoptosis were calculated to shed light on the timing of caspase-8 activation
at the DISC and compare different model variants (Figure 7.10). Figure 7.15 shows
half-lives of the different caspase-8 intermediates for the validated ’cis/trans’ model
variant. The half-lives of p55 and p30 decrease over time as more p43 is generated,
which catalyzes the processing of these intermediates. p43 is processed to p18 via an
apparent cis mechanism, implying a constant half-life of p43. According to the best
fits of the model, this half-life was around 1 hour. In contrast, the model predicted
that p18 is active for 7 minutes only, which indicates that mostly p43 contributes
to caspase-8 activity in the cell. However, the final product p18 never accumulates.
Therefore, caspase-8 can be regarded as a molecular timer that determines the du-
ration of its activity by the combination of the low cleavage constant for prodomain
site cleavage and the rapid inactivation of p18. As p43 is restricted to the DISC,
this also indicates that the activity is spatially restricted to the plasma membrane
and is not significantly propagated to the cytosol.
The term ’molecular timer’ describes the mechanism for the activation of the re-
lated enzyme caspase-9 [182,183]: After the event of mitochondria outer membrane
permeabilization (MOMP), apoptosomes are assembled from the proteins Apaf-1
and cytochrome c that serve as a platform for procaspase-9 binding. When bind-
ing to apoptosomes, procaspase-9 becomes active, cleaves downstream substrates
and processes itself to caspase-9. While procaspase-9 has a high binding affinity to
apoptosomes, caspase-9 has a low binding affinity and becomes inactive after being
released from apoptosomes [183]. Therefore, procaspase-9 is a stable intermediate
enzyme form that generates most of the cleavage activity, while the final product
caspase-9 is quickly inactivated. Here, model analysis indicated that caspase-8 ac-
tivation at the DISC is mechanistically equivalent to procaspase-9 activation at
apoptosomes: p43 is a stable intermediate form that processes itself to the unstable
form p18, which is quickly inactivated after being released from the DISC.
Taken together, the model is consistent with the idea that p43 is the main active
form of caspase-8 during apoptosis. It maintains its activity through a molecular
clock to eventually switch off caspase-8 activity after p18 formation.
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Figure 7.15. Half-lives for caspase-8 intermediates. Lines show means and areas
indicate standard deviations for the best 1% best of n = 1000 ’cis/trans’ model fits,
simulated at [CD95L] = 500ng/ml. While p43 accumulates at the DISC, due to a
higher half-life than p55, p18 has a low stability and does not accumulate.
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8. Simulating the variability of
apoptosis in heterogeneous cell
populations
In the cell ensemble model on caspase-8 activation, cell-to-cell variability in probe
cleavage, single cell caspase-8 activities and apoptosis times was explained by dif-
ferent levels of initial protein concentrations. From estimated initial protein levels,
a multivariate lognormal joint distribution was derived to randomly sample vectors
of initial concentrations and simulate the behavior of a heterogeneous population
of cells. Originating at random sets of initial protein concentrations the model was
integrated until certain tBID levels were reached that were sufficient to induce mito-
chondria outer membrane permeabilization (MOMP) and thereby irreversibly lead
to cell death.
First, this procedure was applied, as described in section 8.1, to validate the
model of caspase-8 activation. For this purpose the model was calibrated to a
training data set and then validated with a test data set as described in section 8.2.
Then, the model calibrated to the entire data set was used to simulate a variety of
overexpression or knock-down conditions in order to study functional roles of the
involved signaling protein species (section 8.3).
8.1. Simulating cell-to-cell variability by a
multivariate lognormal joint distribution
It is known that protein concentrations in cells commonly follow lognormal distribu-
tions as they result from a sequence of processes with stochastic influences, which
depend on each other in a multiplicative manner [184,185]. A fundamental origin of
lognormal distributions of protein concentrations is the intrinsic noise at the level of
the transcription of genes, which leads to lognormally distributed mRNA levels [186].
Therefore, it was assumed that a lognormal joint distribution of initial protein lev-
els is sufficient to explain cell-to-cell variability in the caspase-8 activation model.
While initial concentrations were allowed to be variable the kinetic parameters were
assumed to be equal for each cell. This assumption is justified as the model reactions
exactly describe the reactions of molecular species rather than collective processes,
in which the interactions of several proteins are involved, as it is the case for the
model described in part II.
By model fitting, the initial concentrations for CD95R, FADD, p55 and BID were
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estimated for each cell included in the cell ensemble model. To link the model of
caspase-8 activation to cell death, the arrival at a certain tBID threshold level was
regarded as sufficient trigger for apoptosis [39, 167], which happens a few minutes
after MOMP [81,82]. In the cells, which were used to extract observables for probe
cleavage and caspase-8 activities, these critical tBID levels were estimated from
integrating the model with estimated kinetic parameters until their apoptosis time.
The multivariate lognormal density for a vector of concentrations ~x0 with n di-
mensions is defined by the vector of parameters ~µ and the covariance matrix D and
reads
p(~x0) =
1
(2pi)n/2 det(D)1/2∏ni=1 x0,i exp
(
−12(ln ~x0 − ~µ)
TD−1(ln ~x0 − ~µ)
)
as described in [187]. In order to estimate the parameters µ and σ, one-dimensional
lognormal distributions were fitted to the estimated initial single cell concentrations
for CD95R, FADD, p55, and BID. Estimated initial levels of BID and estimated
tBID levels at apoptosis times were slightly correlated, despite the fixation of the
mean BID and tBID levels to population observables for BID and tBID. To eliminate
the bias of this correlation from the parameter estimation process, tBID threshold
fractions [tBID](tapt)/[BID] were used instead of absolute tBID concentrations.
Then, correlation coefficients and covariances were calculated between estimated
initial concentrations and critical tBID fractions to define the covariance matrix
D of a combined multivariate lognormal joint distribution. To randomly sample
from the multivariate lognormal distribution using a random number generator for
multivariate normal distributions, the covariance matrix D ≡ cov(x0,i, x0,j) of vari-
ables x0,i and x0,j had to be transformed to the covariance matrix cov(yi, yj) of the
corresponding normal distribution of variables yi = ln x0,i and yj = ln x0,j. The cor-
relation coefficient ρx0,ix0,j of a lognormal distribution is related to the correlation
coefficient ρyiyj of normally distributed variables by the relation
ρx0,ix0,j =
cov(x0,i, x0,j)
σiσj
=
exp(ρyiyjσiσj)− 1√(
eσ
2
i − 1
) (
eσ
2
j − 1
) .
Therefore, in order to generate random vectors from the corresponding multivari-
ate normal distribution, the corresponding covariance matrix
cov(yi, yj) = ρyiyjσiσj = ln
(
ρx0,ix0,j
√(
eσ
2
i − 1
) (
eσ
2
j − 1
)
+ 1
)
was calculated from lognormal correlation coefficients ρx0,ix0,j . Using the covariance
matrix cov(yi, yj) multiple random vectors ~y were sampled to use ~x0 = exp(~y) as
input of initial concentrations and critical tBID fractions for model integration. The
time points when the sampled fractions [tBID](tapt)/[BID] were reached were re-
garded as apoptosis times.
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Figure 8.1. For validation, fits of the ’cis/trans’ model to CD95-HeLa cells and
the experimentally determined average receptor number of HeLa wt cells were used
to generate a lognormal multivariate joint distribution. Random vectors of initial
concentrations and tBID threshold fractions were drawn from this distribution to
calculate equivalent cell death times for HeLa wt cells and compare simulated with
experimental kinetics and variability.
Employing this procedure the determinants of cell death timing, variability and
survival in a heterogeneous population of cells were studied as described in the
following sections.
8.2. Testing the predictive capability of a model of
cell death induction
To further validate the ’cis/trans’ model, its capacity to predict cell death kinetics
and the variability in cell death time was tested. For this purpose, the ’cis/trans’
model was fitted to a test data set from CD95-HeLa cells to predict cell death
kinetics and variability of cell death times in HeLa wt cells expressing about ten
times less CD95 death receptors.
In order to predict required conditions for cell death, an ensemble of 40 single
cell models was fitted to a training data set of 40 CD95-HeLa single cell datasets
(10 cells per ligand concentration) combined with western blot data for caspase-8
intermediates, BID and tBID (Figure 8.1). The trained model was then used to
predict individual fractions of tBID in total BID levels at death times, regarded as
tBID thresholds that are sufficient for apoptosis, in combination with initial protein
levels for each cell in the training data set.
Then, to simulate kinetics of HeLa wt cells, it was assumed that all levels of all
involved signaling proteins are lognormally distributed and equal, except the CD95
receptor, between CD95-HeLa and HeLa wt cells. A lognormal multivariate distribu-
tion was defined from median FADD, p55 and BID level and median tBID threshold
estimates, and the experimentally determined mean CD95 receptor level of HeLa wt
cells. Therein, covariances of initial concentration estimates and tBID thresholds in
the training data set were taken into account, according to the procedure of previ-
ous studies [95], except for CD95 receptor. Covariances with CD95 receptor levels
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were neglected as it was likely that they were unequal for CD95-HeLa and HeLa wt
cells. Random vectors of initial concentrations and tBID thresholds were sampled
from this distribution, representing simulated conditions of HeLa wt cells. For dif-
ferent ligand concentrations, the model was integrated for 100 randomly chosen sets
of initial concentrations and tBID fractions, respectively, until the respective tBID
threshold was reached, which was regarded as time of cell death. This procedure was
executed for each of the 1% best of 103 model fits. Cells, in which tBID thresholds
were not reached, were hypothetically regarded as survivors. It was distinguished
between simulated cells, in which tBID thresholds were not reached within the time
of the experiment (13 hours) or within the maximal integration time (104 minutes).
Predicted median cell death times in HeLa wt cells were in good accordance with
experimental measurements, except for one data point for the ligand concentration of
500ng/ml (Figure 8.2A). Furthermore, the model predicted a much larger coefficient
of variation of cell death times for HeLa wt than for CD95-HeLa cells, which is in
good agreement with experimental data (Figure 8.2B).
In summary, CD95-HeLa observables could be successfully used as training data
set in order to predict death kinetics and variability in HeLa wt cells for model
validation.
8.3. Ligand, receptor and FADD control timing and
variability while p55 and BID control survival
Regulatory control in signaling networks is often distributed unequally, implying
that different signaling species control different aspects of the signaling response.
To this end, a systematic sensitivity analysis was conducted to analyze how the
total cellular concentrations of CD95L, CD95R, FADD, procaspase-8/p55 and BID
control the cell death kinetics and variability.
To study functional roles of involved signaling proteins, cell death was simulated
at different fold-changes of initial protein concentrations, now using the ’cis/trans’
model fitted to the complete set of CD95-HeLa and HeLa wt data (Figure 8.3).
From initial protein concentration and tBID threshold estimates, separate lognormal
multivariate joint distributions were determined for CD95-HeLa and HeLa wt cells,
now including all variances and covariances. Random vectors were sampled from
these distributions and the model was integrated with different fold-changes between
0.1 and 10 times the original concentration, separately for each protein. Again,
equivalent death times were determined by integrating the model until tBID levels
arrived at required thresholds. Cells, in which tBID thresholds were not reached
within the maximum integration time, were considered as survivors.
From simulations of 100 random samples for each condition and each of the 1%
best of 103 fits, median cell death times, coefficients of variation of cell death times
and surviving fractions were determined. Additionally, trajectories of surviving frac-
tions of cells with an apoptosis time smaller than the experimental duration of 13
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Figure 8.2. Validation of the ’cis/trans’ model. (A) Experimental values (squares)
and predictions (lines and shaded areas) of median cell death times for HeLa wt
and CD95-HeLa cells. For validation, model fits to CD95-HeLa cells were used to
predict HeLa wt death kinetics. Error bars represent standard deviations between
medians in different fields of view on the object carrier (solid lines: means, shaded
areas: standard deviations, best 1% of n = 103 fits). (B) Coefficients of variation for
cell death times had values in the range of 0.5 to 0.6 for HeLa wt and in the range of
0.1 to 0.2 for CD95-HeLa cells (squares with error bars estimated by bootstrapping)
and from ’cis/trans’ model simulations, based on fits to CD95-HeLa data. Lines and
shaded areas correspond to standard deviations as in panel (A). Predicted coefficients
of variation (V arK) were calculated at ligand concentrations, at which at least 50%
of the simulated cells underwent apoptosis during texp (limits marked by ’V’). V arK
estimates including cells undergoing apoptosis later than texp are shown as dotted line.
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Figure 8.3. Procedure for predicting the behavior of a heterogeneous cell population.
To study functional roles of involved signaling proteins, fits of the ’cis/trans’ model to
CD95-HeLa cells and HeLa wt cells were used to generate lognormal multivariate joint
distributions for the two cell lines, and sample random vectors of initial concentrations
and tBID threshold fractions with different fold-changes of initial concentrations.
hours (tapt < texp) were calculated, representing fractions of cells that survive the
duration of the experiment. Predictions originating at the ligand concentration of
500ng/ml, are shown in Figure 8.4, while predictions originating from the other ex-
perimentally used ligand concentrations, which mostly lead to similar characteristic
observations, are shown in Figures A.3 and A.4.
Simulations showed that cell-to-cell variability and the cell death times are strongly
dependent on levels of the upstream signaling species CD95L, CD95 and FADD.
These species determine the number of active DISCs, which represent the bottleneck
in caspase-8 activation, especially in HeLa wt cells. In CD95-HeLa cells, overexpres-
sion of proteins does not influence cell death variability, and reduction only weakly
does so (Figures 8.4B and A.4). In contrast to upstream species, the downstream
species procaspase-8 and BID levels have minor influence on cell death timing and
variability.
Cellular survival, however, is strongly regulated by the downstream signaling
proteins procaspase-8 and BID. Below a certain level of procaspase-8 or BID the
required apoptosis inducing tBID thresholds are not reached anymore (Figures 8.4A
and 8.4B, lower rows). Procaspase-8 can restrict tBID production because of its
limited life time. During the turnover of p55 to p18 only a limited number of
substrate molecules can be cleaved before p18 becomes inactive. Therefore, reducing
p55 levels increases the amount of surviving cells, in which not enough tBID is
processed by the available pool of procaspase-8. Similarly, but with much weaker
influence, the upstream receptor and FADD levels have influence on survival fraction.
Especially in CD95-HeLa cells survival is independent from ligand, receptor and
FADD levels. From simulations, further experiments can be predicted: pulse-wash
experiments, in which caspase-8 activation is induced for a limited time, should show
transient cleavage activity of p43 and the decay of caspase-8 activity after CD95L
removal.
It can be concluded that upstream and downstream signaling species inversely
control the dynamics of cells death: upstream species control speed of cell death
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Figure 8.4. Determinants of cell death kinetics and variability. (A) Predicted co-
efficients of variation for cell death times, median cell death times and fractions of
surviving cells at different fold changes of initial protein concentrations for CD95
ligands, receptors, FADD, p55 and BID for HeLa wt cells. The origins represent con-
ditions at ligand stimulation with a concentration of 500ng/ml. In the subplots for
surviving fractions, dotted lines represent the surviving fractions within the duration
of the single cell experiments (13 hours), while solid lines represent surviving fractions
within the total integration time interval. V arK(tapt) and t50%apt are only calculated
in situations, where ≥90% of the cells die (limits marked by ’V’). (B) Predictions for
CD95-HeLa cells as in panel (A) (dotted or solid lines: means from 1% best of n = 103
fits, shaded areas around lines: standard deviations).
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and its variability, while the downstream species control fraction of cells killed.
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9. Discussion
To study the initiation of extrinsic apoptosis, a model-based method to estimate
caspase-8 activity in single cells and a multi-scale modeling approach combining
single cell with cell population measurements were developed. The approach extends
previous apoptosis models, which were trained on cell population measurements only
and thereby may not fully capture the detailed kinetics at the single cell level.
The developed caspase-8 activation model complements previous apoptosis mod-
els, which were more focused on MOMP dynamics [35, 39] or downstream effector
caspases activation [40, 45, 49, 54, 55]. Models that included details of DISC as-
sembly [41, 46, 48] did not discriminate between putative molecular mechanisms of
caspase-8 activation, and were primarily focused on the role of c-FLIP proteins in
the life/death decision.
Using a model selection approach, intradimeric (’cis’) processing of procaspase-8
dimers was excluded and an interdimeric cleavage (’trans’) mechanism could be re-
vealed, in which DISCs need to be assembled at least transiently into higher-order
clusters at the plasma membrane. Experimental data was best explained by the
’cis/trans’ model variant, in which the prodomain site in pro-caspase-8 is cleaved
in cis and the enzymatic domain site in trans. Interdimeric trans cleavage mecha-
nism establishes a positive feedback loop with important functional implications for
signaling: Auto-amplification of p43 allows a more pronounced switch between low
and high activity states. As a consequence, the caspase-8 network may promote sur-
vival upon weak transient cell death ligand expositions, while prolonged stimulation
efficiently triggers cell death. A delay in caspase-8 activation as a consequence of a
positive feedback may help to separate the apoptosis signal from the dynamics of
other CD95 dependent pathways involved in proliferation or cellular differentiation
(Figure 9.1) [173,188].
Recently, a study employing mass spectrometry of CD95 receptor immune-pre-
cipitates showed that after stimulation with LZ-CD95 the number of procaspase-
8 molecules exceeds the number of FADD molecules several-fold, interpreted as
chain formation of several procaspase-8 at single FADD molecules [36, 189]. In this
study the formation of such protein conglomerates was not explicitly included. This
simplification was introduced as this modeling study was mainly focused on effective
mechanisms of caspase-8 activation while neglecting the stoichiometric details of the
complexes. The simplified model of the DISC is justified, as DISC formation occurs
on a shorter time scale than the subsequent procaspase-8 autoprocessing [6].
Based on model fitting to a complex dataset, the kinetic parameters describing
caspase-8 autoprocessing could be reliably estimated, revealing that p43 efficiently
accumulates at the DISC, whereas p18 is highly unstable. Caspase-8 processing
Discussion
Figure 9.1. The ’cis/trans’ cleavage mechanism facilitates pathway branching. A
weak cell death stimulus generates low caspase-8 cleavage activity: Low numbers of
active DISCs generate low levels of p43 during weak feedback from p43. In this sit-
uation, p55 is rather processed via the inactive intermediate p30. Therefore, rather
non-apoptotic pathways can be activated by caspase-8, stimulating cell growth, ac-
tivation of the transcription factor NF-κB and cellular differentiation. A stronger
stimulus enhances production of the active intermediate p43 by causing stronger feed-
back therefore increasing the efficiency of procaspase-8 usage to generate an apoptosis
inducing cleavage activity.
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is thus mechanistically similar to procaspase-9 auto-activation at the apoptosome.
Apoptosome-bound procaspase-9 cleaves downstream substrates and cleaves itself to
caspase-9. After dissociation of caspase-9 the cleavage activity is lost, implying the
function as a ’molecular timer’, in which the cleavage probabilities control the active
time or the extent of cleavage activity [182, 183]. Here, procaspase-8 processing at
the DISC shows the same phenomenon of the stable intermediate enzyme p43 and
the unstable product p18. Accordingly, a previous study showed that the catalytic
activity of caspase-8 can be increased by mutating the prodomain cleavage sites
[87]: this prevents the conversion of the stable p43 intermediate into unstable p18,
alleviating the timer effect.
By systematic sensitivity analysis it could be demonstrated that signaling compo-
nents upstream of procaspase-8 such as cell death ligand, receptor and the adaptor
protein FADD primarily shape the cell death kinetics and variability. In contrast,
downstream species like procaspase-8 and BID rather influence the fraction of cells
surviving the cell death stimulus. Furthermore, survival by lacking caspase-8 ac-
tivity underlines that an ’efficient’ use of procaspase-8, employing p43 for cleaving
downstream substrates, is a requirement for apoptosis, as caspase-8 cleavage capac-
ity is limited due to rapid p18 inactivation. In summary, the multi-scale model
presented in this study, calibrating an ensemble of single cell models to observables
of a heterogeneous population of cells, represents an important conceptual advance
in the understanding of mechanisms involved in variable response of individual cells
to cell death stimuli.
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II
Cellular heterogeneity determined by variable
kinetic parameters: cell ensemble model of Epo
receptor traffic

This part describes a modeling study of Epo receptor traffic in single cells that was
based on experimental data recorded by confocal microscopy. The experiments that
were conducted for this purpose were carried out in collaboration with Anne-Lucia
Unger from the group of Prof. Dirk-Peter Herten (Institute for Physical Chemistry,
Heidelberg University).
10. Modeling EpoR receptor traffic
in single cells
In cells, external signals from ligands are transmitted by receptors to intracellular
signaling cascades. Receptor signaling is typically regulated by receptor internaliza-
tion and transport processes between the plasma membrane and other cellular com-
partments [190]. Internalization not only weakens the signal but was also shown to
enhance the accuracy of signaling [191]. The signal transduction by erythropoietin
receptors (EpoR) was shown to be strongly dependent on receptor internalization
kinetics [123]. A characteristic property of the EpoR system is that only a small
fraction of the total receptor amout is present at the membrane and can be acti-
vated by external ligands. The receptor signal is attenuated by rapid internalization
of active EpoR, which is followed by receptor inactivation [124]. While the traffic
and signaling of EpoR has been described in models that were based on population
data [123, 124], no study has quantified EpoR transport kinetics in single cells yet.
This part addresses an approach to characterize cell-to-cell variability in EpoR traf-
fic based on cell ensemble models that are calibrated with quantitative single cell
data.
In the model of caspase-8 activation (part I), the underlying biochemical reac-
tions could be explicitly described. Therefore, reaction kinetics was assumed to be
equal in different cells. Single cell models in the cell ensemble model were linked
by the boundary condition of equal kinetic parameters. Cellular variability was
explained by variable initial protein concentrations. In current models of Epo re-
ceptor signaling, the receptor transport processes were described by unimolecular
reactions, which are in fact dependent on several biochemical processes. Unimolecu-
lar reactions masked several processes involved in vesicle formation, the activation of
kinases and phosphatases [117], ubiquitinylation reactions [118], cargo protein and
cytoskeleton dependent processes, as the assembly of actin oligomers [192]. In the
current study, direct measures of EpoR concentrations in different cellular compart-
ments were recorded, and the heterogeneous behavior of different cells was described
by variable kinetic parameters.
In order to test several model hypotheses, an experimental setup was developed
to extract quantitative information of EpoR traffic in single cells by using confocal
Modeling EpoR receptor traffic in single cells
microscopy of GFP fused EpoR and Epo that was labeled with the fluorescent
inorganic dye Cy5.5 (section 10.1). To quantify receptor synthesis and degradation,
auxiliary experiments were performed to record GFP-EpoR synthesis after bleaching
and GFP-EpoR degradation after blocking its synthesis. In order to learn, which
processes are relevant for EpoR traffic in single cells, cell ensemble models were
constructed and calibrated with single cell data (section 10.2). An optimal model
could be selected, in which internalized active EpoR are directly recycled to the
plasma membrane and unbound Epo is accumulated inside the endocytic recycling
compartment. Analyzing the variability of kinetic parameters between cells showed
that cell-to-cell variability mostly originates from the processes of active receptor
internalization and receptor recycling (section10.3).
10.1. Quantification of EpoR traffic in single cells
An experimental setup was developed to quantify internalization and intracellular
transport of EpoR in single cells by confocal live cell imaging. These quantitative
single cell data were required to calibrate kinetic models of intracellular EpoR traffic.
The fusion protein of EpoR with the fluorescent protein GFP was used to image re-
ceptors. Epo labeled with the inorganic dye Cy5.5 was used to quantify the amount
of internalized ligand. Furthermore, a membrane marker protein fused to the fluo-
rescent protein mCherry was used to quantify the amount of EpoR at the plasma
membrane or near the plasma membrane.
Live-cell experiments For live-cell experiments, a cell line stably expressing EpoR-
GFP was used, which was derived from H838 lung adenocarcinoma cells. The cell
line was stably transfected with a plasmid encoding for a fusion protein consist-
ing of a myristoylation-palmitoylation domain and the fluorescent protein mCherry
(MyrPalm-mCh). This membrane marker was similar to the caspase-8 cleavage
probe described in chapter 7 (Figure 7.11) but without a cleavage site. In a sim-
ilar setup as described in part I, microscopic stack images were recorded (Figure
10.1). After the first time point was recorded, cells were treated with Epo-Cy5.5
at a concentration of 4.2nM corresponding to 10U/ml in enzyme activity units.
While EpoR was labeled with the fluorescent protein GFP, which is degraded to-
gether with EpoR, Epo was labeled with the inorganic dye Cy5.5, which cannot be
degraded by the cell. This combination of a degradable EpoR label with an non-
degradable label of Epo was chosen to improve estimates of intracellularly degraded
EpoR. Data was recorded for a total period of 6 hours. For each time point, an im-
age stack with 26 slices and a slice thickness of ∆z = 0.7µm was recorded to enclose
the whole cell volumes. In the first 30 minutes, a time interval of 5 minutes and
afterwards of 10 minutes was chosen, which resulted in 40 time points. To obtain
quantitative measurements of EpoR-GFP synthesis and degradation, further live-cell
experiments were conducted, which employed photobleaching and blocking protein
synthesis by the drug cycloheximide (CHX). A microscope appliance that was orig-
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Figure 10.1. Measurements of EpoR-GFP and Epo-Cy5.5 internalization in H838
cells. Single planes of 3D stack images are shown for different time points. Epo-Cy5.5
was added after the first recorded stack. The membrane ROI was defined from the
outer cell borders in MyrPalm-mCherry images as indicated by the white dotted line
at t = 0′.
inally designed for FRAP experiments (fluorescence recovery after photobleaching)
was used to bleach GFP in complete volumes of single cells. After recording the first
image stack, the laser pulse for photobleaching was applied. Then, new synthesis
and recovery of the fluorescent Epo-GFP signals was recorded for 6 hours as for Epo
treated cells.
Image segmentation A simple segmentation software was developed to semiau-
tomatically define regions of interest (ROIs) for subcellular compartments of the
cells within each image stack (Figure B.1), according to intensity threshold values
Ith,GFP , Ith,Cy5.5 and Ith,mCh. In each image with intensities Ic = Ic(xi, yj, zk) of a
cell at the height zk within an image stack of channel c, ROIs were defined for the
plasma membrane, the enclosed cytoplasmic volume and vesicles therein. Intensity
threshold values were manually determined by classifying multiple small image re-
gions as membrane, vesicle or background voxels, and choosing average intensity
values that separate between these regions. The outer border line of the area with
ImCh ≥ Ith,mCh, having a line width of three pixels, which corresponds to a width
of ≈ 1µm, was segmented to define the membrane ROI. In the plane of the con-
tact area between the plasma membrane and the specimen slide, the whole bottom
area of the cell with ImCh ≥ Ith,mCh was included to the membrane ROI. In the
volume enclosed by the membrane ROI, further ROIs were defined for EpoR-GFP
vesicles (IGFP ≥ Ith,GFP ), Epo-Cy5.5 vesicles (ICy5.5 ≥ Ith,Cy5.5) and vesicles, which
contained EpoR-GFP and Epo-Cy5.5 (IGFP ≥ Ith,GFP and ImCh ≥ Ith,mCh). Figure
10.2 shows a visualization of exemplary membrane and vesicle ROIs. For each subre-
gion, mean IGFP and ICy5.5 values were multiplied with ROI volumes and divided by
the total cell volumes to obtain measures that correspond to cellular concentrations.
The available set of single cell data comprised time-resolved measurements in
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Figure 10.2. Segmentation of ROIs for the plasma membrane (left), EpoR-GFP
vesicles (center) and vesicles containing EpoR-GFP and Epo-Cy5.5 (right).
10 Epo treated, 10 photobleached and 2 CHX treated cells. The complete set of
single cell data is shown together with model trajectories (Figure 10.6). Intensity
trajectories were linked to model variables describing cellular concentrations of EpoR
and Epo as described in the following section.
10.2. Model of EpoR traffic
To study the internalization of Epo and EpoR, the transport of Epo and EpoR
to endocytic recycling compartment and the intracellular traffic of EpoR in single
cells, different ODE models were developed and calibrated with single cell measure-
ments from confocal microscopic experiments. Model variants comprised ODEs for
different sets of intracellular transport reactions to determine, which reaction fluxes
effectively contribute to EpoR traffic. By model selection, a minimal model vari-
ant was identified, which contains components for EpoR recycling and intracellular
accumulation of internalized Epo.
The EpoR model variants, consisting of a basic model and variable extensions,
describe the two observed species, free EpoR and EpoR bound to Epo, in different
cellular compartments or at the plasma membrane. The basic model describes re-
versible binding of Epo to EpoR at the plasma membrane (EpoRm) and formation
of active EpoR (EpoR∗m) (Figure 10.3). In model reactions, free Epo is not depleted
by binding or increased by unbinding, as the amount of Epo in the medium largely
exceeds the total amount of EpoR and can therefore be assumed to be constant.
Epo receptors permanently cycle between the membrane pool (EpoRm) and the in-
tracellular pool (EpoRi). The intracellular pool of EpoR is subject to degradation
and refilled by synthesis. Active EpoR at the membrane EpoR∗m are internalized to
the endocytic recycling compartment (EpoR∗RE). The so far described reactions of
the basic model, visualized as black arrows in Figure 10.3, were extended by vari-
able parts A to D, which were formulated under the following premises: Internalized
Epo is unbound from EpoR and either released back into the cytosol (A and C) or
degraded and accumulated inside the cell (B and D) [123,124]. After the internaliza-
tion of active EpoR, receptors can recycle back to the plasma membrane (A and B)
or are degraded (C and D) [124, 193]. From the endocytic recycling compartment,
110
10.2. Model of EpoR traffic
Figure 10.3. Model of EpoR traffic. A basic model (black arrows) can be extended
by variable parts A to D.
receptors can be recycled via path A directly to the membrane (EpoRm) or via B to
the intracellular pool (EpoRi). Following path A, ’consumed’ Epo is released to the
plasma membrane with EpoR and leaves the cell, while path B leads to accumulation
of inactivated Epo (Epodeg,i) inside the cell. By appending variable combinations of
parts A to D to the basic model, the 16 possible model variants were formulated.
For all model variants, cell ensemble models were constructed, similar as in the
caspase-8 activation model (part I), which consisted of independent sets of ODEs
for each described cell, and were linked by certain boundary conditions. An ensem-
ble model consisted of single cell models for Epo internalizing cells, and auxiliary
models for photobleached and CHX treated cells. One single cell model describing
an Epo treated cell contained 6 ODEs and between 7 and 11 parameters (Tables
10.1 and 10.2). Auxiliary models of photobleached cells contained a subset of reac-
tions describing only synthesis, degradation, shuttling of EpoR between the plasma
membrane and the intracellular pool and an additional reaction on the effect of
photobleaching (Table B.1). The auxiliary model for CHX treated cells, in which
synthesis was inhibited, consisted of ODEs describing EpoR degradation and shut-
tling between the plasma membrane and the intracellular pool of EpoR (Table B.1).
Models of photobleached cells consisted of 3 ODEs with 5 kinetic parameters, models
of CHX treated cells contained 3 ODEs with 3 kinetic parameters.
The parameters for Epo binding and unbinding, kEpo,on and kEpo,off were defined
as being equal for each single cell model. All other kinetic parameters were allowed
to vary between cells. Therefore, an ensemble model containing the complete avail-
able dataset of 10 Epo treated, 10 photobleached, and 2 CHX treated cells comprised
between 106 and 146 kinetic parameters, scaling factors for the GFP and Cy5.5 mi-
croscope channels, and initial concentrations [EpoRm](t0) and [EpoRi](t0) resulting
111
Modeling EpoR receptor traffic in single cells
reaction rates
v1 = kon,Epo[EpoRm][Epo]
v2 = koff,Epo[EpoR∗m]
v3 = kEpoR,ItoM [EpoRi]
v4 = kEpoR,MtoI [EpoRm]
v5 = kEpoR∗RE ,MtoRE[EpoR
∗
m]
v7 = ksyn
v8 = kdeg[EpoRi]
vA = kEpoR∗RE ,REtoM [EpoR
∗
RE]
vB = kEpoR∗RE ,REtoI [EpoR
∗
RE]
vC = kEpoR∗RE ,deg,REtoEx[EpoR
∗
RE]
vD = kEpoR∗RE ,deg,REtoI [EpoR
∗
RE]
Table 10.1. Reaction rates for variants of the EpoR traffic model with variable parts
A to D.
differential equations
basic model A B C D
d[EpoRm]
dt
= −v1 + v2 + v3 − v4 +vA
d[EpoR∗m]
dt
= v1 − v2 − v5
d[EpoR∗RE ]
dt
= v5 −vA −vB −vC −vD
d[EpoRi]
dt
= −v3 + v4 + v7 − v8 +vB
d[EpoRdeg ]
dt
= v8 +vC +vD
d[Epodeg ]
dt
= 0 +vB +vD
Table 10.2. Equations of the EpoR traffic model variants. The variable terms for A
to D can be included or set to zero.
112
10.2. Model of EpoR traffic
IGFP,mem ∼ sGFP ([EpoRm] + [EpoR∗m])
IGFP,ves ∼ sGFP [EpoRi]
IGFP&Cy5.5,ves ∼ sGFP [EpoR∗RE]
ICy5.5,mem ∼ sCy5.5[EpoR∗m]
ICy5.5,ves ∼ sCy5.5 ([EpoR∗RE] + [Epodeg])
Table 10.3. Links between experimental quantities and model variables
in a total number of 152 to 192 parameters, which were estimated by model fitting.
To exactly estimate the scaling factor between normalized fluorescence intensities
in cellular compartment ROIs and absolute receptor amounts, average EpoR lev-
els were determined by a calibrated western blot. Cell lysates of certain numbers
of cells were blotted together with known amounts of recombinant GFP. The cali-
brated western blot and image stack segmentations showed that each cell contained
on average 145.000 receptors and had a mean volume of about 6.97pl, which resulted
in an average cellular concentration of [EpoR]tot = 34.5nM .
Variability between cells was introduced by differences in kinetic parameters. In
the EpoR model, these parameter variability reflected differences in initial concen-
trations of not observable signaling species, which are involved in vesicle formation
and transport processes, different degrees of posttranslational modifications of sig-
naling proteins and differences in spatial distributions of cellular compartments due
to the individual cellular architecture. It was assumed that processes involving a low
number of unknown processes, show less variability, and complex processes, which
involve several reactions and a high degree of spatial organization, are highly vari-
able between cells. Section 10.3 will describe an attempt to obtain insights into the
complexity of not observable processes, which can be mechanistically described as
’bundled’ uni-molecular reactions but cause cell-to-cell variability.
Model fitting
For model fitting, the experimental quantities were linked to model variable for free
and Epo bound EpoR at different cellular compartments, thus defining single cell
residuals that were minimized by the parameter estimation procedure. Furthermore,
the residual function was extended by penalty terms to assure the same means
and variabilities of kinetic parameters for groups of cells that underwent different
experimental treatments.
Table 10.3 shows the relations between experimental quantities IGFP and ICy5.5,
the fluorescence intensities of EpoR-GFP and Epo-Cy5.5, in different cellular com-
partments and the corresponding model variables, multiplied by scaling factors sGFP
or sCy5.5, respectively.
To improve the accuracy of parameter estimations, and restrict the model to
physiologically reasonable parameter ranges, single cell models of Epo internalizing
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cells were combined with auxiliary single cell models. These comprised models of
cells, in which EpoR synthesis could be observed after photobleaching, and models
of cells, in which EpoR degradation could be quantified after inhibiting synthesis
by CHX treatment. As the cells from the same cell line were treated with Epo,
photobleaching or CHX, the single cell models for each experimental setting had to
account for the same means and variabilities of kinetic parameters. To implement
this physiological boundary condition in the parameter fitting procedure, the resid-
ual function, which contained the single cell residuals Rsc, had to be extended by
two penalty terms for deviations between distributions of kinetic parameters ki in
cell populations from different experiments.
R = Rsc +Rm +RV arK (10.1)
The first term in Equation 10.1
Rsc =
∑
i,j,n
y˜jn(ti)− yjn(~k, ~x0, ~s, ti)
ijn
contains deviations between experimental data y˜jn(ti) of cell n and experimental
quantity j, and the corresponding model observables yjn(~k, ~x0, ~s, ti), which are func-
tions of the estimated kinetic parameters ~k, initial concentrations ~x0 and scaling
factors ~s, weighted by experimental errors εijn. The next term
Rm =
∑
s
Ns
∑
i,s
k¯i − k¯is
k¯i
(10.2)
penalizes for differences between mean kinetic parameter values k¯is in cells of
experimental set s, and the overall mean kinetic parameter value k¯i. The deviations
were weighted by the total number of cells ∑
s
Ns in all included experimental subsets
in accordance to the number of cells contributing to the term for single cell residuals
Rsc. This penalty term contained contributions for parameters kItoM , kMtoI and
kdeg for all three included experimental subsets, and additionally the contribution
for ksyn between the subset for Epo treated and photobleached cells. Another term
RV arK =
∑
s
Ns
∑
i,s
V arK(ki)− V arK(kis)
V arK(ki)
(10.3)
was introduced to penalize deviations of coefficients of variation V arK(kis) in subsets
s from mean coefficients of variation V arK(ki) for all involved subsets. As the subset
of CHX treated cells was too small, only deviations of V arK(kis) between Epo
and photobleaching treated cells were taken into account for parameter estimations.
Again, the term RV arK was multiplied by the number of cells
∑
s
Ns. The squared
residual function was minimized for parameter estimations.
This procedure could successfully adjust the means and variabilities of kinetic
parameters in the experimental subsets of cells and improved parameter estimations
as described in the following paragraphs.
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Figure 10.4. Selection of the optimal model variant ’AD’. The basic model with
components A and D had the lowest AICcorr value. ∆AICcorr values calculated
relative to the the ’AD’ variant indicate that the second- and third-best variants, ’A’
and ’ACD’, have significantly higher AICcorr values (’AD’ vs. ’A’ with p = 6.61 ·10−8,
’AD’ vs. ’ACD’ with p = 0.013).
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Model selection
The cell ensemble model variants were fitted to experimental data to select the
minimal topology that explains the data sufficiently well and to exclude irrelevant
reactions. The corrected Akaike information criterion (AICcorr, Equation 2.17) was
used for this purpose. The AIC penalizes for the number of model parameters in
order to prefer a model variant if it can explain the experimental data equally well
compared to a larger model with additional reactions. Figure 10.4 shows differences
∆AICcorr for all model variants relative to the optimal variant ’AD’ that contained
components A for recycling and D for EpoR degradation. Further extending the
variant ’AD’ did not increase the fit quality and can therefore be neglected. Figures
10.5 and 10.6 show model fits of the variant ’AD’ to the complete set of experimental
data. Model predictions of single cell concentrations of EpoRm, EpoRi, EpoR∗m and
EpoR∗RE are shown in Figure 10.7.
The model variant confirms assumptions of earlier population based models,
which similarly described the direct EpoR recycling to the plasma membrane to-
gether with exocytosis of degraded Epo [123,124]. In contrast, reactions for receptor
degradation inside the cell together with exocytosis of intracellular Epo, which were
included in the study of Becker et al. [124], did not substantially contribute to EpoR
traffic in single cells. After degradation of EpoR∗RE, the internalized Epo-Cy5.5 was
rather accumulated inside cells. Analyzing reaction fluxes, however, showed that
the flux for intracellular EpoR degradation and Epo-Cy5.5 accumulation was rela-
tively small compared to the flux of recycling reactions (Figure 10.8). Flux analysis
furthermore shows that about half of the internalized receptors were recycled to
the plasma membrane, while only a small receptor fraction was degraded. Reaction
fluxes in different cells varied approximately by a factor of ten implying that the
consumption of Epo and the signal strength strongly differs between cells. After
adding Epo, nearly all EpoR at the plasma membrane are quickly bound to Epo.
The transport from the intracellular pool of EpoR (EpoRi) to the plasma mem-
brane can compensate for the internalization of Epo-bound EpoR (EpoR∗m), which
results in approximately constant total EpoR levels in the membrane ROI. Fluxes
for EpoR recycling (FEpoR∗,REtoM in Figure 10.8) reach similar magnitudes as fluxes
of unoccupied EpoR from the intracellular pool to the plasma membrane (FItoM).
The cell-to-cell variability of kinetic parameters will be addressed in section 10.3.
Consequences of the boundary conditions for parameter estimations It was
tested to which extent estimates of the kinetic parameters ksyn and kdeg were in-
fluenced by merging single cell models of Epo treated cells with single cell models
of photobleached and CHX treated cells, which were included to obtain more accu-
rate insights into EpoR synthesis and degradation. To this end, model fits of the
’AD’ variant, using the modified residual function described in Equation 10.1, were
compared with model fits without using additional penalty terms that adjust for
differences in kinetic parameter means and variabilities between cells of different
experimental settings. It was found that without additional penalty terms, ksyn es-
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Figure 10.5. Fits of the basic model with components A and D to data from Epo
internalizing cells (n = 10).
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Figure 10.6. Fits of the basic model with components A and D to data from n = 10
FRAP treated cells (A), and n = 2 cycloheximide (CHX) treated cells (B).
timates are changed on average by 29% and kdeg estimates by 57%, which indicates
that the modified residual function successfully adjusts estimates of these parameters
between different experimental settings.
Figure 10.9. Coefficients
of variation for parameter esti-
mates. Small circles indicate
VarKs for Epo treated model
cells.
In order to evaluate the accuracy of kinetic parameter estimates in single cells,
coefficients of variation for kinetic parameters in Epo internalizing cells were calcu-
lated from the best 2% of n = 500 model fits of the variant ’AD’ to the complete
set of experimental data (Figure 10.9). In most of the parameters the coefficients of
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Figure 10.7. Predictions in Epo internalizing model cells of the ’AD’ variant. Lines
represent the means and shaded areas standard deviations of 1% best of n = 500 fits
(EpoRm: membrane bound EpoR, EpoRi: intracellular EpoR, EpoR∗m: Epo bound
EpoR at the plasma membrane, EpoR∗RE : Epo bound EpoR in the endocytic recycling
compartment).
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Figure 10.8. Predictions of EpoR fluxes in Epo internalizing model cells of the
’AD’ variant. Half of the internalized EpoR∗ is recycled while only small frac-
tions are degraded (lines: means, shaded areas: standard deviations of 1% best of
n = 500 fits, F syn: EpoR synthesis, Fdeg: degradation, FItoM ,FMtoI : from intra-
cellular pool to plasma membrane and reverse, FEpo,on,FEpo,off : Epo binding and
unbinding, FEpoR∗,MtoI : internalization of Epo bound EpoR, FEpoR∗,REtoM : recycling,
FEpoR∗,REtoI : degradation from endocytic recycling compartment).
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variation were smaller than 0.3, indicating that the 1σ confidence intervals deviated
less than 30% from the mean parameter values. Similarly, coefficients of variation
were calculated for kinetic parameter estimates of ’AD’ model that was fitted to
a reduced set of experimental data. Thereby, it should be tested to which extent
the combination of data from Epo internalizing cells with auxiliary data from pho-
tobleached and CHX treated cells can improve parameter estimations. To this end,
differences between the coefficients of variation ∆V arK(kin) for the parameters ki
in cells n were calculated to compare model fits to the complete dataset with model
fits to the reduced set of experimental data. As shown in Figure 10.10, reducing
the ensemble model by leaving out single cell models of photobleached and CHX
treated cells increases the confidence intervals for parameter estimates in most cells,
which is indicated by positive ∆V arK values (red dots). Furthermore, coefficients of
variation were calculated for the same kinetic parameters estimated with the largest
model variant ’ABCD’. Figure 10.10 shows V arK(kin) differences between the ’AD’
and the ’ABCD’ variants (blue dots), which indicate that using the smaller model
variant clearly improves the accuracy of kinetic parameter estimates.
Figure 10.10. VarK changes
in Epo treated model cells de-
pendent on the training dataset
and model size. Parameters
can be estimated more accu-
rately by combining data from
Epo treated with data from
FRAP or CHX treated cells
(red dots), and by model sim-
plification from ’ABCD’ to ’AD’
(blue dots). The 2% best of
n = 500 fits were taken into ac-
count, respectively.
In summary, a minimal model variant could be selected, which includes reactions
for direct recycling of internalized Epo-bound EpoR (EpoR∗RE) from the endocytic
recycling compartment to the plasma membrane, and intracellular accumulation of
Epo-Cy5.5 after degradation of internalized Epo-bound EpoR. In general, intracel-
lular EpoR traffic in single cells can be sufficiently well described implying similar
model assumptions as in studies that were based on population data but varies by
an order of magnitude between cells (Figures 10.7 and 10.8). Combining single cell
models of Epo internalizing cells with auxiliary models based on experiments focused
on EpoR synthesis and degradation increased the accuracy of parameter estimations.
Using a modified residual function to adjust means and variabilities of kinetic param-
eters between single cell models that were based on different experiments adapted
the cell ensemble model to physiologically reasonable conditions.
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10.3. Cell-to-cell variability in EpoR traffic
A central motivation of this study was to test if the kinetics observed on the level
of population average data can be transferred to the single cell level, and to which
degree EpoR transport kinetics varies between cells. It was found that Epo-bound
EpoR at the membrane (EpoR∗m) and in the endosomal recycling compartment
(EpoR∗RE) approximate constant levels after the first two hours and that these con-
stant levels strongly vary between cells.
After having assured that kinetic parameters could be determined with reasonable
accuracy, the variability of kinetic parameters between different cells was analyzed.
Interestingly, coefficients of variation of all single cell kinetic parameters had values
around 0.5 besides the parameter kEpoR∗RE ,deg,REtoI describing intracellular degrada-
tion of Epo-bound EpoR, a process, which had the smallest reaction fluxes (Figure
10.11). Kinetic parameter estimates show that EpoR traffic in single cells is a highly
dynamic and variable process. Estimates of ksyn shows that EpoR is produced at a
very high rate of around 4000 proteins per minute, implying its fast turnover, which
could be already noticed in photobleaching and CHX experiments. Epo treated cells
consumed between 200 and 2000 Epo molecules per minute. From the amount of
2000 to 2 · 104 EpoR at the plasma membrane about one tenth is exchanged per
minute with the intracellular pool of EpoR. Correlations between the kinetic model
parameters for different cells were in general not significant besides a significant cor-
relation between ksyn and kdeg (Table B.2). Some unsignificant positive correlations
could be observed between kinetic parameters describing vesicle transport processes.
However, no clear interrelations between the velocities of different model reactions
were found.
Figure 10.11. Best fit parame-
ters of Epo internalizing model
cells and coefficients of varia-
tion. VarKs values were around
0.5 for all but the smallest ki-
netic parameter (kEpoR∗,REtoI).
The parameter unit for ksyn is
nM/min and 1/min for all other
parameters.
Next, it was tested to which extent different receptor traffic processes account for
the variable EpoR dynamics. So far, all kinetic parameters besides the parameters
kEpo,on and kEpo,off were variable in single cell models of the cell ensemble model.
Iteratively, different kinetic parameters were fixed to global values for all included
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cells while the other parameters were allowed to have individual values. The cor-
rected Akaike information criterion (AICcorr) was used to assess if fixing a certain
parameter to a global value for all cells causes significant deterioration of the model.
For the model variant ’AD’, all possible combinations for fixing kinetic parameters
to global values were tested. To account for different initial concentrations of EpoR
in cells, the parameter ksyn was allowed to be variable for different cells in every
case, which leads to 64 different model variants with different possible combinations
of global kinetic parameters.
To obtain a ’parameter ranking’, Figure 10.12 visualizes differences in AICcorr be-
tween the model variant, in which all kinetic parameters besides kEpo,on and kEpo,off
were individually estimated in different cells (top) and all other model variants with
global kinetic parameters. The ∆AICcorr values for each model variant are shown
as colors of squares, and abbreviated names of parameters defined as being equal for
all single cell models are listed below squares for each variant, respectively. Starting
from the model, in which all parameters besides ksyn are equal for all cells (bot-
tom), in each successive row one of the global kinetic parameters is allowed to vary
between cells. The path of maximal AICcorr changes, starting for the maximally
restricted model version, is indicated by blue lines in Figure 10.12. The sequence, in
which the smallest improvements in AICcorr are gained is indicated by red lines. In
this sequence, changes in parameter restrictions, which cause the strongest model
improvements, occur at the end. This sequence
kEpoR∗RE ,deg,REtoI → kdeg → kEpoR,MtoI
→ kEpoR,ItoM → kEpoR∗RE ,REtoM → kEpoR∗RE ,MtoRE
suggestest a ranking of parameters, which have the strongest capacity for explain-
ing cell-to-cell variability. The strongest deteriorations in AICcorr can be observed
for fixing the two parameters for internalization of Epo-bound EpoR (kEpoR∗m,MtoRE)
and EpoR recycling (kEpoR∗RE ,REtoM), and for additionally fixing the parameter for
transport of free EpoR to the plasma membrane (kEpoR,ItoM). This suggests that
the processes of EpoR∗m internalization, EpoR recycling and transport to the plasma
membrane have the strongest impact on cell-to-cell variability in EpoR dynamics.
Fixing other parameters as kdeg or kEpoR,MtoI in the model variant, in which other
kinetic parameters were defined as variable, causes weak changes in AICcorr but still
slightly deteriorate the model.
In summary, an experimental setup could be developed to quantify EpoR trans-
port in single cells and analyze cellular heterogeneity in Epo consumption, EpoR
transport and recycling based on mathematical models. A minimal model variant
was selected, which reliably explains the EpoR transport dynamics in a heteroge-
neous ensemble of cells. Kinetic parameter estimates in different cells showed that
processes of EpoR transport, recycling, synthesis and degradation are variable to
similar extent, indicated by coefficients of variation around 0.5. The kinetics of
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Figure 10.12. Decreases in AICcorr by restricting the variability of kinetic param-
eters. For model variants, AICcorr differences to the variant, in which all kinetic
parameters were variable, are indicated by colors (best fit of n = 100 fits per variant),
and abbreviated names of parameters defined as being equal for all ensemble model
cells are listed below colored boxes, respectively. Links were drawn between variants,
in which one additional parameter was defined as equal or variable between cells. Red
lines indicate the path of minimal and blue lines for maximal AICcorr changes from
the most restricted variant (bottom) to the least restricted variant (top).
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EpoR synthesis and internalization, Epo consumption and receptor recycling varied
between cells by an order of magnitude. For comparison, the cell ensemble model
of caspase-8 activation described in part I could explain the variable behavior of
different cells sufficiently well by assuming equal kinetic parameters but individual
initial concentrations for all cells. In the caspase-8 activation model, the described
biochemical reactions were sufficiently simple, and it can be assumed that all in-
volved signaling species were known and included in the model. Contrarily, in the
EpoR system, model reactions summarize the kinetics of a complex interplay of sev-
eral processes, which are involved in vesicle transport and functions of the endocytic
recycling compartment. A cell ensemble model consisting of single cell models that
were similar to population data based models could explain the variable behavior
of a group of cells sufficiently well by assuming variable kinetic parameters. An
approach to rank kinetic parameters according to their capacity of explaining cell
to cell variability showed that model parameters on EpoR∗ internalization, EpoR
recycling and transport to the plasma membrane explain most of the cell-to-cell
variability.
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10.3. Cell-to-cell variability in EpoR traffic
This thesis presents a new approach for describing biochemical signal transduction
networks in heterogeneous cell populations by cell ensemble models. These models
consist of sets of ordinary differential equations for each included cell. Single cell
models of the ensemble are linked by boundary conditions that assure compliance
with physiological limitations. The approach allows merging experimental data from
single cells and population average data to combine information of different qualities.
Merging single cell and population data could be shown to facilitate discrimination
between different hypotheses on underlying biochemical mechanisms (chapter 7) and
increase the accuracy of parameter estimations (chapter 10).
The approach was applied in two biochemical systems, the initiation of extrinsic
apoptosis by activation of caspase-8 (part I) and the intracellular transport of ery-
thropoietin receptors (EpoR) (part II). As described in chapter 4 of part I, a new
method was developed to quantify protease enzyme activities in single cells based on
confocal microscopy of compartmentalized cleavage probes. A large set of single cell
data was recorded from two cell lines, HeLa wt and death receptor overexpressing
HeLa cells, stimulated with different doses of cell death ligand. The dataset was
enriched by population data, using the conventional method of western blots, which
was the basis of earlier apoptosis models (chapter 5). An interesting phenomenon
was detected with regard to receptor oligomerization: At extremely high ligand
concentrations apoptosis was decelerated. This non-intuitive phenomenon could be
explained by mathematical models based on ordinary differential equations that
could be analytically solved (chapter 6). With regard to the molecular mechanism
of caspase-8 activation, complementary hypotheses on the described in the literature
were implemented in different kinetic cell ensemble models, and a minimal model
variant was selected, which indicated that CD95 receptor clustering is required for
the initiation of apoptosis (chapter 7). In particular, the model predicted differ-
ent cleavage mechanisms of two cleavage sites in procaspase-8, which establish a
positive feedback mechanism that contributes to a controlled cell death initiation.
While the prodomain cleavage site was cleaved by an intramolecular (’cis’) mecha-
nism, an interdimeric (’trans’) cleavage mechanism was predicted for cleavage of the
enzymatic domain cleavage site in procaspase-8. The model could be experimentally
verified by cleavage probes containing prodomain or enzymatic domain cleavage se-
quences. The identified ’cis/trans’ mechanism supports ’pathway branching’: at
weak ligand concentrations, procaspase-8 is consumed without inducing an effective
cleavage activity towards apoptosis inducing substrates, which inhibits apoptosis,
while non-apoptotic signaling pathways of death receptors can be sustained. At in-
creasing ligand concentrations, the production of active caspase-8 intermediates is
strongly accelerated to initialize cell death. An analogy could be drawn between the
activation process of caspase-8 and the related enzyme caspase-9, which is activated
at protein complexes denoted as apoptosomes. In both enzymes, the final product,
caspase-8/p18 or caspase-9 is short-lived after being separated from the activating
protein complex, compared to a more stable intermediate form, which causes most of
the integrated cleavage activity of the enzyme. This principle, denoted as ’molecular
timer’, assures the efficient use of procaspase-8 or procaspase-9 to cleave downstream
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signaling proteins and allows rapid termination of the response after removal of the
cell death stimulus.
The experimental data was explained by a multivariate log-normal joint distribu-
tion of initial protein concentrations and threshold concentrations of the signaling
protein tBID, which were sufficient for inducing apoptosis (8). Thereby, functional
roles of signaling proteins could be characterized. While signaling proteins upstream
of caspase-8 control the timing and the variability of programmed cell death, down-
stream signaling proteins control the survival of cells. In this context, the model can
be used to predict cell death in a heterogeneous population of cells under various
experimental conditions. The model might be used to predict the effects of co-drugs
for cancer chemotherapy, which impact on the distributions of initial protein concen-
trations of pro-apoptotic proteins and lower tBID thresholds that are sufficient for
apoptosis, in order to quantitatively optimize therapeutic drug concentrations and
concentration trajectories.
A second cell ensemble model was formulated to study cell-to-cell variability
in intracellular traffic of erythropoietin receptors (EpoR). An experimental setup
was developed to quantitatively measure the internalization of fluorescently labeled
erythropoietin (Epo) in cell that express EpoR fused to the fluorescent protein GFP.
Contrary to the model of apoptosis initiation (part II), initial concentrations of all
included model species could be directly determined from experimental data, but
model reactions had to be described by variable kinetic parameters. Whereas, in
the caspase-8 activation model all signaling species were known and included in
the model, intracellular transport reactions in the EpoR model summarized several
non-observable processes involved in vesicle traffic. A cell ensemble model, which
simultaneously described data from Epo internalizing cells and data from auxiliary
experiments on EpoR synthesis and degradation, could explain the heterogeneous
kinetics of different cells by variable kinetic parameters. Reaction fluxes showed
that EpoR turnover an transport kinetics differed by an order of magnitude between
cells. By systematically restricting the degrees of freedom of the model it could be
demonstrated that a subset of kinetic parameters, which describe the internalization
of Epo-bound EpoR, receptor recycling and transport of free EpoR to the plasma
membrane accounts for most of the variability between cells.
In the future, characterizing the variable response kinetics of cells based on model
predictions might support the optimization of therapeutically used cytokines as Epo
or interferons in targeted cell populations. In the context of cell-to-cell variability of
initial protein concentrations and intracellular signaling processes one is reminded
of the problem of fractional killing by chemotherapies: while applying a certain
chemotherapeutic protocol stimulates apoptosis in a fraction of cancer cells, the sur-
viving fraction will continue dividing. Characterizing the variability of initial protein
concentrations in a tumor cell population combined with mathematical modeling
might facilitate the eradication of a heterogeneous population of cancer cells.
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A. Additional material on the cell
ensemble model of apoptosis
A.1. Additional figures
Figure A.1. Schematic representation of model variants. The enzymatic domain
sites and the prodomain sites are potentially cleaved in cis, in trans or both in cis
and trans leading to nine alternative model topologies. The full topology, in which
both sites are cleaved in cis and trans can be iteratively simplified to four minimal
topologies, in which only two cleavage modes are possible. The variants surrounded
by boxes were fitted to experimental data.
Models with different prodomain site cleavage constants for p55 and p43 have
only slight improvements in fit quality In the initial formulation of the ’cis/cis’
model variant, a single kinetic constant was assumed for both prodomain cleavage
reactions (p55→p30 and p43→p18) and one for enzymatic domain cleavage reactions
(p55→p43 and p30→p18). The inability of this model to fit the data may be due to
an oversimplification: faster cis prodomain cleavage from p43 to p18 than from p55
to p30 may be expected, because the active center of p43 is constantly open after
cleavage of the enzymatic domain. Therefore an extended ’cis/cis’ variant with two
Additional material on the cell ensemble model of apoptosis
Figure A.2. Fit qualities of extended ’cis/cis’ and ’cis/trans’ model variants. Cis
cleavage of p43 to p18 could be faster than cis cleavage of p55 to p30. Alterna-
tively both reactions could have equal speed as the same site is cleaved. Therefore,
cis cleavage of the prodomain site can be described with either different or equal ki-
netic constants for cleavage reactions from p55 to p30 (kprodomain,p55) and from p43
(kprodomain,p43) to p18. This hypothesis was tested in the rejected ’cis/cis’ topology
and the ’cis/trans’ topology, which was the best fitting smallest model variant. As in-
dicated by χ2/N values for the best fits models with unequal constants do not improve
fit quality substantially compared to models with equal parameters.
different prodomain cleavage parameters for the reactions p55→p30 and p43→p18
was implemented, and its ability to fit the data was tested. However, this model
extension did not improve fit quality (Figure A.2). Therefore, also a pure cis model
topology with separate cleavage constants for the two prodomain cleavage reactions
is not capable in explaining experimental data and can therefore be ruled out.
Simulations to predict effects of initial concentration changes originating at
different ligand concentrations To further illustrate functional roles of signaling
protein species at different ligand concentrations, changes in cell death medians
and coefficients of variation due to two-fold changes in initial concentrations were
calculated, originating at different ligand levels (Figures A.3 and A.4). For this
purpose, effects of increases from to times the original initial concentrations were
determined. Simulations showed that the cell-to-cell variability and the speed of
cell death are strongly dependent on levels of the death ligand, death receptors and
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FADD. Due to inverse bell-shaped active receptor profiles, the influence of cell death
ligand and receptor level fold changes on cell death timing and variability can be
small or large, dependent on initial ligand levels. It was shown, that overexpression of
an apoptotic signaling protein can increase its influence on cell death variability [95].
Here, the contrary phenomenon, that receptor overexpression causes the cell death
variability of CD95-HeLa cells to be less sensitive towards CD95R level changes,
could be observed.
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Figure A.3. ’cis/trans’ model predictions in HeLa wt cells on effects of fold changes
in initial protein concentrations. For estimations from each of the best 1% of n =
1000 fits, hundred sets of initial protein concentrations were randomly sampled from
multivariate joint distributions of estimated initial levels for CD95 receptors, FADD,
p55 and BID, as well as tBID thresholds. (A) Effects in HeLa wt cells of two-fold
increases in initial protein concentrations on median cell death times originating from
ligand concentrations used in single cell experiments. Bars represent effects of two-
fold changes around the origin at one. In HeLa wt cells, amounts of CD95 receptors
represent a bottleneck for cell death kinetics as indicated by strong changes of median
cell death times dependent on receptor level fold-changes. (B) Effects of two-fold
increases in initial protein concentrations on coefficients of variation of cell death
times. (C) Predicted fold change trajectories of coefficients of variation of apoptosis
times. Effects of fold changes between on tenth and ten times of the initial protein
concentrations were simulated. Error bars in panels (A) and (B) and shaded areas in
panel (C) show standard deviations from the best 1% of n = 1000 fits.
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Figure A.4. ’cis/trans’ model predictions in CD95-HeLa cells on effects of fold
changes in initial protein concentrations as in Figure A.3. (A) Effects of two-fold
increases in initial protein concentrations on median cell death times originating from
ligand concentrations used in single cell experiments. The strong influence of receptor
levels in HeLa wt cells is completely lost in CD95-HeLa cells, in which changes in
all involved proteins have similar effects on cell death timing. (B) Effects of two-fold
increases in initial protein concentrations on coefficients of variation of cell death times.
(C) Predicted fold change trajectories of coefficients of variation of apoptosis times as
in Figure A.3.
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A.2. Model equations and kinetic parameters
reaction rates
v1 = kon,FADD[CD95active][FADD]
v2 = koff,FADD[DISC]
v3 = kon,p55[DISC][p55]
v4 = kcl,D216,cis[DISC_p55]
v5 = kcl,D216,trans,p55[DISC_p55]
([DISC_p55] + [p30])
v6 = kcl,D216,trans,p43[DISC_p55][p43]
v7 = kcl,D374,cis[DISC_p55]
v8 = kcl,D374,trans,p55[DISC_p55]
([DISC_p55] + [p30])
v9 = kcl,D374,trans,p43[DISC_p55][p43]
v10 = kcl,D374,cis[p30]
v11 = kcl,D374,trans,p55[p30]
([DISC_p55] + [p30])
v12 = kcl,D374,trans,p43[p30][p43]
v13 = kcl,D216,cis[p43]
v14 = kcl,D216,trans,p55[p43]
([DISC_p55] + [p30])
v15 = kcl,D216,trans,p43[p43]2
v16 = kp18,inactive[p18]
v17 = kcl,BID[BID] ([p43] + [p18])
v18 = kcl,probe[PrERF1][p18]
v19 = kcl,probe[PrcplF2] ([p43] + [p18])
Table A.1. Reaction rates in ’cis+trans/cis+trans’ and ’cis/trans’ model variants.
differential equations
’cis+trans/cis+trans’
differential equations
’cis/trans’
d[CD95active]
dt
= −v1 + v2 (1) d[CD95active]dt = −v1 + v2 (1)
d[FADD]
dt
= −v1 + v2 (2) d[FADD]dt = −v1 + v2 (2)
d[p55]
dt
= −v3 (3) d[p55]dt = −v3 (3)
d[DISC]
dt
= v1 − v2 + v10 + v11
+v12 + v13 + v14 + v15
(4) d[DISC]
dt
= v1− v2 + v11 + v12 + v13 (4)
d[DISC_p55]
dt
= v3 − v4 − v5 − v6
−v7 − v8 + v9 (5)
d[DISC_p55]
dt
= v3 − v4 − v8 + v9 (5)
d[p30]
dt
= v4+v5+v6−v10−v11−v12 (6) d[p30]dt = v4 − v11 − v12 (6)
d[p43]
dt
= v7+v8+v9−v13−v14−v15 (7) d[p43]dt = v8 + v9 − v13 (7)
d[p18]
dt
= v10 + v11 + v12 + v13
+v14 + v15 − v16 (8)
d[p18]
dt
= v11 + v12 + v13 − v16 (8)
d[tBID]
dt
= v17 (9) d[tBID]dt = v17 (9)
d[PrER]
dt
= v18 (10) d[PrER]dt = v18 (10)
d[Prcpl]
dt
= v19 (11) d[Prcpl]dt = v19 (11)
Table A.2. Equations of the model variants ’cis+trans/cis+trans’ and ’cis/trans’.
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parameter value ofbest fit mean ±σ
kon,FADD [1/min] 8.12 · 10−4 0.00276± 0.00175 (±63.4%)
koff,FADD [1/min] 0.00567 0.00940± 0.0107 (±114%)
kon,p55 [1/min] 4.92 · 10−4 4.04 · 10−4 ± 9.53 · 10−5 (±23.6)
kcl,D216 (prodomain) [1/min] 0.0114 0.0110± 8.82 · 10−4(±8.01%)
kcl,D374 (enc. domain),trans,p55
[nM/min] 4.47 · 10
−4 4.39 · 10−4 ± 2.49 · 10−4 (±56.7)
kcl,D374 (enc. domain),trans,p43
[nM/min] 0.00344 0.00333± 4.58 · 10
−4 (±13.7)
kp18,inactive [1/min] 0.0950 0.0943± 0.00694 (±7.36)
kcl,BID [nM/min] 5.29 · 10−4 5.29 · 10−4 ± 6.28 · 10−5 (±11.9%)
kcl,probe (nM/min) 0.00152 0.00157± 0.0147 (±9.35%)
KD,R (nM) 8.98 196± 145 (±73.8)
KD,L [nM ] 15.4 55.2± 26.1 (±47.2
scaspase−8 [nM/min] 0.00149 0.00153± 1.46 · 10−4 (±9.51%)
sPr,mCherry [nM ] 0.0173 0.0144± 0.00212 (±14.7)
sPr,mGFP [nM ] 0.00350 0.00350± 4.24 · 10−4 (±12.1%)
Table A.3. Parameters of the fitted ’cis/trans’ model. Values of the 1% best of
n=1000 fits to single cell and western blot data (CD95-HeLa and HeLa wt cells) were
included for means and standard deviations.
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A.3. Flux analysis in caspase-8 cleavage model
variants
Figure A.5. Reaction fluxes for the ‘cis/trans’ topology (prodomain site cleavage in
cis, enzymatic domain cleavage in trans) as in Figure 7.8. Integrated reaction fluxes
for procaspase-8 cleavage are shown in panel (A) for CD95-HeLa and in panel (C) for
HeLa wt cells. Panels (B) and (D) show fractions of initial p55 levels that are processed
within the different cleavage reactions. Similar as in the ‘cis+trans/cis+trans’ variant,
trans cleavage of p55 by p43 is the reaction, in which the largest p55 fractions are
cleaved. Solid lines in panels (A) and (C) represent mean trajectories from the best
1% of 1000 fits to the complete set of single cell and population data, respectively.
Shaded areas (A and C) and error bars (B and D) represent standard deviations of
these fits.
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Figure A.6. Reaction fluxes for the ‘trans/trans’ topology (prodomain site and
enzymatic domain site cleavages in trans) as in Figure A.5. Integrated reaction fluxes
for procaspase-8 cleavage are shown in panel (A) for CD95-HeLa and in panel (C)
for HeLa wt cells. Panels (B) and (D) show fractions of initial p55 levels that are
processed within the different cleavage reactions.
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Figure A.7. Comparison between model estimates of protein half-lives τ1/2 between
the ‘trans/trans’ and the ‘cis+trans/cis+trans’ model variants for CD95-HeLa and
HeLa wt cells as in Figure 7.10. Both variants show very similar half-life estimates
for p55 and p30, but differ in predicted half-life times for p43 and p18. Notably, the
‘trans/trans’ variant predicts much larger half-life times for p18, meaning that p18
is rarely inactivated before the time of apoptosis of CD95-HeLa and HeLa wt cells.
Solid lines represent mean trajectories and shaded areas represent standard deviations
from the best 1% of 1000 fits to the complete set of single cell and population data,
respectively.
A.4. Quantification of total signaling protein numbers
Absolute signaling protein concentrations and their variability were determined by
quantitative western blotting and flow cytometry based assays in order to further
constrain the mathematical model of caspase-8 processing.
Estimates of average protein levels of FADD, procaspase-8 and BID in probe ex-
pressing cells were obtained by calibrated western blots (Table 5.1). The order of
samples was shuﬄed to avoid biases from gel and blotting inhomogeneities [170]. Cell
lines stably expressing FADD-GFP or p55-GFP were generated from HeLa wt cells.
The same cell line was used to transiently express BID-GFP-mCherry. The concen-
trations of FADD-GFP, p55-GFP and BID-GFP-mCherry in fusion protein lysates
were estimated by simultaneously blotting fusion protein lysates together with dif-
ferent doses of recombinant GFP. Endogenous levels of FADD, p55, BID and cytoso-
lic cleavage probes (NES-GIETDS-mCherry) were determined by blotting different
doses of fusion protein lysates together with lysates of probe expressing CD95-HeLa
and HeLa wt cells (Figures A.10-A.12). For ER probe (Calnexin-GIETDS-mGFP)
level estimations, lysates of probe expressing cell lines were blotted together with
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recombinant GFP (Figure A.12). Estimates of FADD and p55 had the same order
of magnitude as in the study of Fricker et al. [46] (NFADD ≈ 200.000/cell compared
to 130.000/cell, and Np55 ≈ 320.000/cell compared to 250.000/cell). Here, FADD
and p55 levels of similar magnitude in probe expressing CD95-HeLa and HeLa wt
cells were measured.
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Figure A.8. Caspase-8 western blot time series were used to generate population
observables for model fitting. (A-C) Exemplary western blots from experiments in
CD95-HeLa cells at 50ng/ml and 500ng/ml. For each data point included in model
fitting three replicates were measured. Intensities of every band were background
corrected and normalized to the sum of all caspase-8 bands (p55/53, p43/41, p30 and
p18), respectively. Western blots are shown with original orders of lines (left plots)
and sorted according to time points and experiments (right plots). An unspecific band
is marked by a star. (D) Background corrected and normalized intensities for p55 and
p43 were used for model fitting at times before cells started to undergo apoptosis (until
80′ at [CD95L] = 50ng/ml and until 50′ at [CD95L] = 500ng/ml), and if at least
three replicates were recorded. Time points included for model fitting are displayed
as solid squares and not included time points as empty squares (error bars: standard
error of the mean). (E) Background corrected and normalized intensities for p30 and
p18 as in (D).
Figure A.9. BID and tBID western blot time series served as population observables
for model fitting. (A-C) As for caspase-8, for each time point included in model
fitting three replicates were measured in CD95-HeLa cells at 50ng/ml and 500ng/ml.
Intensities of every band were background corrected and normalized to the sum of BID
and tBID, respectively. (D) As for caspase-8, background subtracted and normalized
intensities were used for model fitting before the first cells underwent apoptosis, and if
at least three replicates were available to estimate experimental errors (solid squares:
time points included for model fitting, empty squares: not included data points).
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CD95R-HeLa HeLa
Vˆcell (c. i.) in fl 3585 (3457, 3717) 4236 (3903, 4597)
c(u5%, u95%) (2554, 5031) (2751, 6521)
Vˆcpl (c. i.) in fl 2515 (2413, 2622) 2980 (2722, 3263)
c(u5%, u95%) (1705, 3711) (1845, 4813)
Aˆcell (c. i.) in µm2 1475 (1424, 1527) 1404 (1314, 1501)
c(u5%, u95%) (1063, 2046) (988, 1995)
Iˆ0(Pr, cpl) (c. i.) in A.U. 54,46 (51.09, 58.05) 61.68 (58.41, 65.15)
c(u5%, u95%) (29.95, 99.02) (46.24, 82.29)
Iˆ0(Pr,ER) (c. i.) in A.U. 34.88 (33.77, 36.03) 22.21 (19.59, 25.17)
c(u5%, u95%) (25.77, 47.21) (11.46, 43.04)
Table A.4. Cellular and cytosolic volumes, cell surface areas and average fluores-
cence intensities for the cytosolic and the ER-anchored cleavage probes were obtained
by segmentation from confocal microscopy image stacks. Median values, confidence
intervals for the median estimates, and percentiles of the lognormal distributions are
given in brackets.
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Figure A.10. Estimation of average FADD and p55 levels in probe expressing CD95-
HeLa and HeLa wt cells by calibrated western blot. (A) Blotting FADD-GFP and
p55-GFP together with doses of recombinant GFP served to estimate concentrations of
FADD and p55 fusions (B). (C, D) To estimate FADD levels, FADD-GFP lysate doses
were blotted together with 5µl or 15µl of lysates from probe expressing CD95-HeLa
and HeLa wt cells. In panel (C) a part between 30kDa and 50kDa was cut out. (E, F)
p55 levels were estimated by simultaneously blotting p55-GFP with lysates from probe
expressing cells. Intensities were background corrected. Values in brackets indicate
oversaturated bands that were excluded from evaluations.
Figure A.11. Estimation of average BID levels in probe expressing CD95-HeLa and
HeLa wt cells (A, B) BID-GFP-mCherry levels were calibrated by blotting together
with doses of recombinant GFP. (C, D) BID levels in probe expressing CD95-HeLa and
HeLa wt cells were estimated by blotting together with FADD-GFP lysates. White
lines indicate that intervening lanes were cut out.
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Figure A.12. Estimation of average cleavage probe levels in probe expressing CD95-
HeLa and HeLa wt cells. (A, B) Levels of ER anchored probes (Calnexin-GIETDS-
GFP) could be directly estimated by blotting together with recombinant GFP (B).
BID-GFP-mCherry, expressed in HeLa wt cells, was calibrated with recombinant GFP
to estimate cytosolic probe (NES-GIETDS-mCherry) levels (abbreviations: caln - cal-
nexin, mCh - mCherry). Values in brackets indicate oversaturated bands that were
excluded from evaluations. Bands for ER probes were evaluated despite signs of
oversaturation as it was sufficient to estimate lower boundaries of expression levels
(NERprobes ≥ 8 · 106/cell). (C, D) To estimate cytosolic probe levels, probe express-
ing cell lysates were blotted together with BID-GFP-mCherry lysate. In panel (C)
intervening lanes were spliced out.
A.5. Using flow cytometry to estimate receptor levels
and set upper and lower boundaries for initial
concentrations
Mean levels of CD95 receptors and variability of CD95 receptors, FADD, p55 and
BID were determined in probe expressing or not probe expressing HeLa wt and
CD95-HeLa cells by immunostaining followed by flow cytometry (Figures A.13 and
A.14). The absolute concentration of CD95 receptors was estimated with help of
calibration beads carrying defined epitope numbers for secondary antibodies (Table
5.2, Figure A.13). FACS distributions were used to restrict the variability of initial
protein concentrations in the model to physiologically reasonable levels. To measure
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initial concentrations
variability of protein levels independent from cell size, FACS events were filtered for
cells of similar volumes by gating for narrow front scatter and side scatter intervals.
As controls in FACS measurements, cells were treated with secondary but no primary
antibodies. To correct intensity measurements for background fluorescence, medi-
ans of normal distribution function fits to intensities of control measurements were
subtracted. The lognormal distribution parameters µ and σ for initial concentration
distributions were determined by fitting to rescaled and background corrected FACS
signals. In order to restrict initial protein concentrations in the model, 5% and 95%
percentiles were calculated and combined with mean signals from western blots to
set lower and upper limit for parameter fitting, respectively (Table 5.3).
Coefficients of variation in the range of V arK = 0.8 . . . 1.1 were obtained, which
are rather large compared to studies on the variability of protein levels [171, 172],
probably due to additional variability from intracellular antibody staining and FACS
measurements. For this reason, the obtained 5% percentiles were used as lower
and 95% percentiles as upper allowed boundaries for estimations of initial protein
concentrations in each cell. Cellular volumes that were used to calculate average
protein concentrations from protein numbers per cell as well as surface areas were
determined by segmentation from confocal microscopic image stacks (Table A.4).
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Figure A.13. Flow cytometry of cells immunostained for CD95 receptors. (A)
To estimate average levels of membrane bound receptors, beads with five different
numbers of epitopes for fluorescence labeled secondary antibodies were used. Thereby,
the FACS signal representing the common logarithm of fluorescence intensity plus
background was rescaled. In not probe expressing HeLa wt (B) or CD95-HeLa (C),
and probe expressing HeLa (D) or CD95-HeLa (E) cells, receptor levels were estimated
by fitting normal distribution functions (’fits’) and subtracting background signals of
control measurements (’ctr’).
Figure A.14. Flow cytometry of cells immunostained for p55, FADD and BID.
Native HeLa wt (A-C) and CD95-HeLa (D-F), as well as probe expressing HeLa (G-I)
and CD95-HeLa cells (J-L) were stained for p55 (left column), FADD (central column)
and BID (right column). Normal distribution functions were fitted to cells stained with
primary antibodies and control measurements.
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Additional material on the cell ensemble model of Epo receptor traffic
Figure B.1. GUI of the segmentation software. Three windows display EpoR-GFP
(left), MyrPalm-mCherry (center) and Epo-Cy5.5 (right) images and segmented ROIs.
Inside predefined areas for single cells, membrane and vesicle ROIs (containing EpoR-
GFP, Epo-Cy5.5 or EpoR-GFP and Epo-Cy5.5) are segmented according to intensity
threshold values to determine ROI volumes and mean EpoR-GFP and Epo-Cy5.5
intensities for each time point. ROI borders can be manually corrected. Background
ROIs are manually selected to determine background GFP and Cy5.5 intensity values
that are subtracted from intensities in cellular ROIs (light blue area in left image
window).
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v1 = kEpoR,ItoM [EpoRi]
v2 = kEpoR,MtoI [EpoRm]
v3 = ksyn
v4 = kdeg[EpoRi]
v5 = kFRAP ([EpoRm] + [EpoRi])θ(t− ton)θ(toff − t)
differential equations, auxiliary
models
photobleached cells CHX treated cells
d[EpoRm]
dt
= v1 − v2 − v5 d[EpoRm]dt = v1 − v2
d[EpoRi]
dt
= −v1 + v2 + v3 − v4 − v5 d[EpoRi]dt = −v1 + v2 − v4
d[EpoRdeg ]
dt
= v4 d[EpoRdeg ]dt = v4
Table B.1. Reaction rates and equations of the auxiliary EpoR traffic model variants.
In photobleached cells, a short FRAP pulse was applied to decrease the total amount
of GFP fused EpoR, implemented by the kinetic constant kFRAP and Heaviside func-
tions describing the pulse between ton and toff . Auxiliary models of photobleached
cells were implemented to independently estimate the variable kinetics of EpoR-GFP
synthesis in single cells. In cycloheximide (CHX) treated cells new synthesis of EpoR
was inhibited to quantify the variable degradation kinetics in single cells.
kItoM kMtoI ksyn kdeg k∗MtoRE k∗REtoM k∗REtoI
kItoM -0,04 0,60 0,05 0,61 0,31 -0,48
kMtoI -0,04 0,28 0,16 -0,11 0,47 -0,39
ksyn 0,60 0,28 0,70 0,60 0,55 -0,46
kdeg 0,05 0,16 0,70 0,17 0,16 0,06
k∗MtoRE 0,61 -0,11 0,60 0,17 0,22 -0,28
k∗REtoM 0,31 0,47 0,55 0,16 0,22 -0,56
k∗REtoI -0,48 -0,39 -0,46 0,06 -0,28 -0,56
Table B.2. Correlation coefficients for kinetic parameters of Epo internalizing cells.
The only significant correlation was the positive correlation between ksyn and kdeg
(p = 0.024).
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